10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

þQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

or

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________________ to __________________________

Commission File Number 001-31921

Compass Minerals International, Inc.

(Exact name of registrant as specified in its charter)

Delaware	36-3972986
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

9900 West 109th Street

Suite 100

Overland Park, KS 66210

(913) 344-9200

(Address of principal executive offices, zip code and telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.            

Yes: þ     No:  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes: þ     No:  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ	Accelerated filer ¨	Non-accelerated filer ¨	Smaller reporting company ¨
			Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes: ¨     No: þ

The number of shares outstanding of the registrant’s common stock, $0.01 par value per share, as of October 27, 2017, was 33,827,501 shares.

COMPASS MINERALS INTERNATIONAL, INC.

TABLE OF CONTENTS

		Page
	PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements
	Consolidated Balance Sheets as of September 30, 2017, (unaudited) and December 31, 2016	2
	Consolidated Statements of Operations for the three and nine months ended September 30, 2017, and 2016 (unaudited)	3
	Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2017, and 2016 (unaudited)	4
	Consolidated Statement of Stockholders’ Equity for the nine months ended September 30, 2017 (unaudited)	5
	Consolidated Statements of Cash Flows for the nine months ended September 30, 2017, and 2016 (unaudited)	6
	Notes to Consolidated Financial Statements (unaudited)	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	34
Item 4.	Controls and Procedures	34
	PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	35
Item 1A.	Risk Factors	35
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 3.	Defaults Upon Senior Securities	35
Item 4.	Mine Safety Disclosures	35
Item 5.	Other Information	35
Item 6.	Exhibits	35
SIGNATURES		36
EXHIBIT INDEX		37

1

PART I. FINANCIAL INFORMATION

Item 1.    Financial Statements

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

	(Unaudited)
	September 30, 2017			December 31, 2016
ASSETS
Current assets:
Cash and cash equivalents	$	39.1		$	77.4
Receivables, less allowance for doubtful accounts of $10.9in 2017 and $9.0 in 2016	209.6			320.9
Inventories	336.0			280.6
Other	47.4			36.1
Total current assets	632.1			715.0
Property, plant and equipment, net	1,140.0			1,092.3
Intangible assets, net	150.9			157.6
Goodwill	421.6			412.2
Investment in equity investee	24.7			24.9
Other	77.5			64.5
Total assets	$	2,446.8		$	2,466.5
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt	$	55.4		$	130.2
Accounts payable	94.6			100.8
Accrued expenses	70.2			105.3
Accrued salaries and wages	25.5			22.6
Income taxes payable	—			4.4
Accrued interest	5.3			8.7
Total current liabilities	251.0			372.0
Long-term debt, net of current portion	1,274.2			1,194.8
Deferred income taxes, net	123.7			130.8
Other noncurrent liabilities	49.9			51.8
Commitments and contingencies (Note 8)
Stockholders’ equity:
Common stock: $0.01 par value, 200,000,000 authorized shares; 35,367,264 issued shares	0.4			0.4
Additional paid-in capital	101.2			97.1
Treasury stock, at cost — 1,540,418 shares at September 30, 2017, and 1,577,960 shares at December 31, 2016	(2.9		)	(3.0		)
Retained earnings	701.3			727.5
Accumulated other comprehensive loss	(52.0		)	(104.9		)
Total stockholders’ equity	748.0			717.1
Total liabilities and stockholders’ equity	$	2,446.8		$	2,466.5

The accompanying notes are an integral part of the consolidated financial statements.

2

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in millions, except share and per share data)

	Three Months Ended September 30,					Nine Months Ended September 30,
	2017			2016		2017			2016
Sales	$	290.7		$	179.6	$	906.5		$	694.8
Shipping and handling cost	45.5			38.4		179.8			164.9
Product cost	169.1			96.0		524.1			340.8
Gross profit	76.1			45.2		202.6			189.1
Selling, general and administrative expenses	44.7			25.7		123.8			79.8
Operating earnings	31.4			19.5		78.8			109.3
Other expense (income):
Interest expense	13.5			5.4		39.5			16.8
Net (earnings) loss in equity investee	(0.4		)	0.4		(0.6		)	1.7
Other, net	(1.2		)	1.5		0.5			1.6
Earnings before income taxes	19.5			12.2		39.4			89.2
Income tax (benefit) expense	(12.5		)	3.1		(7.7		)	24.1
Net earnings	$	32.0		$	9.1	$	47.1		$	65.1
Basic net earnings per common share	$	0.94		$	0.27	$	1.38		$	1.92
Diluted net earnings per common share	$	0.94		$	0.27	$	1.38		$	1.92
Weighted-average common shares outstanding (in thousands):
Basic	33,825			33,786		33,817			33,772
Diluted	33,825			33,789		33,817			33,775
Cash dividends per share	$	0.72		$	0.695	$	2.16		$	2.085

The accompanying notes are an integral part of the consolidated financial statements.

3

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited, in millions)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
Net earnings	$	32.0		$	9.1		$	47.1		$	65.1
Other comprehensive income (loss):
Unrealized gain from change in pension obligations, net of tax of $(0.0) in both the three and nine months ended September 30, 2017, and 2016.	—			—			0.2			0.2
Unrealized (loss) gain on cash flow hedges, net of tax of $0.4 and $0.9 in the three and nine months ended September 30, 2017, respectively, and $0.0 and $(0.8) in the three and nine months ended September 30, 2016, respectively.	(0.7		)	(0.1		)	(1.6		)	1.3
Cumulative translation adjustment	46.1			(3.9		)	54.3			27.2
Comprehensive income	$	77.4		$	5.1		$	100.0		$	93.8

The accompanying notes are an integral part of the consolidated financial statements.

4

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

For the nine months ended September 30, 2017

(Unaudited, in millions)

	Common Stock		Additional Paid-In Capital			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Loss			Total
Balance, December 31, 2016	$	0.4	$	97.1		$	(3.0	)	$	727.5		$	(104.9	)	$	717.1
Comprehensive income									47.1			52.9			100.0
Dividends on common stock			0.1						(73.3		)				(73.2		)
Shares issued for stock units			(0.1		)	0.1									—
Stock options exercised			0.3												0.3
Stock-based compensation			3.8												3.8
Balance, September 30, 2017	$	0.4	$	101.2		$	(2.9	)	$	701.3		$	(52.0	)	$	748.0

The accompanying notes are an integral part of the consolidated financial statements.

5

COMPASS MINERALS INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in millions)

	Nine Months Ended September 30,
	2017			2016
Cash flows from operating activities:
Net earnings	$	47.1		$	65.1
Adjustments to reconcile net earnings to net cash flows provided by operating activities:
Depreciation, depletion and amortization	89.1			62.7
Finance fee amortization	1.7			1.0
Early extinguishment of debt	—			0.1
Stock-based compensation	3.8			3.8
Deferred income taxes	(11.9		)	(4.5		)
Net (earnings) loss in equity method investee	(0.6		)	1.7
Gain on settlement of acquisition-related contingent consideration	(1.9		)	—
Other, net	(1.7		)	0.5
Changes in operating assets and liabilities:
Receivables	116.6			33.6
Inventories	(49.0		)	3.1
Other assets	(20.2		)	(12.8		)
Accounts payable and accrued expenses	(46.1		)	(46.6		)
Other liabilities	(0.2		)	(0.6		)
Net cash provided by operating activities	126.7			107.1
Cash flows from investing activities:
Capital expenditures	(81.0		)	(148.7		)
Investment in equity method investee	—			(4.7		)
Other, net	(3.8		)	(2.9		)
Net cash used in investing activities	(84.8		)	(156.3		)
Cash flows from financing activities:
Proceeds from revolving credit facility borrowings	183.5			264.9
Principal payments on revolving credit facility borrowings	(137.9		)	(147.4		)
Proceeds from issuance of long-term debt	52.9			850.0
Principal payments on long-term debt	(95.6		)	(474.5		)
Acquisition-related contingent consideration payment	(12.8		)	—
Dividends paid	(73.3		)	(70.5		)
Fees paid to refinance debt	(0.1		)	(1.5		)
Deferred financing costs	(0.7		)	(5.8		)
Proceeds received from stock option exercises	0.3			0.7
Excess tax benefit (deficiency) from equity compensation awards	—			(0.2		)
Other, net	1.0			—
Net cash (used in) provided by financing activities	(82.7		)	415.7
Effect of exchange rate changes on cash and cash equivalents	2.5			7.3
Net change in cash and cash equivalents	(38.3		)	373.8
Cash and cash equivalents, beginning of the year	77.4			58.4
Cash and cash equivalents, end of period	$	39.1		$	432.2

Supplemental cash flow information:
Interest paid, net of amounts capitalized	$	33.5	$	18.6
Income taxes paid, net of refunds	$	22.9	$	54.0

The accompanying notes are an integral part of the consolidated financial statements.

6

COMPASS MINERALS INTERNATIONAL, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Accounting Policies and Basis of Presentation:

Compass Minerals International, Inc. (“CMI”), through its subsidiaries (collectively, the “Company”), is a leading producer of essential minerals that solve nature’s challenges, including salt for winter roadway safety and other consumer, industrial and agricultural uses, specialty plant nutrition minerals that improve the quality and yield of crops, and specialty chemicals for water treatment and other industrial processes. The Company’s principal products are salt, consisting of sodium chloride and magnesium chloride, sulfate of potash (“SOP”), various micronutrient products, and specialty chemicals for water treatment and other industrial processes. The Company’s production sites are located in the United States (“U.S.”), Canada, Brazil and the United Kingdom (the “U.K.”). Except where otherwise noted, references to North America include only the continental U.S. and Canada, and references to the U.K. include only England, Scotland and Wales. References to “Compass Minerals,” “our,” “us” and “we” refer to CMI and its consolidated subsidiaries. The Company also provides records management services to businesses located in the U.K. In October 2016, the Company acquired Produquímica Indústria e Comércio S.A. (“Produquímica”), which operates two primary businesses in Brazil – agricultural productivity and chemical solutions.

CMI is a holding company with no significant operations other than those of its wholly-owned subsidiaries. The consolidated financial statements include the accounts of CMI and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

The Company uses the equity method of accounting for equity securities when it has significant influence or when it has more than a minor ownership interest or more than minor influence over an investee’s operations but does not have a controlling financial interest. Initial investments are recorded at cost (including certain transaction costs) and are adjusted by the Company’s share of the investees’ undistributed earnings and losses.

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2016, as filed with the Securities and Exchange Commission in its Annual Report on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments considered necessary for a fair presentation, have been included.

The Company experiences a substantial amount of seasonality in its sales with respect to its deicing salt products. As a result, sales and operating income are generally higher in the first and fourth quarters and lower during the second and third quarters of each year. In particular, sales of highway and consumer deicing salt and magnesium chloride products vary based on the severity of the winter conditions in areas where the products are used. Following industry practice in North America and the U.K., the Company seeks to stockpile sufficient quantities of deicing salt throughout the second, third and fourth quarters to meet the estimated requirements for the upcoming winter season. Production of deicing salt can also vary based on the severity or mildness of the preceding winter season. Due to the seasonal nature of the deicing product lines, operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.

The Company’s plant nutrition business is also seasonal. For example, the strongest demand for the Company’s plant nutrition products in Brazil typically occurs during the spring planting season. As a result, the Company and its customers generally build inventories during the low demand periods of the year to ensure timely product availability during the peak sales season. The seasonality of this demand results in the Company’s sales volumes and net sales for the Plant Nutrition South America segment usually being the highest during the third and fourth quarters of each year (as the spring planting season begins in September in Brazil).

Recent Accounting Pronouncements

In January 2017, the Financial Accounting Standards Board (the “FASB”) issued guidance to simplify the accounting for goodwill impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance will remain largely unchanged. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted

7

for annual and interim goodwill impairment testing dates after January 1, 2017. The Company plans to early adopt the guidance for its 2017 impairment testing.

In August 2016, the FASB issued guidance to clarify how certain cash receipts and payments should be presented and classified in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements.

In June 2016, the FASB issued guidance for estimating credit losses on certain types of financial instruments, including trade receivables, by introducing an approach based on expected losses. The expected loss approach will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, requires a modified retrospective transition method and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements.

In March 2016, the FASB issued guidance to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company adopted this guidance in the first quarter of 2017 on a prospective basis, and prior periods have not been adjusted. The Company elected the option available under the new guidance to continue to estimate the effect of forfeitures in the calculation of share-based payment expense. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In February 2016, the FASB issued guidance which requires lessees to recognize on their balance sheet a right-of-use asset which represents a lessee’s right to use the underlying asset. Under this guidance, an entity must also recognize a lease liability which represents a lessee’s obligation to make lease payments for the right to use the asset. In addition, the standard requires expanded qualitative and quantitative disclosures. The guidance is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and requires a modified retrospective transition method. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements.

In July 2015, the FASB issued guidance that requires entities to measure inventory within the scope of the standard at the lower of cost or net realizable value. “Net realizable value” is defined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company adopted this guidance in the first quarter of 2017. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In May 2014, the FASB issued guidance to provide a single, comprehensive revenue recognition model for all contracts with customers. The new revenue recognition model supersedes existing revenue recognition guidance and requires revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration an entity expects to receive in exchange for those goods or services. The guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those years, and early adoption is permitted. The guidance permits the use of either a full or modified retrospective transition method. The Company plans to use the modified retrospective transition method. While the Company has not identified any material differences in the amount and timing of revenue recognition for the revenue streams management has reviewed to date, the Company is still evaluating the impact of this guidance and has not concluded on the overall impact of adopting this guidance. Adoption of this guidance will significantly impact the Company’s financial statement disclosures regarding revenue.

2. Acquisition:

Background and Financing

On December 16, 2015, Compass Minerals do Brasil Ltda., a wholly owned subsidiary of the Company (“Compass Minerals Brazil”), entered into (i) a subscription agreement and other covenants (as amended, the “Subscription Agreement”) with certain shareholders of Produquímica and Produquímica and (ii) a share purchase and sale agreement and other covenants (the “Purchase Agreement”) with certain shareholders of Produquímica and Produquímica. Pursuant to the Subscription Agreement and the Purchase Agreement, Compass Minerals Brazil acquired 35% of the issued and outstanding capital stock of Produquímica on December 23, 2015, for R$452.4 million Brazilian Reais (“R” or “BRL”), or $114.1 million U.S. dollars at closing, and paid additional consideration of $4.7 million in the second quarter of 2016 related to Produquímica’s 2015 financial performance.

The Subscription Agreement also contained a put right (the “Put”), allowing the Produquímica shareholders to sell the remainder of their interests in Produquímica to Compass Minerals Brazil. On August 12, 2016, Produquímica shareholders notified Compass

8

Minerals Brazil of their exercise of the Put. On October 3, 2016, the Company acquired the remaining 65% of the issued and outstanding capital stock of Produquímica.

The Company entered into a new $100.0 million term loan tranche in the fourth quarter of 2015 to fund the acquisition of the 35% of Produquímica’s equity. In September 2016, the Company entered into a new $450.0 million term loan tranche to fund the acquisition of the remaining 65% of Produquímica’s equity. See Note 7 for more information regarding these financings.

Based in São Paulo, Brazil, Produquímica operates two primary businesses – agricultural productivity and chemical solutions. The agricultural productivity division manufactures and distributes a broad offering of specialty plant nutrition solution-based products. These include micronutrients, controlled release fertilizers and other specialty supplements that are used in direct soil and foliar applications, as well as through irrigation systems and for seed treatment. Many of these products are developed through Produquímica’s research and development capabilities. Produquímica also manufactures and markets specialty chemicals used primarily in the industrial chemical and water treatment industries in Brazil. The acquisition broadens the Company’s geographic scope of operations and expands its specialty plant nutrition portfolio while reducing the Company’s dependence on winter weather conditions.

Purchase Price Allocation

The Company accounted for the Produquímica acquisition as a business combination in accordance with U.S. GAAP. The accounting guidance for business combinations requires estimates and judgments regarding expectations for future cash flows of the acquired entity as well as other valuation assumptions and an allocation to the net assets acquired. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s best estimates. As of September 30, 2017, the purchase price allocation was finalized.

A summary of the acquisition-date fair value of the consideration transferred is presented in the table below:

Fair Value of Consideration Transferred (in millions)	October 3, 2016
Cash paid at closing	$	317.1
Additional cash due at closing	20.6
Fair value of contingent consideration	31.4
Fair value of 35% equity investment	178.7
Total	$	547.8

The calculation of the purchase price at closing was based in part on an estimate of full-year 2016 operating results of Produquímica. As of the acquisition closing date, some of the periods included in the 2016 operating results of Produquímica had not ended and actual results were not known. The portion of the purchase price which was based on management’s estimate of results relating to periods which occurred after the closing date was classified as contingent consideration. There were no thresholds or tiers in the payment structure, and management used an income approach to estimate the acquisition date fair value of the contingent consideration. As of the closing date, the Company had estimated the fair value of contingent consideration to be $31.4 million.

During the first quarter of 2017, the purchase price was adjusted based on the final full-year 2016 operating results of Produquímica, and a final payment was made to the Produquímica shareholders. The difference between the estimated closing date fair value of the contingent consideration and the final amount paid resulted in the recognition of a gain of $1.9 million in the first quarter of 2017, which was included as a component of operating earnings in the Company’s Plant Nutrition South America segment.

Prior to the acquisition closing date, the Company accounted for its 35% interest in Produquímica as an equity method investment. The acquisition-date fair value of the previously held equity investment was $178.7 million and is included in the consideration transferred. To measure the acquisition closing date fair value of the equity interest, the Company utilized a market-based approach which relied on Level 3 inputs (see Note 12 for a discussion of the levels in the fair value hierarchy). The Company recognized a $59.3 million non-cash gain during the fourth quarter of 2016 as a result of remeasuring its prior equity interest in Produquímica held before the business combination.

Under the acquisition method of accounting, the total purchase price is allocated on a preliminary basis to Produquímica’s assets and liabilities based upon their estimated fair value as of the closing date of the acquisition. During the first nine months of 2017, the Company adjusted the preliminary purchase price allocation based on additional information obtained regarding facts and circumstances which existed as of the acquisition date. These adjustments resulted in a decrease of $3.6 million to goodwill, a decrease of $4.4 million to other noncurrent liabilities and an increase of $0.8 million to net deferred income taxes. Additionally,

9

during the third quarter of 2017 in connection with finalizing the accounting for the acquisition, the Company recorded an adjustment increasing depreciation expense by $1.9 million. This adjustment resulted from finalizing the Company’s estimate of the useful lives of acquired tangible assets.

Based upon the final purchase price and the updated valuation, the final purchase price allocation is presented in the table below:

Recognized amounts of identifiable assets acquired and liabilities assumed (in millions):	Purchase Price Allocation
Cash and cash equivalents	$	73.8
Accounts receivable	89.4
Inventory	77.1
Other current assets	13.7
Property, plant and equipment	189.4
Identified intangible assets	81.2
Investment in equity method investee	24.5
Other noncurrent assets	6.9
Accounts payable	(27.1		)
Accrued expenses	(40.3		)
Current portion of long-term debt	(129.6		)
Other current liabilities	(14.0		)
Long-term debt, net of current portion	(62.0		)
Deferred income taxes, net	(66.0		)
Other noncurrent liabilities	(21.9		)
Total identifiable net assets	195.1
Goodwill	352.7
Total fair value of business combination	$	547.8

The total purchase price in excess of the net identifiable assets has been recognized as goodwill in the amount of $352.7 million and has been assigned to the Company’s new Plant Nutrition South America segment. The goodwill recognized is attributable primarily to expected synergies with the Company’s existing plant nutrition business and the assembled workforce of Produquímica. The future deductibility of the goodwill for income tax purposes is uncertain at this time.

The Company determined that the book value of the accounts receivables included in the purchase price allocation approximates their fair value due to their short-term nature. The gross contractual amounts of the receivables exceeded their fair value by the amount of an allowance for doubtful accounts of approximately $8 million.

In connection with the acquisition, the Company acquired identifiable intangible assets which consisted principally of trade names, developed technologies and customer relationships. The fair values were determined using Level 3 inputs (see Note 12 for a discussion of the levels in the fair value hierarchy). The fair values of the identifiable intangible assets were estimated using an income approach method.

The estimated fair values and weighted average amortization period of the identifiable intangible assets are presented in the table below:

	Estimated Fair Value (in millions)		Weighted-Average Amortization Period (in years)
Trade names	$	36.9	11.0
Developed technology	37.5		5.3
Customer relationships	6.8		13.5
Total identifiable intangible assets	$	81.2	8.6

10

Impact on Operating Results

During the three and nine months ended September 30, 2017, Produquímica contributed revenues of $123.2 million and $250.6 million, respectively, and net earnings of $29.5 million and $20.7 million, respectively, to the Company.

The following table presents combined unaudited pro forma results for the three and nine months ended September 30, 2016. The pro forma financial information combines the historical results of operations for Produquímica and Compass Minerals as though the acquisition occurred on January 1, 2015. The pro forma information does not purport to represent the actual results of operations that Produquímica and Compass Minerals would have achieved had the companies been combined during the periods presented nor is the information intended to project the future results of operations. Certain adjustments to Produquímica’s historical results have been made to conform to U.S. GAAP and amounts have been translated to U.S. dollars.

Unaudited Combined Pro Forma Results of Operations (in millions)	Three Months Ended September 30, 2016		Nine Months Ended September 30, 2016
Revenues	$	289.7	$	938.1
Net earnings	18.5		68.7

Significant adjustments to the pro forma information above include:

• Adjustments to exclude non-recurring direct incremental costs of the acquisition;

• Adjustments to expenses relating to the financing transactions described above;

• Adjustments to reflect incremental amortization and depreciation from the preliminary allocation of the purchase price;

• Adjustments to reflect certain income tax effects of the acquisition; and

• Adjustments to remove net earnings related to the previously held 35% equity interest in Produquímica.

3. Inventories:

Inventories consist of the following (in millions):

	September 30, 2017		December 31, 2016
Finished goods	$	260.3	$	206.1
Raw materials and supplies	75.7		74.5
Total inventories	$	336.0	$	280.6

4. Property, Plant and Equipment, Net:

Property, plant and equipment, net, consists of the following (in millions):

	September 30, 2017			December 31, 2016
Land, buildings and structures, and leasehold improvements	$	507.6		$	480.1
Machinery and equipment	914.9			848.2
Office furniture and equipment	51.5			28.3
Mineral interests	173.1			168.5
Construction in progress	267.2			243.6
	1,914.3			1,768.7
Less accumulated depreciation and depletion	(774.3		)	(676.4		)
Property, plant and equipment, net	$	1,140.0		$	1,092.3

5. Goodwill and Intangible Assets, Net:

Aggregate amortization expense for the Company’s finite-lived intangible assets was $4.1 million and $1.1 million in the third quarters of 2017 and 2016, respectively, and $12.2 million and $3.2 million in the first nine months of 2017 and 2016, respectively. The increases in amortization expense were primarily due to amortization of the additional finite-lived intangible assets which were recognized as a result of the purchase price allocation for the Produquímica acquisition (see Note 2 for more information).

11

The Company had goodwill of $421.6 million and $412.2 million as of September 30, 2017, and December 31, 2016, respectively, in its consolidated balance sheets. Of these amounts, $57.5 million and $53.6 million of the amounts recorded for goodwill as of September 30, 2017, and December 31, 2016, respectively, were recorded in the Company’s Plant Nutrition North America segment, and $358.1 million and $352.8 million of the amounts recorded for goodwill as of September 30, 2017 and December 31, 2016, respectively, were recorded in the Company’s Plant Nutrition South America segment. The remaining amounts in both periods were immaterial and recorded in the Company’s Salt segment and corporate and other. The change in goodwill between December 31, 2016, and September 30, 2017, was primarily due to the impact from translating foreign-denominated amounts to U.S. dollars and purchase price adjustments made related to the Produquímica acquisition (see Note 2 for more information).

6. Income Taxes:

The Company’s effective income tax rate differs from the U.S. statutory federal income tax rate primarily due to U.S. statutory depletion, state income taxes (net of federal tax benefit), foreign income tax rate differentials, foreign mining taxes, domestic manufacturing deductions, interest expense recognition differences for book and tax purposes and a partial release of valuation allowance in connection with the acquisition of Produquímica. The Company’s effective rate is impacted by permanent tax deductions which have a less favorable impact as pretax income increases.

During the nine months ended September 30, 2017, the Company determined it is more likely than not that a portion of its Brazilian deferred tax assets acquired in connection with the acquisition of Produquímica will be used to reduce taxable income. Based on current estimates of taxable income, the Company projects to release approximately $25 million of valuation allowances during the year ending December 31, 2017. For the nine months ended September 30, 2017, the Company included approximately $12 million of this valuation allowance release in the calculation of the estimated annual effective tax rate for the current fiscal year, and approximately $13 million as a discrete income tax benefit.

The Company had $52.0 million and $53.6 million as of September 30, 2017, and December 31, 2016, respectively, of gross foreign federal net operating loss (“NOL”) carryforwards that have no expiration date. In addition, the Company had $10.8 million and $7.5 million as of September 30, 2017, and December 31, 2016, respectively, of gross foreign federal NOL carryforwards which expire beginning in 2033 and $1.3 million and $0.9 million as of September 30, 2017, and December 31, 2016, respectively, of tax-effected state NOL carryforwards which expire beginning in 2033.

Canadian provincial tax authorities have challenged tax positions claimed by one of the Company’s Canadian subsidiaries and have issued tax reassessments for years 2002-2012. The reassessments are a result of ongoing audits and total $104.4 million, including interest through September 30, 2017. The Company disputes these reassessments and will continue to work with the appropriate authorities in Canada to resolve the dispute. Although the Company believes it has recorded an adequate reserve for this matter, there is a reasonable possibility that the ultimate resolution of this dispute, and any related disputes for other open tax years, may be materially higher or lower than the amounts the Company has reserved for such disputes. In connection with this dispute, local regulations require the Company to post security with the tax authority until the dispute is resolved. The Company has posted collateral in the form of a $63.6 million performance bond, has paid $35.2 million (most of which is recorded in other assets in its consolidated balance sheets) and the remaining balance of $5.6 million is expected to be addressed later this year, which is necessary to proceed with future appeals or litigation.

In addition, Canadian federal and provincial taxing authorities had reassessed the Company for years 2004-2006, which had been previously settled by agreement among the Company, the Canada Revenue Agency and the Internal Revenue Service of the United States. The Company sought to enforce the agreement, which provided the basis upon which the returns were previously filed and settled. In July 2016, a trial commenced in the Tax Court of Canada with respect to the Canadian federal tax issues for these matters, and in March 2017, the Tax Court of Canada ruled in favor of the Company. The decision of the Tax Court of Canada was not appealed by the Canada Revenue Agency. As a result, the Company believes that reassessed Canadian tax, penalties and interest for the Company for years 2004-2006 of approximately $94.7 million are effectively resolved. The Company is in the process of having certain posted collateral returned in connection with the resolution of the dispute.

The Company received Canadian income tax reassessments for years 2007-2008. The total amount of the reassessments, including penalties and interest through September 30, 2017, related to this matter is $37.2 million. The Company does not agree with these adjustments and is receiving assistance from the tax jurisdictions for relief from the impact of double taxation as available in the tax treaty between the U.S. and Canada. The Company has filed protective Notices of Objection and has posted collateral in the form of a $10.2 million performance bond and a $8.0 million bank letter guarantee, which is necessary to proceed with future appeals or litigation. Although the outcome of examinations by taxing authorities is uncertain, the Company believes it has adequately reserved for this matter.

12

The Company expects that it will be required by local regulations to provide security for additional interest on the above unresolved disputed amounts and for any future reassessments issued by these Canadian tax authorities in the form of cash, letters of credit, performance bonds, asset liens or other arrangements agreeable with the tax authorities until the disputes are resolved.

The Company expects that the ultimate outcome of these matters will not have a material impact on its results of operations or financial condition. However, the Company can provide no assurance as to the ultimate outcome of these matters, and the impact could be material if they are not resolved in the Company’s favor. As of September 30, 2017, the amount reserved related to these reassessments was immaterial to the Company’s consolidated financial statements.

Additionally, the Company has other uncertain tax positions as well as assessments and disputed positions with taxing authorities in its various jurisdictions, which are consistent with those matters disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

7. Long-term Debt:

Long-term debt consists of the following (in millions):

	September 30, 2017			December 31, 2016
Term Loans due July 2021	$	839.5		$	845.9
Revolving Credit Facility due July 2021	151.2			105.4
4.875% Senior Notes due July 2024	250.0			250.0
Banco Bradesco Loan due February 2017	—			13.2
Banco Votorantim Loan due April 2017	—			12.4
Banco Bradesco Loan due July 2017	—			4.8
Scotiabank Loan due August 2017	—			20.2
Scotiabank Loan due September 2017	—			15.1
Banco Votorantim Loan due September 2017	—			0.8
Banco Bradesco Loan due October 2017	—			16.8
Rabobank Loan due November 2017	22.4			22.6
Banco Itaú Loans due May 2019 to April 2020	2.3			3.1
Financiadora de Estudos e Projetos Loan due November 2023	14.1			7.4
Banco do Brasil Loans due October 2017	0.4			—
Banco do Brasil Loan due November 2017	0.5			—
Banco do Brasil Loan due February 2018	0.2			—
Banco Santander Loan due September 2019	20.5			—
Banco Itaú Loans due March 2019(a)	15.0			15.1
Banco Scotiabank Loan due September 2019	20.6			—
	1,336.7			1,332.8
Less unamortized debt issuance costs	(7.1		)	(7.8		)
Total debt	1,329.6			1,325.0
Less current portion	(55.4		)	(130.2		)
Long-term debt	$	1,274.2		$	1,194.8

(a) In September 2017, the maturity date of this loan was extended from September 2017 to March 2019.

In September 2017, the Company entered into an amendment to its credit agreement, which increased the maximum allowed leverage ratio under the credit agreement through September 2018. In connection with this amendment, the Company paid fees totaling $0.6 million ($0.1 million was recorded as an expense and $0.5 million was capitalized as deferred financing costs).

In September 2017, the Company refinanced $32.1 million of its Brazilian loans using proceeds from $41.1 million of new loans. The new loans bear interest rates ranging from 116.25% and 118% of CDI, an overnight inter-bank lending rate in Brazil, and mature in September 2019. No material fees were paid in connection with these transactions. A portion of the loans are denominated in U.S. dollars and a portion of the loans are denominated in Brazilian Reais. In September 2017, the Company also entered into

13

foreign currency swap agreements whereby the Company agreed to swap interest and principal payments on the loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian Reais, Produquímica’s functional currency (see Note 11 for further discussion).

In September 2016, the Company entered into a new $450 million term loan tranche under its existing credit agreement to fund the acquisition of the remaining 65% of Produquímica’s equity in October 2016 (see Note 2 for more information). This additional tranche will mature July 1, 2021, and bears interest at LIBOR plus 2.0%. In connection with this transaction, the Company incurred $2.2 million of financing fees in 2016 ($0.7 million was recorded as an expense and $1.5 million was capitalized as deferred financing costs).

In April 2016, the Company entered into a new credit agreement to refinance its existing $471 million term loans and $125 million revolving credit facility with a new $400 million senior secured term loan and a $300 million senior secured revolving credit facility, which both mature July 1, 2021. The new term loan and revolving credit facility bear interest at LIBOR plus 1.75% based on the Company’s current leverage ratio and credit rating. In connection with the refinancing, the Company incurred $5.8 million of refinancing fees ($1.4 million was recorded as an expense and $4.4 million was capitalized as deferred financing costs) and wrote-off $0.1 million of existing deferred financing costs related to the previous term loans and revolving credit facility.

As of September 30, 2017, the term loans and revolving credit facility under the credit agreement were secured by substantially all existing and future U.S. assets, the Goderich mine in Ontario, Canada, and capital stock of certain subsidiaries.

8. Commitments and Contingencies:

The Company was involved in proceedings alleging unfair labor practices at its Cote Blanche, Louisiana, mine. This matter arose out of a labor dispute between the Company and the United Steelworkers Union over the terms of a contract for certain employees at the mine. These employees initiated a strike that began on April 7, 2010, and ended on June 15, 2010. In September 2012, the U.S. National Labor Relations Board (the “NLRB”) issued a decision finding that the Company had committed unfair labor practices in connection with the labor dispute. Under the ruling, the Company is responsible for back pay to affected employees as a result of changes made in union work rules and past practices beginning April 1, 2010. In the fourth quarter of 2013, this ruling was upheld by an appeals court. As of December 31, 2016, the Company had recorded a reserve of $7.4 million in its consolidated financial statements related to expected payments, including interest, required to resolve the dispute.

In March 2017, the Company reached a settlement with the United Steelworkers Union and the NLRB with respect to this matter. Under the terms of the agreement, the Company paid $7.7 million to the affected employees in the second quarter of 2017. As a result of the settlement, the Company recognized an immaterial loss in its consolidated financial statements in 2017.

The Wisconsin Department of Agriculture, Trade and Consumer Protection (“DATCP”) has information indicating that agricultural chemicals are present within the subsurface area of the Company’s Kenosha, Wisconsin, plant. The agricultural chemicals were used by previous owners and operators of the site. None of the identified chemicals have been used in association with the Company’s operations since it acquired the property in 2002. DATCP directed the Company to conduct further investigations into the possible presence of agricultural chemicals in soil and ground water at the Kenosha plant. The Company has completed initial on-property investigations and has provided the findings to DATCP. A second series of sampling and analysis is underway. All investigations and mitigation activities to date, and any potential future remediation work, are being conducted under the Wisconsin Agricultural Chemical Cleanup Program (the “ACCP”), which would provide for reimbursement of some of the costs. The Company may seek participation by, or cost reimbursement from, other parties responsible for the presence of any agricultural chemicals found in soil and ground water at this site if the Company does not receive an acknowledgment of no further action and is required to conduct further investigation or remedial work that may not be eligible for reimbursement under the ACCP.

The Company conducts business operations in several countries and is subject to various federal and local labor, social security, environmental and tax laws. While the Company believes it complies with such laws, they are complex and subject to interpretation. In addition to the tax assessments discussed in Note 6, the Company’s Brazilian subsidiaries are party to administrative tax proceedings and claims which totaled $18.7 million as of September 30, 2017, and relate primarily to value added tax, state tax (ICMS) and social security tax (PIS and COFINS) assessments. The Company has assessed the likelihood of a loss at less than probable and therefore, has not established a reserve for these matters. The Company also has assumed liabilities for labor-related matters in connection with the acquisition of Produquímica, which are primarily related to compensation, labor benefits and consequential tax claims and totaled $11.5 million as of September 30, 2017. The Company believes the maximum exposure for these other labor matters totaled approximately $46 million as of September 30, 2017.

The Company is also involved in legal and administrative proceedings and claims of various types from the ordinary course of the Company’s business.

14

Management cannot predict the outcome of legal claims and proceedings with certainty. Nevertheless, management believes that the outcome of legal proceeding and claims, which are pending or known to be threatened, even if determined adversely, will not, individually or in the aggregate, have a material adverse effect on the Company’s results of operations, cash flows or financial position.

9. Operating Segments:

The Company’s reportable segments are strategic business units that offer different products and services, and each business requires different technology and marketing strategies. The Company has three reportable segments: Salt, Plant Nutrition North America and Plant Nutrition South America. The Salt segment produces and markets salt and magnesium chloride for use in road deicing and dust control, food processing, water softeners and agricultural and industrial applications. SOP crop nutrients, industrial-grade SOP, micronutrients and magnesium chloride for agricultural purposes are produced and marketed through the Plant Nutrition North America segment. The Plant Nutrition South America segment represents the results of Produquímica, which was acquired in October 2016. This segment operates two primary businesses in Brazil – agricultural productivity and chemical solutions. See Note 2 for a further discussion of the acquisition. The agricultural productivity division manufactures and distributes a broad offering of specialty plant nutrition solution-based products that are used in direct soil and foliar applications, as well as through irrigation systems and for seed treatment. Produquímica also manufactures and markets specialty chemicals for the industrial chemical industry.

Segment information is as follows (in millions):

Three Months Ended September 30, 2017	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	124.7	$	40.3	$	123.2	$	2.5		$	290.7
Intersegment sales	—		1.5		—		(1.5		)	—
Shipping and handling cost	34.9		4.8		5.8		—			45.5
Operating earnings (loss) (b)	22.5		2.3		21.4		(14.8		)	31.4
Depreciation, depletion and amortization	13.5		9.2		7.5		2.5			32.7
Total assets (as of end of period)	948.7		593.1		844.2		60.8			2,446.8

Three Months Ended September 30, 2016	Salt		Plant Nutrition North America(c)		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	135.7	$	41.5	$	—	$	2.4		$	179.6
Intersegment sales	—		0.6		—		(0.6		)	—
Shipping and handling cost	33.3		5.1		—		—			38.4
Operating earnings (loss)	30.0		2.5		—		(13.0		)	19.5
Depreciation, depletion and amortization	12.2		8.3		—		1.3			21.8
Total assets (as of end of period)	1,249.3		794.1		—		59.0			2,102.4

Nine Months Ended September 30, 2017	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	508.5	$	140.0	$	250.6	$	7.4		$	906.5
Intersegment sales	—		4.4		—		(4.4		)	—
Shipping and handling cost	147.6		18.4		13.8		—			179.8
Operating earnings (loss) (b)	78.6		17.5		24.0		(41.3		)	78.8
Depreciation, depletion and amortization	39.1		26.7		18.2		5.1			89.1

15

Nine Months Ended September 30, 2016	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	546.9	$	140.4	$	—	$	7.5		$	694.8
Intersegment sales	—		2.7		—		(2.7		)	—
Shipping and handling cost	147.7		17.2		—		—			164.9
Operating earnings (loss)	136.0		12.5		—		(39.2		)	109.3
Depreciation, depletion and amortization	34.2		24.6		—		3.9			62.7

(a) Corporate and other includes corporate entities, records management operations and other incidental operations and eliminations. Operating earnings (loss) for corporate and other includes indirect corporate overhead, including costs for general corporate governance and oversight, as well as costs for the human resources, information technology, legal and finance functions.

(b) Operating results for the three months ended September 30, 2017 include $4.3 million of restructuring charges.

(c) In 2016, total assets for Plant Nutrition North America include the equity investment in Produquímica.

10. Stockholders’ Equity and Equity Instruments:

In May 2015, the Company’s stockholders approved the 2015 Incentive Award Plan (the “2015 Plan”), which authorizes the issuance of 3,000,000 shares of Company common stock. Since the date the 2015 Plan was approved, the Company ceased issuing equity awards under the 2005 Incentive Award Plan (the “2005 Plan”). The 2005 Plan and 2015 Plan allow for grants of equity awards to executive officers, other employees and directors, including restricted stock units (“RSUs”), performance stock units (“PSUs”), stock options and deferred stock units. The grants occur following approval by the compensation committee of the Company’s board of directors, with the amount and terms communicated to employees shortly thereafter. 

Options

Substantially all stock options granted under the 2005 Plan and 2015 Plan vest ratably, in tranches, over a four-year service period. Unexercised options expire after seven years. Options do not have dividend or voting rights. Upon vesting, each option can be exercised to purchase one share of the Company’s common stock. The exercise price of options is equal to the closing stock price on the grant date.

To estimate the fair value of options on the grant date, the Company uses the Black-Scholes option valuation model. Award recipients are grouped according to expected exercise behavior. Unless better information is available to estimate the expected term of the options, the estimate is based on historical exercise experience. The risk-free rate, using U.S. Treasury yield curves in effect at the time of grant, is selected based on the expected term of each group. The Company’s historical stock price is used to estimate expected volatility. The inputs used to calculate fair value for options granted in 2017 are included in the table below:

Fair value of options granted	$9.54
Exercise price	$68.00
Expected term (years)	4.5
Expected volatility	23.2%
Dividend yield	3.5%
Risk-free rate of return	1.8%

RSUs

Substantially all of the RSUs granted under the 2005 Plan and 2015 Plan vest after three years of service, entitling the holders to one share of common stock for each vested RSU. Unvested RSUs do not have voting rights but are entitled to receive non-forfeitable dividends (generally after a performance hurdle has been satisfied for the year of the grant) or other distributions equal to those declared on the Company’s common stock for RSUs that are earned as a result of the satisfaction of the performance hurdle. The closing stock price on the grant date is used to determine the fair value of RSUs.

PSUs

Substantially all of the PSUs granted under the 2005 Plan and 2015 Plan are either total shareholder return PSUs (“TSR PSUs”) or return on invested capital PSUs (“ROIC PSUs”). The actual number of shares of the Company’s common stock that may be earned with respect to TSR PSUs is calculated by comparing the Company’s total shareholder return to the total shareholder return

16

for each company comprising the Russell 3000 Index over the three-year performance period and may range from 0% to 150% of the target number of shares based upon the attainment of these performance conditions. The actual number of shares of common stock that may be earned with respect to ROIC PSUs is calculated based on the average of the Company’s annual return on invested capital for each year in the three-year performance period and may range from 0% to 200% of the target number of shares based upon the attainment of these performance conditions.

PSUs represent a target number of shares of the Company’s common stock that may be earned before adjustment based upon the attainment of certain performance conditions. Holders of PSUs do not have voting rights but are entitled to receive non-forfeitable dividends or other distributions equal to those declared on the Company’s common stock for PSUs that are earned, which are paid when the shares underlying the PSUs are paid.

To estimate the fair value of the TSR PSUs on the grant date, the Company uses a Monte-Carlo simulation model, which simulates future stock prices of the Company as well as the companies comprising the Russell 3000 Index. This model uses historical stock prices to estimate expected volatility and the Company’s correlation to the Russell 3000 Index. The risk-free rate was determined using the same methodology as the option valuations as discussed above. The Company’s closing stock price on the grant date was used to estimate the fair value of the ROIC PSUs. The Company will adjust the expense of the ROIC PSUs based upon its estimate of the number of shares that will ultimately vest at each interim date during the vesting period.

During the nine months ended September 30, 2017, the Company reissued the following number of shares from treasury stock: 3,366 shares related to the exercise of stock options, 15,806 shares related to the release of RSUs which vested, 12,946 shares related to the release of PSUs which vested and 5,424 shares related to stock payments. The Company recognized a tax deficiency of $0.6 million from its equity compensation awards as an increase to income tax expense during the first nine months of 2017. During the first nine months of both 2017 and 2016, the Company recorded $3.8 million of compensation expense pursuant to its stock-based compensation plans. No amounts have been capitalized. The following table summarizes stock-based compensation activity during the nine months ended September 30, 2017:

	Stock Options				RSUs				PSUs(a)
	Number		Weighted-average exercise price		Number		Weighted-average fair value		Number		Weighted-average fair value
Outstanding at December 31, 2016	442,755		$	80.07	63,780		$	80.25	89,011		$	89.43
Granted	227,351		68.00		34,635		68.00		58,878		73.08
Exercised(b)	(3,366	)	76.03		—		—		—		—
Released from restriction(b)	—		—		(15,806	)	84.77		(12,946	)	105.77
Cancelled/expired	(80,606	)	76.05		(9,906	)	71.54		(19,416	)	88.18
Outstanding at September 30, 2017	586,134		$	75.97	72,703		$	74.62	115,527		$	79.47

(a) Until they vest, PSUs are included in the table at the target level at their grant date and at that level represent one share of common stock per PSU. The final performance period for the 2014 PSU grant ended in 2016. The Company cancelled 6,900 PSUs in 2017 related to the 2014 PSU grant.

(b) Common stock issued for exercised options and for vested and earned RSUs and PSUs was issued from treasury stock.

Other Comprehensive Income (Loss)

The Company’s comprehensive income (loss) is comprised of net earnings, net amortization of the unrealized loss of the pension obligation, the change in the unrealized gain (loss) on natural gas and foreign currency swap cash flow hedges, and foreign currency translation adjustments. The components of and changes in accumulated other comprehensive income (loss) (“AOCI”) as of and for the three and nine months ended September 30, 2017, and 2016, are as follows (in millions):

Three Months Ended September 30, 2017(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.3	)	$	(3.5	)	$	(93.6	)	$	(97.4	)
Other comprehensive income (loss) before reclassifications(b)	(0.5		)	—			46.1			45.6
Amounts reclassified from accumulated other comprehensive loss	(0.2		)	—			—			(0.2		)
Net current period other comprehensive income (loss)	(0.7		)	—			46.1			45.4
Ending balance	$	(1.0	)	$	(3.5	)	$	(47.5	)	$	(52.0	)

17

Three Months Ended September 30, 2016(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.2	)	$	(3.6	)	$	(71.8	)	$	(75.6	)
Other comprehensive income (loss) before reclassifications(b)	(0.3		)	—			(3.9		)	(4.2		)
Amounts reclassified from accumulated other comprehensive loss	0.2			—			—			0.2
Net current period other comprehensive income (loss)	(0.1		)	—			(3.9		)	(4.0		)
Ending balance	$	(0.3	)	$	(3.6	)	$	(75.7	)	$	(79.6	)

Nine Months Ended September 30, 2017(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	0.6		$	(3.7	)	$	(101.8	)	$	(104.9	)
Other comprehensive income (loss) before reclassifications(b)	(1.4		)	—			54.3			52.9
Amounts reclassified from accumulated other comprehensive loss	(0.2		)	0.2			—			—
Net current period other comprehensive income (loss)	(1.6		)	0.2			54.3			52.9
Ending balance	$	(1.0	)	$	(3.5	)	$	(47.5	)	$	(52.0	)

Nine Months Ended September 30, 2016(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(1.6	)	$	(3.8	)	$	(102.9	)	$	(108.3	)
Other comprehensive income (loss) before reclassifications(b)	(0.1		)	—			27.2			27.1
Amounts reclassified from accumulated other comprehensive loss	1.4			0.2			—			1.6
Net current period other comprehensive income (loss)	1.3			0.2			27.2			28.7
Ending balance	$	(0.3	)	$	(3.6	)	$	(75.7	)	$	(79.6	)

(a) With the exception of the cumulative foreign currency translation adjustment, for which no tax effect is recorded, the changes in the components of accumulated other comprehensive income (loss) presented in the tables above are reflected net of applicable income taxes.

(b) The Company recorded foreign exchange (gains) losses of $(22.0) million and $(20.6) million in the three and nine months ended September 30, 2017, respectively, and $3.8 million and $(22.9) million in the three and nine months ended September 30, 2016, respectively, in accumulated other comprehensive loss related to intercompany notes which were deemed to be of long-term investment nature.

The amounts reclassified from AOCI to (income) expense for the three and nine months ended September 30, 2017, and 2016, are shown below (in millions):

	Amount Reclassified from AOCI
	Three Months Ended September 30, 2017			Nine Months Ended September 30, 2017			Line Item Impacted in the Consolidated Statement of Operations
Gains and (losses) on cash flow hedges:
Natural gas instruments	$	0.2		$	0.2		Product cost
Foreign currency swaps	(0.5		)	(0.5		)	Interest expense
Income tax expense (benefit)	0.1			0.1
Reclassifications, net of income taxes	(0.2		)	(0.2		)
Amortization of defined benefit pension:
Amortization of loss	$	—		$	0.2		Product cost
Income tax expense (benefit)	—			—
Reclassifications, net of income taxes	—			0.2
Total reclassifications, net of income taxes	$	(0.2	)	$	—

18

	Amount Reclassified from AOCI
	Three Months Ended September 30, 2016			Nine Months Ended September 30, 2016			Line Item Impacted in the Consolidated Statement of Operations
Gains and (losses) on cash flow hedges:
Natural gas instruments	$	0.3		$	2.2		Product cost
Income tax expense (benefit)	(0.1		)	(0.8		)
Reclassifications, net of income taxes	0.2			1.4
Amortization of defined benefit pension:
Amortization of loss	$	—		$	0.2		Product cost
Income tax expense (benefit)	—			—
Reclassifications, net of income taxes	—			0.2
Total reclassifications, net of income taxes	$	0.2		$	1.6

11. Derivative Financial Instruments:

The Company is subject to various types of market risks, including interest rate risk, foreign currency exchange rate transaction and translation risk and commodity pricing risk. Management may take actions to mitigate the exposure to these types of risks, including entering into forward purchase contracts and other financial instruments. Currently, the Company manages a portion of its commodity pricing and foreign currency exchange rate risks by using derivative instruments. The Company does not seek to engage in trading activities or take speculative positions with any financial instrument arrangement. The Company has entered into natural gas derivative instruments and foreign currency derivative instruments with counterparties it views as creditworthy. However, the Company does attempt to mitigate its counterparty credit risk exposures by, among other things, entering into master netting agreements with some of these counterparties.The Company records derivative financial instruments as either assets or liabilities at fair value in the consolidated balance sheets.

Derivatives qualify for treatment as hedges when there is a high correlation between the change in fair value of the derivative instrument and the related change in value of the underlying hedged item. Depending on the exposure being hedged, the Company must designate the hedging instrument as a fair value hedge, a cash flow hedge or a net investment in foreign operations hedge. For the qualifying derivative instruments that have been designated as hedges, the effective portion of the change in fair value is recognized through earnings when the underlying transaction being hedged affects earnings, allowing a derivative’s gains and losses to offset related results from the hedged item in the statements of operations. Any ineffectiveness related to these hedges was not material for any of the periods presented. For derivative instruments that have not been designated as hedges, the entire change in fair value is recorded through earnings in the period of change.

Natural Gas Derivative Instruments

Natural gas is consumed at several of the Company’s production facilities, and a change in natural gas prices impacts the Company’s operating margin. The Company’s objective is to reduce the earnings and cash flow impacts of changes in market prices of natural gas by fixing the purchase price of up to 90% of its forecasted natural gas usage. It is the Company’s policy to consider hedging portions of its natural gas usage up to 36 months in advance of the forecasted purchase. As of September 30, 2017, the Company had entered into natural gas derivative instruments to hedge a portion of its natural gas purchase requirements through December 2019. As of September 30, 2017, and December 31, 2016, the Company had agreements in place to hedge forecasted natural gas purchases of 3.3 million and 2.3 million MMBtus, respectively. All natural gas derivative instruments held by the Company as of September 30, 2017, and December 31, 2016, qualified and were designated as cash flow hedges. As of September 30, 2017, the Company expects to reclassify from accumulated other comprehensive loss to earnings during the next twelve months $0.6 million of net losses on derivative instruments related to its natural gas hedges.

Foreign Currency Swaps not Designated as Hedges

In conjunction with the acquisition of Produquímica, the Company assumed U.S. dollar-denominated debt which was previously held by Produquímica. Prior to the acquisition, Produquímica entered into foreign currency swap agreements whereby Produquímica agreed to swap interest and principal payments on the loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian Reais, Produquímica’s functional currency. The objective of the swap agreements is to mitigate the foreign currency fluctuation risk related to holding debt denominated in a currency other than Produquímica’s functional currency. None of the swap agreements relating to the debt assumed in conjunction with the acquisition of Produquímica are designated as hedges.

19

As of September 30, 2017, and December 31, 2016, the Company had swap agreements in place to economically hedge $22.4 million and $119.6 million, respectively, of loans denominated in currencies other than Produquímica’s functional currency. During the three and nine months ended September 30, 2017, the Company recognized losses of $4.9 million and $10.2 million, respectively, in its consolidated statement of operations for the change in fair value of the swap agreements not designated as hedges.

Foreign Currency Swaps Designated as Hedges

In September 2017, the Company entered into new U.S. dollar-denominated debt instruments to provide funds for its operations in Brazil (see Note 7 for more information). Concurrently, the Company entered into additional foreign currency swap agreements whereby the Company agreed to swap interest and principal payments on loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian Reais, Produquímica’s functional currency. The objective of the swap agreements is to mitigate the foreign currency fluctuation risk related to holding debt denominated in a currency other than Produquímica’s functional currency. As of September 30, 2017, the Company had swap agreements in place to hedge $35.6 million of loans denominated currencies other than Produquímica’s functional currency. Payments on these loans are due on various dates extending through September 2019. As of September 30, 2017, these foreign currency swap derivative instruments qualified and were designated as cash flow hedges. As of September 30, 2017, the Company expects to reclassify from accumulated other comprehensive loss to earnings during the next twelve months $0.1 million of net losses on derivative instruments related to its foreign currency swap agreements.

The following tables present the fair value of the Company’s hedged items as of September 30, 2017, and December 31, 2016 (in millions):

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Balance Sheet Location	September 30, 2017		Balance Sheet Location	September 30, 2017
Commodity contracts	Other current assets	$	0.1	Accrued expenses	$	0.7
Commodity contracts	Other assets	—		Other noncurrent liabilities	0.2
Swap contracts	Other current assets	—		Accrued expenses	0.1
Swap contracts	Other assets	—		Other noncurrent liabilities	0.1
Total derivatives designated as hedging instruments(a)		0.1			1.1
Derivatives not designated as hedging instruments:
Swap contracts	Other current assets	$	—	Accrued expenses	$	7.0
Swap contracts	Other assets	—		Other noncurrent liabilities	—
Total derivatives not designated as hedging instruments		—			7.0
Total derivatives(b)		$	0.1		$	8.1

(a) The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its consolidated balance sheets approximately $0.1 million of its commodity contracts that are in receivable positions against its contracts in payable positions.

(b) The Company has commodity hedge and foreign currency swap agreements with three counterparties each, respectively. Amounts recorded as assets for the Company’s commodity contracts are receivable from three counterparties, and the amounts recorded as liabilities for the Company’s commodity contracts are payable to two counterparties. The amounts recorded as liabilities for the Company’s swap contracts are payable to two counterparties. There is also an immaterial amount receivable from one counterparty.

20

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Balance Sheet Location	December 31, 2016		Balance Sheet Location	December 31, 2016
Commodity contracts	Other current assets	$	1.2	Accrued expenses	$	0.3
Commodity contracts	Other assets	0.1		Other noncurrent liabilities	0.1
Total derivatives designated as hedging instruments(a)		1.3			0.4
Derivatives not designated as hedging instruments:
Swap contracts	Other current assets	$	—	Accrued expenses	$	25.8
Swap contracts	Other assets	—		Other noncurrent liabilities	—
Total derivatives not designated as hedging instruments		—			25.8
Total derivatives(b)		$	1.3		$	26.2

(a) The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its consolidated balance sheets approximately $0.4 million of its commodity contracts that are in a payable position against its contracts in receivable positions.

(b) The Company has commodity hedge and foreign currency swap agreements with two and five counterparties, respectively. Amounts recorded as assets for the Company’s commodity contracts are receivable from both counterparties, and amounts recorded as liabilities for the Company’s swap contracts are payable to all five counterparties. 

12. Fair Value Measurements:

The Company’s financial instruments are measured and reported at their estimated fair value. Fair value is the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction. When available, the Company uses quoted prices in active markets to determine the fair values for its financial instruments (Level 1 inputs) or, absent quoted market prices, observable market-corroborated inputs over the term of the financial instruments (Level 2 inputs). The Company does not have any unobservable inputs that are not corroborated by market inputs (Level 3 inputs) other than those described in Note 2.

The Company holds marketable securities associated with its defined contribution and pre-tax savings plans, which are valued based on readily available quoted market prices. The Company also held short-term investments which were classified as trading securities with any gains or losses recognized through earnings. The Company sold these investments during the first quarter of 2017. The Company utilizes derivative instruments to manage its risk of changes in natural gas prices and its risk of changes in foreign currency exchange rates (see Note 11). The fair value of the natural gas and foreign currency swap derivative instruments are determined using market data of forward prices for all of the Company’s contracts. 

The estimated fair values for each type of instrument are presented below (in millions):

	September 30, 2017			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified retirement plan(a)	$	2.1		$	2.1		$	—		$	—
Total Assets	$	2.1		$	2.1		$	—		$	—
Liability Class:
Liabilities related to non-qualified retirement plan	$	(2.1	)	$	(2.1	)	$	—		$	—
Derivatives – natural gas instruments, net	(0.8		)	—			(0.8		)	—
Derivatives – foreign currency swaps, net	(7.2		)	—			(7.2		)	—
Total Liabilities	$	(10.1	)	$	(2.1	)	$	(8.0	)	$	—

(a) Includes mutual fund investments of approximately 30% in common stock of large-cap U.S. companies, 15% in common stock of small to mid-cap U.S. companies, 5% in international companies, 10% in bond funds, 20% in short-term investments and 20% in blended funds.

21

	December 31, 2016			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan(a)	$	1.8		$	1.8		$	—		$	—
Derivatives – natural gas instruments, net	0.9			—			0.9			—
Trading securities	1.8			—			1.8			—
Total Assets	$	4.5		$	1.8		$	2.7		$	—
Liability Class:
Liabilities related to non-qualified savings plan	$	(1.8	)	$	(1.8	)	$	—		$	—
Derivatives – foreign currency swaps, net	(25.8		)	—			(25.8		)	—
Total Liabilities	$	(27.6	)	$	(1.8	)	$	(25.8	)	$	—

(a) Includes mutual fund investments of approximately 25% in the common stock of large-cap U.S. companies, 10% in the common stock of small to mid-cap U.S. companies, 5% in the common stock of international companies, 5% in bond funds, 40% in short-term investments and 15% in blended funds.

Cash and cash equivalents, accounts receivable (net of allowance for bad debts) and payables are carried at cost, which approximates fair value due to their liquid and short-term nature. The Company’s investments related to its nonqualified retirement plan of $2.1 million and $1.8 million at September 30, 2017, and December 31, 2016, respectively, are stated at fair value based on quoted market prices. As of September 30, 2017, the estimated amount a third-party would pay for the Company’s fixed-rate 4.875% senior notes due July 2024, based on available trading information, totaled $245.6 million (Level 2) compared with the aggregate principal amount at maturity of $250.0 million. The estimated amount a third-party would pay at September 30, 2017, for the amounts outstanding under the Company’s term loans and revolving credit facility, based upon available bid information received from the Company’s lender, totaled $974.7 million (Level 2) compared with the aggregate principal balance of $990.7 million. The loans assumed in the Produquímica acquisition have floating rates and their fair value approximates their carrying value.

13. Earnings per Share:

The Company calculates earnings per share using the two-class method. The two-class method requires allocating the Company’s net earnings to both common shares and participating securities. The following table sets forth the computation of basic and diluted earnings per common share (in millions, except for share and per-share data):

	Three months ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
Numerator:
Net earnings	$	32.0		$	9.1		$	47.1		$	65.1
Less: net earnings allocated to participating securities(a)	(0.2		)	(0.1		)	(0.3		)	(0.3		)
Net earnings available to common shareholders	$	31.8		$	9.0		$	46.8		$	64.8
Denominator (in thousands):
Weighted-average common shares outstanding, shares for basic earnings per share	33,825			33,786			33,817			33,772
Weighted-average awards outstanding(b)	—			3			—			3
Shares for diluted earnings per share	33,825			33,789			33,817			33,775
Net earnings per common share, basic	$	0.94		$	0.27		$	1.38		$	1.92
Net earnings per common share, diluted	$	0.94		$	0.27		$	1.38		$	1.92

(a) Weighted participating securities include RSUs and PSUs that receive non-forfeitable dividends and consist of 169,000 and 165,000 weighted participating securities for the three and nine months ended September 30, 2017, respectively, and 148,000 weighted participating securities for both the three and nine months ended September 30, 2016.

(b) For the calculation of diluted earnings per share, the Company uses the more dilutive of either the treasury stock method or the two-class method to determine the weighted-average number of outstanding common shares. In addition, the Company had 695,000 and 637,000 weighted-average equity awards outstanding for the three and nine months ended September 30, 2017, respectively, and 547,000 and 509,000 weighted-average equity awards outstanding for the three and nine months ended September 30, 2016, respectively, which were anti-dilutive and therefore not included in the diluted earnings per share calculation.

22

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

All statements, other than statements of historical fact, contained in this Quarterly Report on Form 10-Q constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include, but are not limited to, the following: risks related to our mining and industrial operations; geological conditions; dependency on a limited number of key production and distribution facilities and critical equipment; the inability to fund necessary capital expenditures or successfully complete capital projects; any inability to successfully implement our restructuring plan; supply constraints or price increases for energy and raw materials used in our production processes; weather conditions; climate change; our indebtedness and ability to pay our indebtedness; restrictions in our debt agreements that may limit our ability to operate our business or require accelerated debt payments; tax liabilities; financial assurance requirements imposed on us; the inability of our customers to access credit or a default by our customers of trade credit extended by us or financing we have guaranteed; restrictions on or ability to pay dividends; the impact of competition on the sales of our products; conditions in the agricultural sector and supply and demand imbalances for competing plant nutrition products; increasing costs or a lack of availability of transportation services; strikes, other forms of work stoppage or slowdown or other union activities; the loss of key personnel; our rights and governmental authorizations to mine and operate our properties; our ability to expand our business through acquisitions, integrate acquired businesses and realize anticipated benefits from acquisitions; compliance with foreign and U.S. laws and regulations applicable to our international operations; compliance with environmental, health and safety laws and regulations; environmental liabilities; the ability to access our computer systems and information technology or the inability to protect confidential data; misappropriation or infringement claims relating to intellectual property; changes in industry standards and regulatory requirements; product liability claims and product recalls; inability to obtain required product registrations or increased regulatory requirements; domestic and international general business and economic conditions; and other risks referenced from time to time in this report and our other filings with the Securities and Exchange Commission (the “SEC”), including the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2016.

In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “could,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” the negative of these terms or other comparable terminology. Forward-looking statements include without limitation statements about our expected outlook, including expected bid volumes, sales volumes, cost reductions and restructuring charges; the seasonal distribution of working capital requirements; our reinvestment of foreign earnings outside the U.S.; our ability to optimize cash accessibility and minimize tax expense and meet debt service requirements; capital expenditures; outcomes of matters with taxing authorities; and the seasonality of our business. These forward-looking statements are only predictions. Actual events or results may differ materially.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We undertake no duty to update any of the forward-looking statements after the date hereof or to reflect the occurrence of unanticipated events.

Unless the context requires otherwise, references to the “Company,” “Compass Minerals,” “our,” “us” and “we” refer to Compass Minerals International, Inc. (“CMI,” the parent holding company) and its consolidated subsidiaries. Except where otherwise noted, references to North America include only the continental United States (the “U.S.”) and Canada, and references to the United Kingdom (the “U.K.”) include only England, Scotland and Wales. Except where otherwise noted, all references to tons refer to “short tons” and all amounts are in U.S. dollars. One short ton equals 2,000 pounds.

Critical Accounting Estimates

Preparation of our consolidated financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Management believes the most complex and sensitive judgments result primarily from the need to make estimates about matters that are inherently uncertain. Management’s Discussion and Analysis and Note 2 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016, describe the significant accounting estimates and policies used in preparation of our consolidated financial statements. Actual results in these areas could differ from management’s estimates.

23

Company Overview

Compass Minerals is a leading producer of essential minerals, including salt, sulfate of potash (“SOP”) specialty fertilizer and magnesium chloride. As of September 30, 2017, we operated 22 production and packaging facilities, including:

• The largest rock salt mine in the world in Goderich, Ontario, Canada;

• The largest dedicated rock salt mine in the U.K. in Winsford, Cheshire;

• A solar evaporation facility located in Ogden, Utah, which is both the largest SOP production site and the largest solar salt production site in the Western Hemisphere; and

• Several facilities producing essential agricultural nutrients and specialty chemicals in Brazil.

Our salt business produces and sells sodium chloride and magnesium chloride, which are used for highway deicing, dust control, consumer deicing, water conditioning, consumer and industrial food preparation and agricultural and industrial applications. Our solar evaporation facility located in Ogden, Utah, is both the largest SOP production site and the largest solar salt production site in North America. In addition, we operate a records management business utilizing excavated areas of our Winsford salt mine with one other location in London, U.K., which provides services to businesses throughout the U.K. The Plant Nutrition South America segment represents the results of Produquímica Indústria e Comércio S.A. (“Produquímica”), which was acquired in October 2016. This segment operates two primary businesses in Brazil – agricultural productivity and chemical solutions.

Consolidated Results of Operations

The following is a summary of our consolidated results of operations for the three and nine months ended September 30, 2017, and September 30, 2016, respectively. The following discussion should be read in conjunction with the information contained in our consolidated financial statements and the notes thereto included in this Quarterly Report on Form 10-Q.

THREE AND NINE MONTHS ENDED SEPTEMBER 30

* Refer to “—Sensitivity Analysis Related to EBITDA and Adjusted EBITDA” for a reconciliation to the most directly comparable U.S. GAAP financial measure and the reasons we use this non-GAAP measure.

24

COMMENTARY: THREE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

• Total sales increased62%, or $111.1 million, primarily due to the acquisition of Produquímica, which was partially offset by a decrease in Salt and Plant Nutrition North America segment sales.

• Operating earnings increased61%, or $11.9 million, due to the inclusion of Produquímica in our operating results. This increase was partially offset by a decline in Salt and Plant Nutrition North America segment operating earnings.

• Earnings before interest, taxes, depreciation and amortization (“EBITDA”)* adjusted for items management believes are not indicative of our ongoing operating performance (“Adjusted EBITDA”)* increased68%, or $27.9 million.

• Diluted earnings per share increased248%, or $0.67.

COMMENTARY: NINE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

• Total sales increased30%, or $211.7 million, primarily due to the acquisition of Produquímica. This increase was partially offset by a decrease in Salt segment sales.

• Operating earnings decreased28%, or $30.5 million, due to lower Salt segment operating earnings, partially offset by an increase in Plant Nutrition North America operating earnings and the inclusion of Produquímica in our operating results.

• Adjusted EBITDA* increased1%, or $2.5 million.

• Diluted earnings per share decreased28%, or $0.54.

THREE AND NINE MONTHS ENDED SEPTEMBER 30

COMMENTARY: THREE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

Gross Profit: Increased68%, or $30.9 million; Gross Margin increased1 percentage point

• The plant nutrition business, on a combined basis, contributed $37.0 million to the increase in gross profit due to the inclusion of Produquímica in our operating results.

• A $6.2 million decrease in Salt segment gross profit partially offset the plant nutrition business’ increase. The decrease was primarily due to lower consumer and industrial sales volumes, higher per-unit shipping costs and restructuring costs.

COMMENTARY: NINE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

Gross Profit: Increased7%, or $13.5 million; Gross Margin decreased5 percentage points

• The plant nutrition business, on a combined basis, contributed $69.4 million to the increase in gross profit primarily due to the inclusion of Produquímica in our operating results.

• Gross profit for Plant Nutrition North America was favorably impacted by slightly higher sales volumes and lower per-unit product costs, which were partially offset by lower average sales prices and higher per-unit shipping and handling costs during the period.

• A $56.0 million decrease in Salt segment gross margin partially offset the plant nutrition business’ increase. The decrease resulted from lower sales and increased per unit product costs.

25

OTHER EXPENSES AND INCOME

COMMENTARY: THREE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

SG&A: Increased$19.0 million, which represented a 1.1 percentage point of sales increase to 15.4% from 14.3%

• The increase in SG&A expense was primarily due to the inclusion of Produquímica in our operating results in 2017 and approximately $1 million in higher corporate depreciation related to a significant software system upgrade. In addition, we incurred charges of approximately $2 million related to ongoing restructuring activities impacting our Salt and Plant Nutrition North America segments as well as corporate SG&A.

Interest Expense: Increased$8.1 million to $13.5 million

• The increase was primarily due to our higher aggregate debt level driven by the acquisition of Produquímica.

Net (earnings) loss in equity investee: Increased from a loss of $0.4 million to earnings of $0.4 million

• The $0.4 million of earnings in the current period represents our share of Fermavi Eletroquímica Ltda.’s (“Fermavi”) net earnings. As a result of the full acquisition of Produquímica, we hold a 50% interest in Fermavi, which was previously held by Produquímica.

• The $0.4 million loss for the prior period represented our share of Produquímica’s net loss based on our initial 35% equity interest in Produquímica prior to the full acquisition.

Other (Income) Expense: Decreased$2.7 million from an expense of $1.5 million to income of $1.2 million

• We realized foreign exchange gains of $1.1 million in the third quarter of 2017 and foreign exchange losses of $1.1 million in the third quarter of 2016. In addition, interest income in the quarter increased by $0.8 million.

Income Tax (Benefit) Expense: Decreased$15.6 million from an expense of $3.1 million to a benefit of $12.5 million

• The decrease was primarily due to the release of approximately $17 million of valuation allowances related to our Brazil business during the third quarter, of which approximately $13 million was accounted for as a discrete item and approximately $4 million resulted from adjustments made to our annual effective tax rate.

• Our income tax provision in both periods differs from the U.S. statutory rate primarily due to U.S. statutory depletion, domestic manufacturing deductions, state income taxes, foreign income, mining and withholding taxes and interest expense recognition differences for tax and financial reporting purposes.

• Our effective tax rate declined from 25% in the third quarter of 2016 to (64)% in the third quarter of 2017, reflecting the release of the Brazilian valuation allowances.

COMMENTARY: NINE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

SG&A: Increased$44.0 million, which represented a 2.2 percentage points of sales increase to 13.7% from 11.5%

• The increase in SG&A expense was primarily due to the inclusion of Produquímica in our operating results in 2017, approximately $1 million in higher corporate depreciation related to a significant software system upgrade. In addition, we incurred charges of approximately $2 million related to ongoing restructuring activities impacting our Salt and Plant Nutrition North America segments as well as corporate SG&A.

Interest Expense: Increased$22.7 million to $39.5 million

• The increase was primarily due to our higher aggregate debt level driven by the acquisition of Produquímica, which was partially offset by lower interest rates due to the refinancing of our term loans and revolving credit facility in April 2016.

Net (earnings) loss in equity investee: Increased from a loss of $1.7 million to earnings of $0.6 million

• The $0.6 million of earnings in the current period represents our share of Fermavi’s net earnings, and the $1.7 million loss for the prior period represented our share of Produquímica’s net loss based on our prior 35% equity interest in Produquímica.

Other Expense: Decreased$1.1 million to $0.5 million

• The decrease in other expense was primarily due to an increase in interest income, which was partially offset by foreign exchange losses. Additionally, the comparative 2016 period included $2.1 million of expenses incurred related to the refinancing of our term loans and revolving credit facility.

Income Tax (Benefit) Expense: Decreased$31.8 million from an expense of $24.1 million to a benefit of $7.7 million

• The decrease was primarily due to the release of $18 million of Brazilian valuation allowances and lower pre-tax income.

26

• Our income tax provision in both periods differs from the U.S. statutory rate primarily due to U.S. statutory depletion, domestic manufacturing deductions, state income taxes, foreign income, mining and withholding taxes and interest expense recognition differences for tax and financial reporting purposes.

• Our effective tax rate declined from 27% in the first nine months of 2016 to (20)% in the first nine months of 2017, reflecting the release of Brazilian valuation allowances.

Operating Segment Performance

The following financial results represent consolidated financial information with respect to sales from our Salt, Plant Nutrition North America and Plant Nutrition South America segments. The results of operations of the consolidated records management business and other incidental revenues include sales of $2.5 million and $2.4 million for the third quarter of 2017 and 2016, respectively, and $7.4 million and $7.5 million for the first nine months of 2017 and 2016, respectively. These revenues are not material to our consolidated financial results and are not included in the following operating segment financial data. 

THREE AND NINE MONTHS ENDED SEPTEMBER 30

27

	3Q 2017		3Q 2016		2017 YTD		2016 YTD
Salt Sales (in millions)	$	124.7	$	135.7	$	508.5	$	546.9
Salt Operating Earnings (in millions)	$	22.5	$	30.0	$	78.6	$	136.0
Salt Sales Volumes (thousands of tons)
Highway deicing	1,157		1,162		5,596		5,944
Consumer and industrial	446		534		1,412		1,458
Total tons sold	1,603		1,696		7,008		7,402
Average Salt Sales Price (per ton)
Highway deicing	$	49.04	$	48.23	$	53.07	$	56.15
Consumer and industrial	$	152.39	$	149.44	$	149.83	$	146.23
Combined	$	77.79	$	80.05	$	72.56	$	73.89

COMMENTARY: THREE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

• Salt sales decreased8%, or $11.0 million, primarily due to lower consumer and industrial sales volumes.

• Salt average sales prices decreased3% due to product sales mix, as consumer and industrial products which have a higher average sales price were a lower proportion of total sales in the current period.

• Highway deicing average sales prices increased2%, primarily as a result of product sales mix partially offset by lower North American highway deicing bid prices for the 2016-2017 winter season. Consumer and industrial average sales prices increased2% due to price increases introduced last year as well as an improvement in product sales mix.

• Salt sales volumes decreased5%, or 93,000 tons, and contributed approximately $13 million to the decline in Salt segment sales. Highway deicing sales volumes were essentially flat. Consumer and industrial sales volumes decreased16% primarily due to lower pre-season orders for packaged deicing products.

• Salt operating earnings decreased25%, or $7.5 million, due to lower sales as well as increased logistics costs and approximately $2 million of restructuring costs applicable to the Salt segment.

COMMENTARY: NINE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

• Salt sales decreased7%, or $38.4 million, due to lower highway deicing average sales prices and highway deicing and consumer and industrial sales volumes, which were partially offset by an increase in consumer and industrial average sales prices.

• Salt average sales price decreased2% and contributed approximately $12 million to the decrease in Salt segment sales. The decrease in average sales price was due to a decrease in highway deicing average sales prices, partially offset by an increase in consumer and industrial products average sales prices.

• Highway deicing average sales prices decreased5%, primarily as a result of lower North American highway deicing bid prices for the 2016-2017 winter season. Consumer and industrial average sales prices increased2% due to price increases introduced last year as well as an improvement in product sales mix.

• Salt sales volumes decreased5%, or 394,000 tons, and contributed approximately $26 million to the decline in Salt segment sales. Highway deicing sales volumes decreased6% primarily due to the carryover impact of two consecutive mild winters. Consumer and industrial sales volumes decreased3%.

• Salt operating earnings decreased42%, or $57.4 million, primarily due to lower sales and higher per-unit product costs due to sales of higher-cost 2016 inventory sold during the period.

• We experienced lower mine operating rates throughout 2016 and unplanned downtime at our Goderich mine in the fourth quarter of 2016, which increased 2017 per-unit product costs.

• In addition, we incurred restructuring costs related to our cost savings initiatives of approximately $3 million during the period in the Salt segment and unfavorable logistics costs contributed to the decline in Salt segment operating earnings.

28

THREE AND NINE MONTHS ENDED SEPTEMBER 30

	3Q 2017		3Q 2016		2017 YTD		2016 YTD
Plant Nutrition North America Sales (in millions)	$	40.3	$	41.5	$	140.0	$	140.4
Plant Nutrition North America Operating Earnings (in millions)	$	2.3	$	2.5	$	17.5	$	12.5
Plant Nutrition North America Sales Volumes (thousands of tons)	65		70		222		218
Plant Nutrition North America Average Sales Price (per ton)	$	626	$	591	$	631	$	645

COMMENTARY: THREE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

• Plant Nutrition North America sales decreased3%, or $1.2 million.

• Plant Nutrition North America sales volumes decreased7%, or 5,000 tons, and contributed approximately $3 million to the decrease in Plant Nutrition North America sales. The decrease in sales volumes was primarily driven by reduced SOP sales volumes due to the impact of hurricane activity in the southeastern U.S.

• The 6%increase in Plant Nutrition North America average sales price partially offset the decrease in Plant Nutrition

29

North America sales by approximately $2 million. The increase in average sales price was impacted by an increase in higher-priced micronutrient sales and reduced lower-priced export sales compared to the prior year.

• Plant Nutrition North America operating earnings decreased8%, or $0.2 million, primarily due to approximately $1 million of restructuring costs and higher depreciation expense associated with commissioning new capital projects at our Ogden facility, which were mostly offset by the impact of an increase in average sales prices.

COMMENTARY: NINE MONTHS ENDED SEPTEMBER 30, 2016 AND 2017

• Plant Nutrition North America sales were essentially flat.

• Plant Nutrition North America sales volumes increased2%, or 4,000 tons, as the North American SOP market was more stable during the nine months ended September 30, 2017.

• The 2%decrease in Plant Nutrition North America average sales price offset the effect of the increase in Plant Nutrition North America sales volumes.

• Plant Nutrition North America operating earnings increased 40%, or $5.0 million, primarily due to a reduction in per-unit product costs, the impact of which was partially offset by unfavorable logistics costs and approximately $1 million of restructuring costs.

PLANT NUTRITION SOUTH AMERICA SEGMENT RESULTS

	3Q 2017		2017 YTD
Plant Nutrition South America Sales	$	123.2	$	250.6
Plant Nutrition South America Operating Earnings	$	21.4	$	24.0
Plant Nutrition South America Sales Volumes (thousands of tons)
Agricultural productivity	163		302
Chemical solutions	70		214
Total tons sold	233		516
Average Plant Nutrition South America Sales Price (per ton)
Agricultural productivity	$	604	$	580
Chemical solutions	$	354	$	353
Combined	$	529	$	486

COMMENTARY: THREE MONTHS ENDED SEPTEMBER 30, 2017

• Plant Nutrition South America sales were $123.2 million for the third quarter. Plant Nutrition South America’s operating results are impacted by seasonality. Sales volumes are usually higher in the third and fourth quarter and lower in the first and second quarters. See “—Seasonality” for more information.

• Plant Nutrition South America average sales price was $529 per ton.

COMMENTARY: NINE MONTHS ENDED SEPTEMBER 30, 2017

• Plant Nutrition South America sales were $250.6 million for the first nine months of 2017. Plant Nutrition South America’s operating results are impacted by seasonality. Sales volumes are usually higher in the third and fourth quarter and lower in the first and second quarters. See “—Seasonality” for more information.

• Plant Nutrition South America average sales price was $486 per ton.

Outlook

• The annual bidding process for North American highway deicing contracts is now complete. Due to the mild winter weather in our North American served market, we expect a contraction of awarded bid volumes when compared to the 2016-2017 bid season of approximately 3%. We expect Salt sales volumes to range from 10.6 million to 11.0 million tons in 2017.

• We expect Plant Nutrition North America sales volumes to range from 320,000 to 340,000 tons in 2017.

• Our Plant Nutrition South America business has been negatively impacted by the delayed start to the planting season in Brazil. As a result, we expect Plant Nutrition South America sales volumes to range from 750,000 to 800,000 tons in 2017.

30

• In July 2017, we initiated a restructuring plan to reduce ongoing costs and further streamline the organization. These initiatives resulted in a charge of $4.3 million in the third quarter of 2017. We continue to actively pursue additional cost reductions in all areas of our business and may incur additional charges in 2017 as a result of these activities.

Liquidity and Capital Resources

Historically, our cash flows from operating activities have generally been adequate to fund our basic operating requirements, ongoing debt service and sustaining investment in property, plant and equipment. We have also used cash generated from operations to fund capital expenditures which strengthen our operational position, pay dividends, fund smaller acquisitions and repay our debt. To a certain extent, our ability to meet our short- and long-term liquidity and capital needs is subject to general economic, financial, competitive, legislative, regulatory, weather, effects of climate change, geological variations in our mine deposits and other factors that are beyond our control. Historically, our working capital requirements have been the highest in the fourth quarter and lowest in the second quarter. As a result of the Produquímica acquisition (described in Note 2 to our consolidated financial statements), we expect a less seasonal distribution of working capital requirements. When needed, we may fund short-term working capital requirements by accessing our $300 million revolving credit facility.

We have been able to manage our cash flows generated and used across Compass Minerals to permanently reinvest earnings in our foreign jurisdictions or efficiently repatriate those funds to the U.S. As of September 30, 2017, we had $36.9 million of cash and cash equivalents (in our consolidated balance sheets) that was either held directly or indirectly by foreign subsidiaries. Due to our ability to generate adequate levels of domestic cash flow on an annual basis, it is our current intention to permanently reinvest our foreign earnings outside of the U.S. However, if we were to repatriate our foreign earnings to the U.S., we may be required to accrue and pay U.S. taxes in accordance with the applicable U.S. tax rules and regulations as a result of the repatriation. We review our tax circumstances on a regular basis with the intent of optimizing cash accessibility and minimizing tax expense.

In addition, the amount of permanently reinvested earnings is influenced by, among other things, the profits generated by our foreign subsidiaries and the amount of investment in those same subsidiaries. The profits generated by our domestic and foreign subsidiaries are impacted by the transfer price charged on the transfer of our products between them. As discussed in Note 6 to our consolidated financial statements, our calculated transfer price on certain products between one of our foreign subsidiaries and a domestic subsidiary has been challenged by Canadian federal and provincial governments. We currently expect the outcome of these matters will not have a material impact on our results of operations. However, it is possible the resolution could materially impact the amount of earnings attributable to our domestic and foreign subsidiaries, which could impact the amount of permanently reinvested foreign earnings as well as future cash flows from our domestic operations. See Note 6 to our consolidated financial statements for a discussion regarding our Canadian tax reassessments.

In April 2016, we entered into a credit agreement to refinance our existing $471 million term loans and $125 million revolving credit facility with a new $400 million senior secured term loan and a $300 million senior secured revolving credit facility, which both mature July 1, 2021. The new term loan and revolving credit facility bear interest at LIBOR plus 1.75% based on our current leverage ratio and credit rating. In connection with this transaction, we paid $5.8 million of refinancing fees in 2016 ($1.4 million was recorded as an expense and $4.4 million was capitalized as deferred financing costs) and wrote-off $0.1 million of existing deferred financing costs related to the previous term loans and revolving credit facility.

In September 2016, we amended our credit agreement to increase our senior secured term loan by $450 million. This additional tranche will mature July 1, 2021, and bears interest at LIBOR plus 2.0%. In connection with this transaction, we incurred $2.2 million of financing fees ($0.7 million was recorded as an expense and $1.5 million was capitalized as deferred financing costs). Proceeds of this additional tranche were used to fund the acquisition of the remaining 65% of Produquímica’s equity in October 2016.

In September 2017, we entered into an amendment to our credit agreement to increase the maximum allowed leverage ratio under the credit agreement through September 2018. In connection with this amendment, we paid fees totaling $0.6 million ($0.1 million was recorded as an expense and $0.5 million was capitalized as deferred financing costs).

In September 2017, we refinanced $32.1 million of our Brazilian loans using the proceeds from $41.1 million of new loans. The new loans bear interest rates ranging from 116.25% and 118% of CDI, an overnight inter-bank lending rate in Brazil, and mature in September 2019. No material fees were paid in connection with these transactions. A portion of the loans are denominated in U.S. dollars and a portion of the loans are denominated in Brazilian Reais. In September 2017, we also entered into foreign currency swap agreements whereby we agreed to swap interest and principal payments on the loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian Reais, Produquímica’s functional currency. See Note 11 to our consolidated financial statements for a discussion of our foreign currency swap agreements.

31

Cash and cash equivalents of $39.1 million as of September 30, 2017, decreased $38.3 million from December 31, 2016. We generated $126.7 million of operating cash flows in the first nine months of 2017. In the first nine months of 2017, we used cash on hand and cash flows from operations to fund capital expenditures of $81.0 million and pay dividends on our common stock of $73.3 million.

As of September 30, 2017, we had $1.34 billion of indebtedness, consisting of $250.0 million outstanding under our 4.875% Notes, $990.7 million of borrowings outstanding under our senior secured credit facilities (consisting of term loans and a revolving credit facility), including $151.2 million borrowed against our revolving credit facility, and $96.0 million of debt related to Produquímica. We had $8.2 million of outstanding letters of credit as of September 30, 2017, which reduced our revolving credit facility borrowing availability to $140.6 million.

Our debt service obligations could, under certain circumstances, materially affect our financial condition and impair our ability to operate our business or pursue our business strategies. As a holding company, CMI’s investments in its operating subsidiaries constitute substantially all of its assets. Consequently, our subsidiaries conduct substantially all of our consolidated operating activities and own substantially all of our operating assets. The principal source of the cash needed to pay our obligations is the cash generated from our subsidiaries’ operations and their borrowings. Our subsidiaries are not obligated to make funds available to CMI. Furthermore, we must remain in compliance with the terms of our credit agreement governing our term loans and revolving credit facility, including the total leverage ratio and interest coverage ratio, in order to make payments on our debt or pay dividends to our stockholders. We must also comply with the terms of our indenture governing our senior notes. Although we are in compliance with our debt covenants as of September 30, 2017, we can make no assurance that we will remain in compliance with these ratios nor can we make any assurance that the agreements governing the current and future indebtedness of our subsidiaries will permit our subsidiaries to provide us with sufficient dividends, distributions or loans to fund scheduled interest payments on our debt when due. If we consummate an additional acquisition, our debt service requirements could increase. Furthermore, we may need to refinance all or a portion of our indebtedness on or before maturity; however, we cannot provide assurance that we will be able to refinance any of our indebtedness on commercially reasonable terms or at all.

See Notes 6 and 8 to our consolidated financial statements for a discussion regarding labor, environmental and litigation matters.

The table below provides a summary of our cash flows by category:

NINE MONTHS ENDED SEPTEMBER 30, 2017	NINE MONTHS ENDED SEPTEMBER 30, 2016
Operating Activities:
» Net earnings were $47.1 million.	» Net earnings were $65.1 million.
» Non-cash depreciation and amortization expense was $89.1 million.	» Non-cash depreciation and amortization expense was $62.7 million.
» Working capital items were a source of operating cash flows of $1.1 million.	» Working capital items were a use of operating cash flows of $23.3 million.
Investing Activities:
» Net cash flows used by investing activities included $81.0 million of capital expenditures.	» Net cash flows used by investing activities included $148.7 million of capital expenditures and an additional investment in Produquímica.
Financing Activities:
» Net cash flows used by financing activities included the payment of dividends of $73.3 million. » In addition, we had net borrowings on our debt of $2.9 million. » We also paid $12.8 million for the final payment related to the Produquímica acquisition.	» Net cash flows used by financing activities included the payment of dividends of $70.5 million. » In addition, we had net borrowings on our debt of $493.0 million, payments of $7.3 million related to the refinancing of our credit facility in April and September 2016 and $0.7 million in proceeds received from stock option exercises.

Sensitivity Analysis Related to EBITDA and Adjusted EBITDA

Management uses a variety of measures to evaluate our performance. While our consolidated financial statements, taken as a whole, provide an understanding of our overall results of operations, financial condition and cash flows, we analyze components of the consolidated financial statements to identify certain trends and evaluate specific performance areas. In addition to using U.S. GAAP financial measures, such as gross profit, net earnings and cash flows generated by operating activities, management uses EBITDA and Adjusted EBITDA. Both EBITDA and Adjusted EBITDA are non-GAAP financial measures used to evaluate the operating performance of our core business operations, because our resource allocation, financing methods, cost of capital and income tax positions are managed at a corporate level apart from the activities of the operating segments and our operating facilities

32

are located in different taxing jurisdictions, which can cause considerable variation in net earnings. We also use these measures to assess our operating performance and return on capital, and to evaluate potential acquisitions or other capital projects. These measures are not calculated under U.S. GAAP and should not be considered in isolation or as a substitute for net earnings, cash flows or other financial data prepared in accordance with U.S. GAAP or as a measure of our overall profitability or liquidity. EBITDA and Adjusted EBITDA exclude interest expense, income taxes and depreciation and amortization, each of which are an essential element of our cost structure and cannot be eliminated. Furthermore, Adjusted EBITDA excludes other cash and non-cash items including restructuring costs and other (income) expense. Our borrowings are a significant component of our capital structure and interest expense is a continuing cost of debt. We are also required to pay income taxes, a required and ongoing consequence of our operations. We have a significant investment in capital assets and depreciation and amortization reflect the utilization of those assets in order to generate revenues. Consequently, any measure that excludes these elements has material limitations. While EBITDA and Adjusted EBITDA are frequently used as measures of operating performance, these terms are not necessarily comparable to similarly titled measures of other companies due to the potential inconsistencies in the method of calculation. 

The calculation of EBITDA and Adjusted EBITDA as used by management is set forth in the table below (in millions):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2017			2016		2017			2016
Net earnings	$	32.0		$	9.1	$	47.1		$	65.1
Interest expense	13.5			5.4		39.5			16.8
Income tax (benefit) expense	(12.5		)	3.1		(7.7		)	24.1
Depreciation, depletion and amortization	32.7			21.8		89.1			62.7
EBITDA	65.7			39.4		168.0			168.7
Adjustments to EBITDA:
Restructuring charges	4.3			—		4.3			—
Other (income) expense, net	(1.2		)	1.5		0.5			1.6
Adjusted EBITDA	$	68.8		$	40.9	$	172.8		$	170.3

Recent Accounting Pronouncements

See Note 1 to our consolidated financial statements for a discussion of recent accounting pronouncements.

Effects of Currency Fluctuations

Our operations outside of the U.S. are conducted primarily in Canada, Brazil and the U.K. Therefore, our results of operations are subject to both currency transaction risk and currency translation risk. We incur currency transaction risk whenever we or one of our subsidiaries enter into either a purchase or sales transaction using a currency other than the local currency of the transacting entity. With respect to currency translation risk, our financial condition and results of operations are measured and recorded in the relevant local currency and then translated into U.S. dollars for inclusion in our historical consolidated financial statements. Exchange rates between these currencies and the U.S. dollar have fluctuated significantly from time to time and may do so in the future. The majority of revenues and costs are denominated in U.S. dollars, with Canadian dollars, Brazilian Reais and British pounds sterling also being significant. Significant changes in the value of the Canadian dollar, Brazilian Reais or British pound sterling relative to the U.S. dollar could have a material effect on our financial condition.

Although inflation has not had a significant impact on our operations, our efforts to recover cost increases due to inflation may be hampered as a result of the competitive industries and countries in which we operate.

Seasonality

We experience a substantial amount of seasonality in our sales. Our sales of our salt deicing products are seasonal. Consequently, our Salt sales and operating income are generally higher in the first and fourth quarters and lower during the second and third quarters of each year. In particular, sales of highway and consumer deicing salt and magnesium chloride products vary based on the severity of the winter conditions in areas where the product is used. Following industry practice in North America, we seek to stockpile sufficient quantities of deicing salt in the second, third and fourth quarters to meet the estimated requirements for the winter season.

33

Our plant nutrition business is also seasonal. The strongest demand for our Plant Nutrition South America products in Brazil typically occurs during the spring planting season. As a result, we and our customers generally build inventories during the low demand periods of the year to ensure timely product availability during the peak sales season. The seasonality of this demand results in our sales volumes and net sales for our Plant Nutrition South America segment usually being the highest during the third and fourth quarters of each year (as the spring planting season begins in September in Brazil).

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

Our business is subject to various types of market risks that include interest rate risk, foreign currency exchange rate risk and commodity pricing risk. Management has taken actions to mitigate our exposure to commodity pricing and foreign currency exchange risk rate by entering into natural gas derivative instruments and foreign currency swaps. We may take further actions to mitigate our exposure to interest rates, exchange rates and changes in the cost of transporting our products due to variations in our contracted carriers’ cost of fuel, which is typically diesel fuel. However, there can be no assurance that our hedging activities will eliminate or substantially reduce these risks. We do not enter into any financial instrument arrangements for speculative purposes. Our market risk exposure related to these items has not changed materially since December 31, 2016.

Item 4.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2017, to ensure that information required to be disclosed in the reports it files and submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

For this purpose, disclosure controls and procedures include controls and procedures designed to ensure that information that is required to be disclosed under the Exchange Act is accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

The scope of management’s evaluation did not include any disclosure controls or procedures (to the extent that they are subsumed by internal control over financial reporting) of Produquímica, which the Company acquired on October 3, 2016. Produquímica represented approximately 34% of total assets as of December 31, 2016, and 10% of total revenues and 2% of net earnings for the year ended December 31, 2016. Further discussion of this acquisition can be found in Note 2 to the Company’s consolidated financial statements.

Changes in Internal Control Over Financial Reporting

There has been no change in the Company’s internal control over financial reporting during the most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

34

PART II. OTHER INFORMATION

Item 1.    Legal Proceedings

We are involved in the legal proceedings described in Note 6 and Note 8 to our consolidated financial statements and, from time to time, various routine legal proceedings and claims arising from the ordinary course of our business. These primarily involve tax assessments, disputes with former employees and contract labor, commercial claims, product liability claims, personal injury claims and workers’ compensation claims. Management cannot predict the outcome of legal proceedings and claims with certainty. Nevertheless, management believes that the outcome of legal proceedings and claims, which are pending or known to be threatened, even if determined adversely, will not, either individually or in the aggregate, have a material adverse effect on our results of operations, cash flows or financial condition. There have been no material developments since December 31, 2016, with respect to our legal proceedings, except as described in Note 6 and Note 8 to our consolidated financial statements.

Item 1A.    Risk Factors

For a discussion of the risk factors applicable to Compass Minerals, please refer to Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2016. There have been no material changes to our risk factors as disclosed in such Annual Report.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.    Defaults Upon Senior Securities

None.

Item 4.    Mine Safety Disclosures

Information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K is included in Exhibit 95 to this Quarterly Report on Form 10-Q.

Item 5.    Other Information

None.

Item 6.    Exhibits

The Exhibit Index attached to this Quarterly Report on Form 10-Q is incorporated herein by reference.

35

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	COMPASS MINERALS INTERNATIONAL, INC.
Date: October 31, 2017	By:	/s/ James D. Standen
		James D. Standen
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

36

EXHIBIT INDEX

Exhibit No.	Exhibit Description
10.1	Amendment No. 2, dated September 15, 2017 to the Credit Agreement, dated April 20, 2016, among Compass Minerals International, Inc., Compass Minerals Canada Corp., Compass Minerals UK Limited, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto (incorporated herein by reference to Exhibit 10.1 to Compass Minerals International Inc.’s Current Report on Form 8-K filed on September 18, 2017).
31.1*	Section 302 Certifications of Francis J. Malecha, President and Chief Executive Officer.
31.2*	Section 302 Certifications of James D. Standen, Chief Financial Officer.
32**	Certification Pursuant to 18 U.S.C. §1350 of Francis J. Malecha, President and Chief Executive Officer, and James D. Standen, Chief Financial Officer.
95*	Mine Safety Disclosures.
101**	The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, formatted in Extensive Business Reporting Language (XBRL): (i) consolidated balance sheets, (ii) consolidated statements of operations, (iii) consolidated statements of comprehensive income, (iv) consolidated statement of stockholders’ equity, (v) consolidated statements of cash flows, and (vi) the notes to the consolidated financial statements.

* Filed herewith

** Furnished herewith

37

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Francis J. Malecha, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Compass Minerals International, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 31, 2017	By:	/s/ Francis J. Malecha
		Francis J. Malecha
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, James D. Standen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Compass Minerals International, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 31, 2017	By:	/s/ James D. Standen
		James D. Standen
		Chief Financial Officer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. §1350

Each of the undersigned hereby certifies that this quarterly report on Form 10-Q for the period ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof, based on my knowledge, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Compass Minerals International, Inc.

Date: October 31, 2017	By:	/s/ Francis J. Malecha
		Francis J. Malecha
		President and Chief Executive Officer
	By:	/s/ James D. Standen
		James D. Standen
		Chief Financial Officer

EX-95

Exhibit 95

Mine Safety Disclosure

We understand that to prevent employee and contractor injuries, we must approach safety excellence from many directions at once. We have developed a three-pronged approach towards world class safety performance. This approach consists of (1) setting a high standard of risk mitigation, (2) having robust safety management systems, and (3) supporting a culture of full engagement and personal accountability at all levels of the organization.

We continuously monitor our safety performance by assessing injury and non-injury incidents (e.g., near misses/near hits) as well as key performance indicators. We believe our approach to safety excellence will help us deliver on our commitment to our employees, contractors, their families and our customers to provide a safe working environment.

Mine Safety Data

A subsidiary of Compass Minerals International, Inc. owns and operates the Cote Blanche mine, an underground salt mine located in St. Mary Parish, Louisiana. The Cote Blanche mine is subject to regulation by the Mine Safety and Health Administration (“MSHA”) under the Federal Mine Safety and Health Act of 1977, as amended (the “Mine Act”).

MSHA is required to regularly inspect the Cote Blanche mine and issue a citation, or take other enforcement action, if an inspector or authorized representative believes that a violation of the Mine Act or MSHA’s standards or regulations has occurred. MSHA is required to propose a civil penalty for each alleged violation that it cites.

We have the option to contest any enforcement action or related penalty we receive before the Federal Mine Safety and Health Review Commission. As a result of this process, an enforcement action may be modified or vacated and any civil penalty proposed by MSHA for an alleged violation may be increased, reduced or eliminated. However, under the Mine Act, we are required to abate (or correct) each alleged violation within a specified time period, regardless of whether we contest the alleged violation.

The table below sets forth information for the reporting period ended September 30, 2017 concerning certain mine safety violations and other regulatory matters pursuant to requirements under the Dodd-Frank Wall Street Reform and Consumer Protection Act and Securities and Exchange Commission rules and regulations. The information only reflects our U.S. mining operations, as these requirements do not apply to mining operations outside the U.S.

Mine Name/ Mine I.D. Number	Section 104 S&S Citations & Orders1	Section 104(b) Orders2	Section 104(d) Citations & Orders3	Section 110(b)(2) Violations4	Section 107(a) Orders5	Total Dollar Value of MSHA Proposed Assessments (Actual Amount)	Total Number of Mining Related Fatalities	Received Notice of Pattern of Violations under Section 104(e) (Yes/No)6	Legal Actions Pending as of Last Day of Period	Legal Actions Initiated During Period	Legal Actions Resolved During Period
Cote Blanche Mine/16-00358	3	0	0	0	0	$3,426	0	No	0	0	0

¹  Represents the number of citations and orders issued under section 104 of the Mine Act for alleged violations of mandatory health or safety standards that could significantly and substantially contribute to a mine health and safety hazard. The number reported includes no orders alleging an S&S violation issued under Section 104(g) of the Mine Act.

²  Represents the number of orders issued under section 104(b) of the Mine Act for alleged failures to abate a citation issued under section 104(a) of the Mine Act within the time period specified in the citation.

³  Represents the number of citations and orders issued under section 104(d) of the Mine Act for alleged unwarrantable failures (aggravated conduct constituting more than ordinary negligence) to comply with mandatory safety or health standards.

⁴  Represents the number of violations issued under section 110(b)(2) of the Mine Act for alleged “flagrant” failures (reckless or repeated failures) to make reasonable efforts to eliminate a known violation of a mandatory safety or health standard that substantially proximately caused, or reasonably could have been expected to cause, death or serious bodily injury.

⁵  Represents the number of orders issued under section 107(a) of the Mine Act for alleged conditions or practices which could reasonably be expected to cause death or serious physical harm before the condition or practice can be abated.

⁶  Section 104(e) written notices are issued for an alleged pattern of violating mandatory health or safety standards that could significantly and substantially contribute to a mine safety or health hazard.

2

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Oct. 27, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	COMPASS MINERALS INTERNATIONAL INC
Entity Central Index Key	0001227654
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		33,827,501
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 39.1	$ 77.4
Receivables, less allowance for doubtful accounts of $10.9 in 2017 and $9.0 in 2016	209.6	320.9
Inventories	336.0	280.6
Other	47.4	36.1
Total current assets	632.1	715.0
Property, plant and equipment, net	1,140.0	1,092.3
Intangible assets, net	150.9	157.6
Goodwill	421.6	412.2
Investment in equity investee	24.7	24.9
Other	77.5	64.5
Total assets	2,446.8	2,466.5
Current liabilities:
Current portion of long-term debt	55.4	130.2
Accounts payable	94.6	100.8
Accrued expenses	70.2	105.3
Accrued salaries and wages	25.5	22.6
Income taxes payable	0.0	4.4
Accrued interest	5.3	8.7
Total current liabilities	251.0	372.0
Long-term debt, net of current portion	1,274.2	1,194.8
Deferred income taxes, net	123.7	130.8
Other noncurrent liabilities	49.9	51.8
Commitments and contingencies
Stockholders’ equity:
Common stock: $0.01 par value, 200,000,000 authorized shares; 35,367,264 issued shares	0.4	0.4
Additional paid-in capital	101.2	97.1
Treasury stock, at cost — 1,540,418 shares at September 30, 2017, and 1,577,960 shares at December 31, 2016	(2.9)	(3.0)
Retained earnings	701.3	727.5
Accumulated other comprehensive loss	(52.0)	(104.9)
Total stockholders’ equity	748.0	717.1
Total liabilities and stockholders’ equity	$ 2,446.8	$ 2,466.5

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Allowance for doubtful accounts	$ 10.9	$ 9.0
Stockholders’ equity:
Common Stock, par or stated value per share (in dollars per share)	$ 0.01	$ 0.01
Common Stock, shares authorized (in shares)	200,000,000	200,000,000
Common Stock, shares issued (in shares)	35,367,264	35,367,264
Treasury stock, shares (in shares)	1,540,418	1,577,960

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Sales	$ 290.7	$ 179.6	$ 906.5	$ 694.8
Shipping and handling cost	45.5	38.4	179.8	164.9
Product cost	169.1	96.0	524.1	340.8
Gross profit	76.1	45.2	202.6	189.1
Selling, general and administrative expenses	44.7	25.7	123.8	79.8
Operating earnings	31.4	19.5	78.8	109.3
Other expense (income):
Interest expense	13.5	5.4	39.5	16.8
Net (earnings) loss in equity investee	(0.4)	0.4	(0.6)	1.7
Other, net	(1.2)	1.5	0.5	1.6
Earnings before income taxes	19.5	12.2	39.4	89.2
Income tax (benefit) expense	(12.5)	3.1	(7.7)	24.1
Net earnings	$ 32.0	$ 9.1	$ 47.1	$ 65.1
Basic net earnings per common share (in dollars per share)	$ 0.94	$ 0.27	$ 1.38	$ 1.92
Diluted net earnings per common share (in dollars per share)	$ 0.94	$ 0.27	$ 1.38	$ 1.92
Weighted-average common shares outstanding (in thousands):
Basic (in shares)	33,825	33,786	33,817	33,772
Diluted (in shares)	33,825	33,789	33,817	33,775
Cash dividends per share (in dollars per share)	$ 0.72	$ 0.695	$ 2.16	$ 2.085

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
Net earnings	$ 32.0	$ 9.1	$ 47.1	$ 65.1
Other comprehensive income (loss):
Unrealized gain from change in pension obligations, net of tax of $(0.0) in both the three and nine months ended September 30, 2017, and 2016.	0.0	0.0	0.2	0.2
Unrealized (loss) gain on cash flow hedges, net of tax of $0.4 and $0.9 in the three and nine months ended September 30, 2017, respectively, and $0.0 and $(0.8) in the three and nine months ended September 30, 2016, respectively.	(0.7)	(0.1)	(1.6)	1.3
Cumulative translation adjustment	46.1	(3.9)	54.3	27.2
Comprehensive income	$ 77.4	$ 5.1	$ 100.0	$ 93.8

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
Unrealized gain from change in pension obligations, tax	$ 0.0	$ 0.0	$ 0.0	$ 0.0
Unrealized (loss) gain on cash flow hedges, tax	$ 0.4	$ 0.0	$ 0.9	$ (0.8)

XML

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]
Beginning balance at Dec. 31, 2015						$ (108.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	$ 93.8
Ending balance at Sep. 30, 2016						(79.6)
Beginning balance at Jun. 30, 2016						(75.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	5.1
Ending balance at Sep. 30, 2016						(79.6)
Beginning balance at Dec. 31, 2016	717.1	$ 0.4	$ 97.1	$ (3.0)	$ 727.5	(104.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	100.0				47.1	52.9
Dividends on common stock	(73.2)		0.1		(73.3)
Shares issued for stock units	0.0		(0.1)	0.1
Stock options exercised	0.3		0.3
Stock-based compensation	3.8		3.8
Ending balance at Sep. 30, 2017	748.0	0.4	101.2	(2.9)	701.3	(52.0)
Beginning balance at Jun. 30, 2017						(97.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	77.4
Ending balance at Sep. 30, 2017	$ 748.0	$ 0.4	$ 101.2	$ (2.9)	$ 701.3	$ (52.0)

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net earnings	$ 47.1	$ 65.1
Adjustments to reconcile net earnings to net cash flows provided by operating activities:
Depreciation, depletion and amortization	89.1	62.7
Finance fee amortization	1.7	1.0
Early extinguishment of debt	0.0	0.1
Stock-based compensation	3.8	3.8
Deferred income taxes	(11.9)	(4.5)
Net (earnings) loss in equity method investee	(0.6)	1.7
Gain on settlement of acquisition-related contingent consideration	(1.9)	0.0
Other, net	(1.7)	0.5
Changes in operating assets and liabilities:
Receivables	116.6	33.6
Inventories	(49.0)	3.1
Other assets	(20.2)	(12.8)
Accounts payable and accrued expenses	(46.1)	(46.6)
Other liabilities	(0.2)	(0.6)
Net cash provided by operating activities	126.7	107.1
Cash flows from investing activities:
Capital expenditures	(81.0)	(148.7)
Investment in equity method investee	0.0	(4.7)
Other, net	(3.8)	(2.9)
Net cash used in investing activities	(84.8)	(156.3)
Cash flows from financing activities:
Proceeds from revolving credit facility borrowings	183.5	264.9
Principal payments on revolving credit facility borrowings	(137.9)	(147.4)
Proceeds from issuance of long-term debt	52.9	850.0
Principal payments on long-term debt	(95.6)	(474.5)
Acquisition-related contingent consideration payment	(12.8)	0.0
Dividends paid	(73.3)	(70.5)
Fees paid to refinance debt	(0.1)	(1.5)
Deferred financing costs	(0.7)	(5.8)
Proceeds received from stock option exercises	0.3	0.7
Excess tax benefit (deficiency) from equity compensation awards	0.0	(0.2)
Other, net	1.0	0.0
Net cash (used in) provided by financing activities	(82.7)	415.7
Effect of exchange rate changes on cash and cash equivalents	2.5	7.3
Net change in cash and cash equivalents	(38.3)	373.8
Cash and cash equivalents, beginning of the year	77.4	58.4
Cash and cash equivalents, end of period	39.1	432.2
Supplemental cash flow information:
Interest paid, net of amounts capitalized	33.5	18.6
Income taxes paid, net of refunds	$ 22.9	$ 54.0

XML

Accounting Policies and Basis of Presentation

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Accounting Policies and Basis of Presentation

Accounting Policies and Basis of Presentation:

Compass Minerals International, Inc. (“CMI”), through its subsidiaries (collectively, the “Company”), is a leading producer of essential minerals that solve nature’s challenges, including salt for winter roadway safety and other consumer, industrial and agricultural uses, specialty plant nutrition minerals that improve the quality and yield of crops, and specialty chemicals for water treatment and other industrial processes. The Company’s principal products are salt, consisting of sodium chloride and magnesium chloride, sulfate of potash (“SOP”), various micronutrient products, and specialty chemicals for water treatment and other industrial processes. The Company’s production sites are located in the United States (“U.S.”), Canada, Brazil and the United Kingdom (the “U.K.”). Except where otherwise noted, references to North America include only the continental U.S. and Canada, and references to the U.K. include only England, Scotland and Wales. References to “Compass Minerals,” “our,” “us” and “we” refer to CMI and its consolidated subsidiaries. The Company also provides records management services to businesses located in the U.K. In October 2016, the Company acquired Produquímica Indústria e Comércio S.A. (“Produquímica”), which operates two primary businesses in Brazil – agricultural productivity and chemical solutions.

CMI is a holding company with no significant operations other than those of its wholly-owned subsidiaries. The consolidated financial statements include the accounts of CMI and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

The Company uses the equity method of accounting for equity securities when it has significant influence or when it has more than a minor ownership interest or more than minor influence over an investee’s operations but does not have a controlling financial interest. Initial investments are recorded at cost (including certain transaction costs) and are adjusted by the Company’s share of the investees’ undistributed earnings and losses.

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2016, as filed with the Securities and Exchange Commission in its Annual Report on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments considered necessary for a fair presentation, have been included.

The Company experiences a substantial amount of seasonality in its sales with respect to its deicing salt products. As a result, sales and operating income are generally higher in the first and fourth quarters and lower during the second and third quarters of each year. In particular, sales of highway and consumer deicing salt and magnesium chloride products vary based on the severity of the winter conditions in areas where the products are used. Following industry practice in North America and the U.K., the Company seeks to stockpile sufficient quantities of deicing salt throughout the second, third and fourth quarters to meet the estimated requirements for the upcoming winter season. Production of deicing salt can also vary based on the severity or mildness of the preceding winter season. Due to the seasonal nature of the deicing product lines, operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.

The Company’s plant nutrition business is also seasonal. For example, the strongest demand for the Company’s plant nutrition products in Brazil typically occurs during the spring planting season. As a result, the Company and its customers generally build inventories during the low demand periods of the year to ensure timely product availability during the peak sales season. The seasonality of this demand results in the Company’s sales volumes and net sales for the Plant Nutrition South America segment usually being the highest during the third and fourth quarters of each year (as the spring planting season begins in September in Brazil).

Recent Accounting Pronouncements

In January 2017, the Financial Accounting Standards Board (the “FASB”) issued guidance to simplify the accounting for goodwill impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance will remain largely unchanged. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for annual and interim goodwill impairment testing dates after January 1, 2017. The Company plans to early adopt the guidance for its 2017 impairment testing.

In August 2016, the FASB issued guidance to clarify how certain cash receipts and payments should be presented and classified in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements.

In June 2016, the FASB issued guidance for estimating credit losses on certain types of financial instruments, including trade receivables, by introducing an approach based on expected losses. The expected loss approach will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, requires a modified retrospective transition method and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements.

In March 2016, the FASB issued guidance to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company adopted this guidance in the first quarter of 2017 on a prospective basis, and prior periods have not been adjusted. The Company elected the option available under the new guidance to continue to estimate the effect of forfeitures in the calculation of share-based payment expense. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In February 2016, the FASB issued guidance which requires lessees to recognize on their balance sheet a right-of-use asset which represents a lessee’s right to use the underlying asset. Under this guidance, an entity must also recognize a lease liability which represents a lessee’s obligation to make lease payments for the right to use the asset. In addition, the standard requires expanded qualitative and quantitative disclosures. The guidance is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and requires a modified retrospective transition method. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements.

In July 2015, the FASB issued guidance that requires entities to measure inventory within the scope of the standard at the lower of cost or net realizable value. “Net realizable value” is defined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company adopted this guidance in the first quarter of 2017. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In May 2014, the FASB issued guidance to provide a single, comprehensive revenue recognition model for all contracts with customers. The new revenue recognition model supersedes existing revenue recognition guidance and requires revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration an entity expects to receive in exchange for those goods or services. The guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those years, and early adoption is permitted. The guidance permits the use of either a full or modified retrospective transition method. The Company plans to use the modified retrospective transition method. While the Company has not identified any material differences in the amount and timing of revenue recognition for the revenue streams management has reviewed to date, the Company is still evaluating the impact of this guidance and has not concluded on the overall impact of adopting this guidance. Adoption of this guidance will significantly impact the Company’s financial statement disclosures regarding revenue.

XML

Acquisition

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Acquisition

Acquisition:

Background and Financing

On December 16, 2015, Compass Minerals do Brasil Ltda., a wholly owned subsidiary of the Company (“Compass Minerals Brazil”), entered into (i) a subscription agreement and other covenants (as amended, the “Subscription Agreement”) with certain shareholders of Produquímica and Produquímica and (ii) a share purchase and sale agreement and other covenants (the “Purchase Agreement”) with certain shareholders of Produquímica and Produquímica. Pursuant to the Subscription Agreement and the Purchase Agreement, Compass Minerals Brazil acquired 35% of the issued and outstanding capital stock of Produquímica on December 23, 2015, for R$452.4 million Brazilian Reais (“R” or “BRL”), or $114.1 million U.S. dollars at closing, and paid additional consideration of $4.7 million in the second quarter of 2016 related to Produquímica’s 2015 financial performance.

The Subscription Agreement also contained a put right (the “Put”), allowing the Produquímica shareholders to sell the remainder of their interests in Produquímica to Compass Minerals Brazil. On August 12, 2016, Produquímica shareholders notified Compass Minerals Brazil of their exercise of the Put. On October 3, 2016, the Company acquired the remaining 65% of the issued and outstanding capital stock of Produquímica.

The Company entered into a new $100.0 million term loan tranche in the fourth quarter of 2015 to fund the acquisition of the 35% of Produquímica’s equity. In September 2016, the Company entered into a new $450.0 million term loan tranche to fund the acquisition of the remaining 65% of Produquímica’s equity. See Note 7 for more information regarding these financings.

Based in São Paulo, Brazil, Produquímica operates two primary businesses – agricultural productivity and chemical solutions. The agricultural productivity division manufactures and distributes a broad offering of specialty plant nutrition solution-based products. These include micronutrients, controlled release fertilizers and other specialty supplements that are used in direct soil and foliar applications, as well as through irrigation systems and for seed treatment. Many of these products are developed through Produquímica’s research and development capabilities. Produquímica also manufactures and markets specialty chemicals used primarily in the industrial chemical and water treatment industries in Brazil. The acquisition broadens the Company’s geographic scope of operations and expands its specialty plant nutrition portfolio while reducing the Company’s dependence on winter weather conditions.

Purchase Price Allocation

The Company accounted for the Produquímica acquisition as a business combination in accordance with U.S. GAAP. The accounting guidance for business combinations requires estimates and judgments regarding expectations for future cash flows of the acquired entity as well as other valuation assumptions and an allocation to the net assets acquired. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s best estimates. As of September 30, 2017, the purchase price allocation was finalized.

A summary of the acquisition-date fair value of the consideration transferred is presented in the table below:

Fair Value of Consideration Transferred (in millions)	October 3, 2016
Cash paid at closing	$	317.1
Additional cash due at closing	20.6
Fair value of contingent consideration	31.4
Fair value of 35% equity investment	178.7
Total	$	547.8

The calculation of the purchase price at closing was based in part on an estimate of full-year 2016 operating results of Produquímica. As of the acquisition closing date, some of the periods included in the 2016 operating results of Produquímica had not ended and actual results were not known. The portion of the purchase price which was based on management’s estimate of results relating to periods which occurred after the closing date was classified as contingent consideration. There were no thresholds or tiers in the payment structure, and management used an income approach to estimate the acquisition date fair value of the contingent consideration. As of the closing date, the Company had estimated the fair value of contingent consideration to be $31.4 million.

During the first quarter of 2017, the purchase price was adjusted based on the final full-year 2016 operating results of Produquímica, and a final payment was made to the Produquímica shareholders. The difference between the estimated closing date fair value of the contingent consideration and the final amount paid resulted in the recognition of a gain of $1.9 million in the first quarter of 2017, which was included as a component of operating earnings in the Company’s Plant Nutrition South America segment.

Prior to the acquisition closing date, the Company accounted for its 35% interest in Produquímica as an equity method investment. The acquisition-date fair value of the previously held equity investment was $178.7 million and is included in the consideration transferred. To measure the acquisition closing date fair value of the equity interest, the Company utilized a market-based approach which relied on Level 3 inputs (see Note 12 for a discussion of the levels in the fair value hierarchy). The Company recognized a $59.3 million non-cash gain during the fourth quarter of 2016 as a result of remeasuring its prior equity interest in Produquímica held before the business combination.

Under the acquisition method of accounting, the total purchase price is allocated on a preliminary basis to Produquímica’s assets and liabilities based upon their estimated fair value as of the closing date of the acquisition. During the first nine months of 2017, the Company adjusted the preliminary purchase price allocation based on additional information obtained regarding facts and circumstances which existed as of the acquisition date. These adjustments resulted in a decrease of $3.6 million to goodwill, a decrease of $4.4 million to other noncurrent liabilities and an increase of $0.8 million to net deferred income taxes. Additionally, during the third quarter of 2017 in connection with finalizing the accounting for the acquisition, the Company recorded an adjustment increasing depreciation expense by $1.9 million. This adjustment resulted from finalizing the Company’s estimate of the useful lives of acquired tangible assets.

Based upon the final purchase price and the updated valuation, the final purchase price allocation is presented in the table below:

Recognized amounts of identifiable assets acquired and liabilities assumed (in millions):	Purchase Price Allocation
Cash and cash equivalents	$	73.8
Accounts receivable	89.4
Inventory	77.1
Other current assets	13.7
Property, plant and equipment	189.4
Identified intangible assets	81.2
Investment in equity method investee	24.5
Other noncurrent assets	6.9
Accounts payable	(27.1		)
Accrued expenses	(40.3		)
Current portion of long-term debt	(129.6		)
Other current liabilities	(14.0		)
Long-term debt, net of current portion	(62.0		)
Deferred income taxes, net	(66.0		)
Other noncurrent liabilities	(21.9		)
Total identifiable net assets	195.1
Goodwill	352.7
Total fair value of business combination	$	547.8

The total purchase price in excess of the net identifiable assets has been recognized as goodwill in the amount of $352.7 million and has been assigned to the Company’s new Plant Nutrition South America segment. The goodwill recognized is attributable primarily to expected synergies with the Company’s existing plant nutrition business and the assembled workforce of Produquímica. The future deductibility of the goodwill for income tax purposes is uncertain at this time.

The Company determined that the book value of the accounts receivables included in the purchase price allocation approximates their fair value due to their short-term nature. The gross contractual amounts of the receivables exceeded their fair value by the amount of an allowance for doubtful accounts of approximately $8 million.

In connection with the acquisition, the Company acquired identifiable intangible assets which consisted principally of trade names, developed technologies and customer relationships. The fair values were determined using Level 3 inputs (see Note 12 for a discussion of the levels in the fair value hierarchy). The fair values of the identifiable intangible assets were estimated using an income approach method.

The estimated fair values and weighted average amortization period of the identifiable intangible assets are presented in the table below:

	Estimated Fair Value (in millions)		Weighted-Average Amortization Period (in years)
Trade names	$	36.9	11.0
Developed technology	37.5		5.3
Customer relationships	6.8		13.5
Total identifiable intangible assets	$	81.2	8.6

Impact on Operating Results

During the three and nine months ended September 30, 2017, Produquímica contributed revenues of $123.2 million and $250.6 million, respectively, and net earnings of $29.5 million and $20.7 million, respectively, to the Company.

The following table presents combined unaudited pro forma results for the three and nine months ended September 30, 2016. The pro forma financial information combines the historical results of operations for Produquímica and Compass Minerals as though the acquisition occurred on January 1, 2015. The pro forma information does not purport to represent the actual results of operations that Produquímica and Compass Minerals would have achieved had the companies been combined during the periods presented nor is the information intended to project the future results of operations. Certain adjustments to Produquímica’s historical results have been made to conform to U.S. GAAP and amounts have been translated to U.S. dollars.

Unaudited Combined Pro Forma Results of Operations (in millions)	Three Months Ended September 30, 2016		Nine Months Ended September 30, 2016
Revenues	$	289.7	$	938.1
Net earnings	18.5		68.7

Significant adjustments to the pro forma information above include:

• Adjustments to exclude non-recurring direct incremental costs of the acquisition;

• Adjustments to expenses relating to the financing transactions described above;

• Adjustments to reflect incremental amortization and depreciation from the preliminary allocation of the purchase price;

• Adjustments to reflect certain income tax effects of the acquisition; and

• Adjustments to remove net earnings related to the previously held 35% equity interest in Produquímica.

XML

Inventories

9 Months Ended

Sep. 30, 2017

Inventory Disclosure [Abstract]

Inventories

Inventories:

Inventories consist of the following (in millions):

	September 30, 2017		December 31, 2016
Finished goods	$	260.3	$	206.1
Raw materials and supplies	75.7		74.5
Total inventories	$	336.0	$	280.6

XML

Property, Plant and Equipment, Net

9 Months Ended

Sep. 30, 2017

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment, Net

Property, Plant and Equipment, Net:

Property, plant and equipment, net, consists of the following (in millions):

	September 30, 2017			December 31, 2016
Land, buildings and structures, and leasehold improvements	$	507.6		$	480.1
Machinery and equipment	914.9			848.2
Office furniture and equipment	51.5			28.3
Mineral interests	173.1			168.5
Construction in progress	267.2			243.6
	1,914.3			1,768.7
Less accumulated depreciation and depletion	(774.3		)	(676.4		)
Property, plant and equipment, net	$	1,140.0		$	1,092.3

XML

Goodwill and Intangible Assets, Net

9 Months Ended

Sep. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets, Net

Goodwill and Intangible Assets, Net:

Aggregate amortization expense for the Company’s finite-lived intangible assets was $4.1 million and $1.1 million in the third quarters of 2017 and 2016, respectively, and $12.2 million and $3.2 million in the first nine months of 2017 and 2016, respectively. The increases in amortization expense were primarily due to amortization of the additional finite-lived intangible assets which were recognized as a result of the purchase price allocation for the Produquímica acquisition (see Note 2 for more information).

The Company had goodwill of $421.6 million and $412.2 million as of September 30, 2017, and December 31, 2016, respectively, in its consolidated balance sheets. Of these amounts, $57.5 million and $53.6 million of the amounts recorded for goodwill as of September 30, 2017, and December 31, 2016, respectively, were recorded in the Company’s Plant Nutrition North America segment, and $358.1 million and $352.8 million of the amounts recorded for goodwill as of September 30, 2017 and December 31, 2016, respectively, were recorded in the Company’s Plant Nutrition South America segment. The remaining amounts in both periods were immaterial and recorded in the Company’s Salt segment and corporate and other. The change in goodwill between December 31, 2016, and September 30, 2017, was primarily due to the impact from translating foreign-denominated amounts to U.S. dollars and purchase price adjustments made related to the Produquímica acquisition (see Note 2 for more information).

XML

Income Taxes

9 Months Ended

Sep. 30, 2017

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes:

The Company’s effective income tax rate differs from the U.S. statutory federal income tax rate primarily due to U.S. statutory depletion, state income taxes (net of federal tax benefit), foreign income tax rate differentials, foreign mining taxes, domestic manufacturing deductions, interest expense recognition differences for book and tax purposes and a partial release of valuation allowance in connection with the acquisition of Produquímica. The Company’s effective rate is impacted by permanent tax deductions which have a less favorable impact as pretax income increases.

During the nine months ended September 30, 2017, the Company determined it is more likely than not that a portion of its Brazilian deferred tax assets acquired in connection with the acquisition of Produquímica will be used to reduce taxable income. Based on current estimates of taxable income, the Company projects to release approximately $25 million of valuation allowances during the year ending December 31, 2017. For the nine months ended September 30, 2017, the Company included approximately $12 million of this valuation allowance release in the calculation of the estimated annual effective tax rate for the current fiscal year, and approximately $13 million as a discrete income tax benefit.

The Company had $52.0 million and $53.6 million as of September 30, 2017, and December 31, 2016, respectively, of gross foreign federal net operating loss (“NOL”) carryforwards that have no expiration date. In addition, the Company had $10.8 million and $7.5 million as of September 30, 2017, and December 31, 2016, respectively, of gross foreign federal NOL carryforwards which expire beginning in 2033 and $1.3 million and $0.9 million as of September 30, 2017, and December 31, 2016, respectively, of tax-effected state NOL carryforwards which expire beginning in 2033.

Canadian provincial tax authorities have challenged tax positions claimed by one of the Company’s Canadian subsidiaries and have issued tax reassessments for years 2002-2012. The reassessments are a result of ongoing audits and total $104.4 million, including interest through September 30, 2017. The Company disputes these reassessments and will continue to work with the appropriate authorities in Canada to resolve the dispute. Although the Company believes it has recorded an adequate reserve for this matter, there is a reasonable possibility that the ultimate resolution of this dispute, and any related disputes for other open tax years, may be materially higher or lower than the amounts the Company has reserved for such disputes. In connection with this dispute, local regulations require the Company to post security with the tax authority until the dispute is resolved. The Company has posted collateral in the form of a $63.6 million performance bond, has paid $35.2 million (most of which is recorded in other assets in its consolidated balance sheets) and the remaining balance of $5.6 million is expected to be addressed later this year, which is necessary to proceed with future appeals or litigation.

In addition, Canadian federal and provincial taxing authorities had reassessed the Company for years 2004-2006, which had been previously settled by agreement among the Company, the Canada Revenue Agency and the Internal Revenue Service of the United States. The Company sought to enforce the agreement, which provided the basis upon which the returns were previously filed and settled. In July 2016, a trial commenced in the Tax Court of Canada with respect to the Canadian federal tax issues for these matters, and in March 2017, the Tax Court of Canada ruled in favor of the Company. The decision of the Tax Court of Canada was not appealed by the Canada Revenue Agency. As a result, the Company believes that reassessed Canadian tax, penalties and interest for the Company for years 2004-2006 of approximately $94.7 million are effectively resolved. The Company is in the process of having certain posted collateral returned in connection with the resolution of the dispute.

The Company received Canadian income tax reassessments for years 2007-2008. The total amount of the reassessments, including penalties and interest through September 30, 2017, related to this matter is $37.2 million. The Company does not agree with these adjustments and is receiving assistance from the tax jurisdictions for relief from the impact of double taxation as available in the tax treaty between the U.S. and Canada. The Company has filed protective Notices of Objection and has posted collateral in the form of a $10.2 million performance bond and a $8.0 million bank letter guarantee, which is necessary to proceed with future appeals or litigation. Although the outcome of examinations by taxing authorities is uncertain, the Company believes it has adequately reserved for this matter.

The Company expects that it will be required by local regulations to provide security for additional interest on the above unresolved disputed amounts and for any future reassessments issued by these Canadian tax authorities in the form of cash, letters of credit, performance bonds, asset liens or other arrangements agreeable with the tax authorities until the disputes are resolved.

The Company expects that the ultimate outcome of these matters will not have a material impact on its results of operations or financial condition. However, the Company can provide no assurance as to the ultimate outcome of these matters, and the impact could be material if they are not resolved in the Company’s favor. As of September 30, 2017, the amount reserved related to these reassessments was immaterial to the Company’s consolidated financial statements.

Additionally, the Company has other uncertain tax positions as well as assessments and disputed positions with taxing authorities in its various jurisdictions, which are consistent with those matters disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

XML

Long-term Debt

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Long-term Debt

Long-term Debt:

Long-term debt consists of the following (in millions):

	September 30, 2017			December 31, 2016
Term Loans due July 2021	$	839.5		$	845.9
Revolving Credit Facility due July 2021	151.2			105.4
4.875% Senior Notes due July 2024	250.0			250.0
Banco Bradesco Loan due February 2017	—			13.2
Banco Votorantim Loan due April 2017	—			12.4
Banco Bradesco Loan due July 2017	—			4.8
Scotiabank Loan due August 2017	—			20.2
Scotiabank Loan due September 2017	—			15.1
Banco Votorantim Loan due September 2017	—			0.8
Banco Bradesco Loan due October 2017	—			16.8
Rabobank Loan due November 2017	22.4			22.6
Banco Itaú Loans due May 2019 to April 2020	2.3			3.1
Financiadora de Estudos e Projetos Loan due November 2023	14.1			7.4
Banco do Brasil Loans due October 2017	0.4			—
Banco do Brasil Loan due November 2017	0.5			—
Banco do Brasil Loan due February 2018	0.2			—
Banco Santander Loan due September 2019	20.5			—
Banco Itaú Loans due March 2019(a)	15.0			15.1
Banco Scotiabank Loan due September 2019	20.6			—
	1,336.7			1,332.8
Less unamortized debt issuance costs	(7.1		)	(7.8		)
Total debt	1,329.6			1,325.0
Less current portion	(55.4		)	(130.2		)
Long-term debt	$	1,274.2		$	1,194.8

(a) In September 2017, the maturity date of this loan was extended from September 2017 to March 2019.

In September 2017, the Company entered into an amendment to its credit agreement, which increased the maximum allowed leverage ratio under the credit agreement through September 2018. In connection with this amendment, the Company paid fees totaling $0.6 million ($0.1 million was recorded as an expense and $0.5 million was capitalized as deferred financing costs).

In September 2017, the Company refinanced $32.1 million of its Brazilian loans using proceeds from $41.1 million of new loans. The new loans bear interest rates ranging from 116.25% and 118% of CDI, an overnight inter-bank lending rate in Brazil, and mature in September 2019. No material fees were paid in connection with these transactions. A portion of the loans are denominated in U.S. dollars and a portion of the loans are denominated in Brazilian Reais. In September 2017, the Company also entered into foreign currency swap agreements whereby the Company agreed to swap interest and principal payments on the loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian Reais, Produquímica’s functional currency (see Note 11 for further discussion).

In September 2016, the Company entered into a new $450 million term loan tranche under its existing credit agreement to fund the acquisition of the remaining 65% of Produquímica’s equity in October 2016 (see Note 2 for more information). This additional tranche will mature July 1, 2021, and bears interest at LIBOR plus 2.0%. In connection with this transaction, the Company incurred $2.2 million of financing fees in 2016 ($0.7 million was recorded as an expense and $1.5 million was capitalized as deferred financing costs).

In April 2016, the Company entered into a new credit agreement to refinance its existing $471 million term loans and $125 million revolving credit facility with a new $400 million senior secured term loan and a $300 million senior secured revolving credit facility, which both mature July 1, 2021. The new term loan and revolving credit facility bear interest at LIBOR plus 1.75% based on the Company’s current leverage ratio and credit rating. In connection with the refinancing, the Company incurred $5.8 million of refinancing fees ($1.4 million was recorded as an expense and $4.4 million was capitalized as deferred financing costs) and wrote-off $0.1 million of existing deferred financing costs related to the previous term loans and revolving credit facility.

As of September 30, 2017, the term loans and revolving credit facility under the credit agreement were secured by substantially all existing and future U.S. assets, the Goderich mine in Ontario, Canada, and capital stock of certain subsidiaries.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies:

The Company was involved in proceedings alleging unfair labor practices at its Cote Blanche, Louisiana, mine. This matter arose out of a labor dispute between the Company and the United Steelworkers Union over the terms of a contract for certain employees at the mine. These employees initiated a strike that began on April 7, 2010, and ended on June 15, 2010. In September 2012, the U.S. National Labor Relations Board (the “NLRB”) issued a decision finding that the Company had committed unfair labor practices in connection with the labor dispute. Under the ruling, the Company is responsible for back pay to affected employees as a result of changes made in union work rules and past practices beginning April 1, 2010. In the fourth quarter of 2013, this ruling was upheld by an appeals court. As of December 31, 2016, the Company had recorded a reserve of $7.4 million in its consolidated financial statements related to expected payments, including interest, required to resolve the dispute.

In March 2017, the Company reached a settlement with the United Steelworkers Union and the NLRB with respect to this matter. Under the terms of the agreement, the Company paid $7.7 million to the affected employees in the second quarter of 2017. As a result of the settlement, the Company recognized an immaterial loss in its consolidated financial statements in 2017.

The Wisconsin Department of Agriculture, Trade and Consumer Protection (“DATCP”) has information indicating that agricultural chemicals are present within the subsurface area of the Company’s Kenosha, Wisconsin, plant. The agricultural chemicals were used by previous owners and operators of the site. None of the identified chemicals have been used in association with the Company’s operations since it acquired the property in 2002. DATCP directed the Company to conduct further investigations into the possible presence of agricultural chemicals in soil and ground water at the Kenosha plant. The Company has completed initial on-property investigations and has provided the findings to DATCP. A second series of sampling and analysis is underway. All investigations and mitigation activities to date, and any potential future remediation work, are being conducted under the Wisconsin Agricultural Chemical Cleanup Program (the “ACCP”), which would provide for reimbursement of some of the costs. The Company may seek participation by, or cost reimbursement from, other parties responsible for the presence of any agricultural chemicals found in soil and ground water at this site if the Company does not receive an acknowledgment of no further action and is required to conduct further investigation or remedial work that may not be eligible for reimbursement under the ACCP.

The Company conducts business operations in several countries and is subject to various federal and local labor, social security, environmental and tax laws. While the Company believes it complies with such laws, they are complex and subject to interpretation. In addition to the tax assessments discussed in Note 6, the Company’s Brazilian subsidiaries are party to administrative tax proceedings and claims which totaled $18.7 million as of September 30, 2017, and relate primarily to value added tax, state tax (ICMS) and social security tax (PIS and COFINS) assessments. The Company has assessed the likelihood of a loss at less than probable and therefore, has not established a reserve for these matters. The Company also has assumed liabilities for labor-related matters in connection with the acquisition of Produquímica, which are primarily related to compensation, labor benefits and consequential tax claims and totaled $11.5 million as of September 30, 2017. The Company believes the maximum exposure for these other labor matters totaled approximately $46 million as of September 30, 2017.

The Company is also involved in legal and administrative proceedings and claims of various types from the ordinary course of the Company’s business.

Management cannot predict the outcome of legal claims and proceedings with certainty. Nevertheless, management believes that the outcome of legal proceeding and claims, which are pending or known to be threatened, even if determined adversely, will not, individually or in the aggregate, have a material adverse effect on the Company’s results of operations, cash flows or financial position.

XML

Operating Segments

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Operating Segments

Operating Segments:

The Company’s reportable segments are strategic business units that offer different products and services, and each business requires different technology and marketing strategies. The Company has three reportable segments: Salt, Plant Nutrition North America and Plant Nutrition South America. The Salt segment produces and markets salt and magnesium chloride for use in road deicing and dust control, food processing, water softeners and agricultural and industrial applications. SOP crop nutrients, industrial-grade SOP, micronutrients and magnesium chloride for agricultural purposes are produced and marketed through the Plant Nutrition North America segment. The Plant Nutrition South America segment represents the results of Produquímica, which was acquired in October 2016. This segment operates two primary businesses in Brazil – agricultural productivity and chemical solutions. See Note 2 for a further discussion of the acquisition. The agricultural productivity division manufactures and distributes a broad offering of specialty plant nutrition solution-based products that are used in direct soil and foliar applications, as well as through irrigation systems and for seed treatment. Produquímica also manufactures and markets specialty chemicals for the industrial chemical industry.

Segment information is as follows (in millions):

Three Months Ended September 30, 2017	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	124.7	$	40.3	$	123.2	$	2.5		$	290.7
Intersegment sales	—		1.5		—		(1.5		)	—
Shipping and handling cost	34.9		4.8		5.8		—			45.5
Operating earnings (loss) (b)	22.5		2.3		21.4		(14.8		)	31.4
Depreciation, depletion and amortization	13.5		9.2		7.5		2.5			32.7
Total assets (as of end of period)	948.7		593.1		844.2		60.8			2,446.8

Three Months Ended September 30, 2016	Salt		Plant Nutrition North America(c)		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	135.7	$	41.5	$	—	$	2.4		$	179.6
Intersegment sales	—		0.6		—		(0.6		)	—
Shipping and handling cost	33.3		5.1		—		—			38.4
Operating earnings (loss)	30.0		2.5		—		(13.0		)	19.5
Depreciation, depletion and amortization	12.2		8.3		—		1.3			21.8
Total assets (as of end of period)	1,249.3		794.1		—		59.0			2,102.4

Nine Months Ended September 30, 2017	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	508.5	$	140.0	$	250.6	$	7.4		$	906.5
Intersegment sales	—		4.4		—		(4.4		)	—
Shipping and handling cost	147.6		18.4		13.8		—			179.8
Operating earnings (loss) (b)	78.6		17.5		24.0		(41.3		)	78.8
Depreciation, depletion and amortization	39.1		26.7		18.2		5.1			89.1

Nine Months Ended September 30, 2016	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	546.9	$	140.4	$	—	$	7.5		$	694.8
Intersegment sales	—		2.7		—		(2.7		)	—
Shipping and handling cost	147.7		17.2		—		—			164.9
Operating earnings (loss)	136.0		12.5		—		(39.2		)	109.3
Depreciation, depletion and amortization	34.2		24.6		—		3.9			62.7

(a) Corporate and other includes corporate entities, records management operations and other incidental operations and eliminations. Operating earnings (loss) for corporate and other includes indirect corporate overhead, including costs for general corporate governance and oversight, as well as costs for the human resources, information technology, legal and finance functions.

(b) Operating results for the three months ended September 30, 2017 include $4.3 million of restructuring charges.

(c) In 2016, total assets for Plant Nutrition North America include the equity investment in Produquímica.

XML

Stockholders' Equity and Equity Instruments

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Stockholders' Equity and Equity Instruments

Stockholders’ Equity and Equity Instruments:

In May 2015, the Company’s stockholders approved the 2015 Incentive Award Plan (the “2015 Plan”), which authorizes the issuance of 3,000,000 shares of Company common stock. Since the date the 2015 Plan was approved, the Company ceased issuing equity awards under the 2005 Incentive Award Plan (the “2005 Plan”). The 2005 Plan and 2015 Plan allow for grants of equity awards to executive officers, other employees and directors, including restricted stock units (“RSUs”), performance stock units (“PSUs”), stock options and deferred stock units. The grants occur following approval by the compensation committee of the Company’s board of directors, with the amount and terms communicated to employees shortly thereafter. 

Options

Substantially all stock options granted under the 2005 Plan and 2015 Plan vest ratably, in tranches, over a four-year service period. Unexercised options expire after seven years. Options do not have dividend or voting rights. Upon vesting, each option can be exercised to purchase one share of the Company’s common stock. The exercise price of options is equal to the closing stock price on the grant date.

To estimate the fair value of options on the grant date, the Company uses the Black-Scholes option valuation model. Award recipients are grouped according to expected exercise behavior. Unless better information is available to estimate the expected term of the options, the estimate is based on historical exercise experience. The risk-free rate, using U.S. Treasury yield curves in effect at the time of grant, is selected based on the expected term of each group. The Company’s historical stock price is used to estimate expected volatility. The inputs used to calculate fair value for options granted in 2017 are included in the table below:

Fair value of options granted	$9.54
Exercise price	$68.00
Expected term (years)	4.5
Expected volatility	23.2%
Dividend yield	3.5%
Risk-free rate of return	1.8%

RSUs

Substantially all of the RSUs granted under the 2005 Plan and 2015 Plan vest after three years of service, entitling the holders to one share of common stock for each vested RSU. Unvested RSUs do not have voting rights but are entitled to receive non-forfeitable dividends (generally after a performance hurdle has been satisfied for the year of the grant) or other distributions equal to those declared on the Company’s common stock for RSUs that are earned as a result of the satisfaction of the performance hurdle. The closing stock price on the grant date is used to determine the fair value of RSUs.

PSUs

Substantially all of the PSUs granted under the 2005 Plan and 2015 Plan are either total shareholder return PSUs (“TSR PSUs”) or return on invested capital PSUs (“ROIC PSUs”). The actual number of shares of the Company’s common stock that may be earned with respect to TSR PSUs is calculated by comparing the Company’s total shareholder return to the total shareholder return for each company comprising the Russell 3000 Index over the three-year performance period and may range from 0% to 150% of the target number of shares based upon the attainment of these performance conditions. The actual number of shares of common stock that may be earned with respect to ROIC PSUs is calculated based on the average of the Company’s annual return on invested capital for each year in the three-year performance period and may range from 0% to 200% of the target number of shares based upon the attainment of these performance conditions.

PSUs represent a target number of shares of the Company’s common stock that may be earned before adjustment based upon the attainment of certain performance conditions. Holders of PSUs do not have voting rights but are entitled to receive non-forfeitable dividends or other distributions equal to those declared on the Company’s common stock for PSUs that are earned, which are paid when the shares underlying the PSUs are paid.

To estimate the fair value of the TSR PSUs on the grant date, the Company uses a Monte-Carlo simulation model, which simulates future stock prices of the Company as well as the companies comprising the Russell 3000 Index. This model uses historical stock prices to estimate expected volatility and the Company’s correlation to the Russell 3000 Index. The risk-free rate was determined using the same methodology as the option valuations as discussed above. The Company’s closing stock price on the grant date was used to estimate the fair value of the ROIC PSUs. The Company will adjust the expense of the ROIC PSUs based upon its estimate of the number of shares that will ultimately vest at each interim date during the vesting period.

During the nine months ended September 30, 2017, the Company reissued the following number of shares from treasury stock: 3,366 shares related to the exercise of stock options, 15,806 shares related to the release of RSUs which vested, 12,946 shares related to the release of PSUs which vested and 5,424 shares related to stock payments. The Company recognized a tax deficiency of $0.6 million from its equity compensation awards as an increase to income tax expense during the first nine months of 2017. During the first nine months of both 2017 and 2016, the Company recorded $3.8 million of compensation expense pursuant to its stock-based compensation plans. No amounts have been capitalized. The following table summarizes stock-based compensation activity during the nine months ended September 30, 2017:

	Stock Options				RSUs				PSUs(a)
	Number		Weighted-average exercise price		Number		Weighted-average fair value		Number		Weighted-average fair value
Outstanding at December 31, 2016	442,755		$	80.07	63,780		$	80.25	89,011		$	89.43
Granted	227,351		68.00		34,635		68.00		58,878		73.08
Exercised(b)	(3,366	)	76.03		—		—		—		—
Released from restriction(b)	—		—		(15,806	)	84.77		(12,946	)	105.77
Cancelled/expired	(80,606	)	76.05		(9,906	)	71.54		(19,416	)	88.18
Outstanding at September 30, 2017	586,134		$	75.97	72,703		$	74.62	115,527		$	79.47

(a) Until they vest, PSUs are included in the table at the target level at their grant date and at that level represent one share of common stock per PSU. The final performance period for the 2014 PSU grant ended in 2016. The Company cancelled 6,900 PSUs in 2017 related to the 2014 PSU grant.

(b) Common stock issued for exercised options and for vested and earned RSUs and PSUs was issued from treasury stock.

Other Comprehensive Income (Loss)

The Company’s comprehensive income (loss) is comprised of net earnings, net amortization of the unrealized loss of the pension obligation, the change in the unrealized gain (loss) on natural gas and foreign currency swap cash flow hedges, and foreign currency translation adjustments. The components of and changes in accumulated other comprehensive income (loss) (“AOCI”) as of and for the three and nine months ended September 30, 2017, and 2016, are as follows (in millions):

Three Months Ended September 30, 2017(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.3	)	$	(3.5	)	$	(93.6	)	$	(97.4	)
Other comprehensive income (loss) before reclassifications(b)	(0.5		)	—			46.1			45.6
Amounts reclassified from accumulated other comprehensive loss	(0.2		)	—			—			(0.2		)
Net current period other comprehensive income (loss)	(0.7		)	—			46.1			45.4
Ending balance	$	(1.0	)	$	(3.5	)	$	(47.5	)	$	(52.0	)

Three Months Ended September 30, 2016(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.2	)	$	(3.6	)	$	(71.8	)	$	(75.6	)
Other comprehensive income (loss) before reclassifications(b)	(0.3		)	—			(3.9		)	(4.2		)
Amounts reclassified from accumulated other comprehensive loss	0.2			—			—			0.2
Net current period other comprehensive income (loss)	(0.1		)	—			(3.9		)	(4.0		)
Ending balance	$	(0.3	)	$	(3.6	)	$	(75.7	)	$	(79.6	)

Nine Months Ended September 30, 2017(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	0.6		$	(3.7	)	$	(101.8	)	$	(104.9	)
Other comprehensive income (loss) before reclassifications(b)	(1.4		)	—			54.3			52.9
Amounts reclassified from accumulated other comprehensive loss	(0.2		)	0.2			—			—
Net current period other comprehensive income (loss)	(1.6		)	0.2			54.3			52.9
Ending balance	$	(1.0	)	$	(3.5	)	$	(47.5	)	$	(52.0	)

Nine Months Ended September 30, 2016(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(1.6	)	$	(3.8	)	$	(102.9	)	$	(108.3	)
Other comprehensive income (loss) before reclassifications(b)	(0.1		)	—			27.2			27.1
Amounts reclassified from accumulated other comprehensive loss	1.4			0.2			—			1.6
Net current period other comprehensive income (loss)	1.3			0.2			27.2			28.7
Ending balance	$	(0.3	)	$	(3.6	)	$	(75.7	)	$	(79.6	)

(a) With the exception of the cumulative foreign currency translation adjustment, for which no tax effect is recorded, the changes in the components of accumulated other comprehensive income (loss) presented in the tables above are reflected net of applicable income taxes.

(b) The Company recorded foreign exchange (gains) losses of $(22.0) million and $(20.6) million in the three and nine months ended September 30, 2017, respectively, and $3.8 million and $(22.9) million in the three and nine months ended September 30, 2016, respectively, in accumulated other comprehensive loss related to intercompany notes which were deemed to be of long-term investment nature.

The amounts reclassified from AOCI to (income) expense for the three and nine months ended September 30, 2017, and 2016, are shown below (in millions):

	Amount Reclassified from AOCI
	Three Months Ended September 30, 2017			Nine Months Ended September 30, 2017			Line Item Impacted in the Consolidated Statement of Operations
Gains and (losses) on cash flow hedges:
Natural gas instruments	$	0.2		$	0.2		Product cost
Foreign currency swaps	(0.5		)	(0.5		)	Interest expense
Income tax expense (benefit)	0.1			0.1
Reclassifications, net of income taxes	(0.2		)	(0.2		)
Amortization of defined benefit pension:
Amortization of loss	$	—		$	0.2		Product cost
Income tax expense (benefit)	—			—
Reclassifications, net of income taxes	—			0.2
Total reclassifications, net of income taxes	$	(0.2	)	$	—

	Amount Reclassified from AOCI
	Three Months Ended September 30, 2016			Nine Months Ended September 30, 2016			Line Item Impacted in the Consolidated Statement of Operations
Gains and (losses) on cash flow hedges:
Natural gas instruments	$	0.3		$	2.2		Product cost
Income tax expense (benefit)	(0.1		)	(0.8		)
Reclassifications, net of income taxes	0.2			1.4
Amortization of defined benefit pension:
Amortization of loss	$	—		$	0.2		Product cost
Income tax expense (benefit)	—			—
Reclassifications, net of income taxes	—			0.2
Total reclassifications, net of income taxes	$	0.2		$	1.6

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments:

The Company is subject to various types of market risks, including interest rate risk, foreign currency exchange rate transaction and translation risk and commodity pricing risk. Management may take actions to mitigate the exposure to these types of risks, including entering into forward purchase contracts and other financial instruments. Currently, the Company manages a portion of its commodity pricing and foreign currency exchange rate risks by using derivative instruments. The Company does not seek to engage in trading activities or take speculative positions with any financial instrument arrangement. The Company has entered into natural gas derivative instruments and foreign currency derivative instruments with counterparties it views as creditworthy. However, the Company does attempt to mitigate its counterparty credit risk exposures by, among other things, entering into master netting agreements with some of these counterparties.The Company records derivative financial instruments as either assets or liabilities at fair value in the consolidated balance sheets.

Derivatives qualify for treatment as hedges when there is a high correlation between the change in fair value of the derivative instrument and the related change in value of the underlying hedged item. Depending on the exposure being hedged, the Company must designate the hedging instrument as a fair value hedge, a cash flow hedge or a net investment in foreign operations hedge. For the qualifying derivative instruments that have been designated as hedges, the effective portion of the change in fair value is recognized through earnings when the underlying transaction being hedged affects earnings, allowing a derivative’s gains and losses to offset related results from the hedged item in the statements of operations. Any ineffectiveness related to these hedges was not material for any of the periods presented. For derivative instruments that have not been designated as hedges, the entire change in fair value is recorded through earnings in the period of change.

Natural Gas Derivative Instruments

Natural gas is consumed at several of the Company’s production facilities, and a change in natural gas prices impacts the Company’s operating margin. The Company’s objective is to reduce the earnings and cash flow impacts of changes in market prices of natural gas by fixing the purchase price of up to 90% of its forecasted natural gas usage. It is the Company’s policy to consider hedging portions of its natural gas usage up to 36 months in advance of the forecasted purchase. As of September 30, 2017, the Company had entered into natural gas derivative instruments to hedge a portion of its natural gas purchase requirements through December 2019. As of September 30, 2017, and December 31, 2016, the Company had agreements in place to hedge forecasted natural gas purchases of 3.3 million and 2.3 million MMBtus, respectively. All natural gas derivative instruments held by the Company as of September 30, 2017, and December 31, 2016, qualified and were designated as cash flow hedges. As of September 30, 2017, the Company expects to reclassify from accumulated other comprehensive loss to earnings during the next twelve months $0.6 million of net losses on derivative instruments related to its natural gas hedges.

Foreign Currency Swaps not Designated as Hedges

In conjunction with the acquisition of Produquímica, the Company assumed U.S. dollar-denominated debt which was previously held by Produquímica. Prior to the acquisition, Produquímica entered into foreign currency swap agreements whereby Produquímica agreed to swap interest and principal payments on the loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian Reais, Produquímica’s functional currency. The objective of the swap agreements is to mitigate the foreign currency fluctuation risk related to holding debt denominated in a currency other than Produquímica’s functional currency. None of the swap agreements relating to the debt assumed in conjunction with the acquisition of Produquímica are designated as hedges.

As of September 30, 2017, and December 31, 2016, the Company had swap agreements in place to economically hedge $22.4 million and $119.6 million, respectively, of loans denominated in currencies other than Produquímica’s functional currency. During the three and nine months ended September 30, 2017, the Company recognized losses of $4.9 million and $10.2 million, respectively, in its consolidated statement of operations for the change in fair value of the swap agreements not designated as hedges.

Foreign Currency Swaps Designated as Hedges

In September 2017, the Company entered into new U.S. dollar-denominated debt instruments to provide funds for its operations in Brazil (see Note 7 for more information). Concurrently, the Company entered into additional foreign currency swap agreements whereby the Company agreed to swap interest and principal payments on loans denominated in U.S. dollars for principal and interest payments denominated in Brazilian Reais, Produquímica’s functional currency. The objective of the swap agreements is to mitigate the foreign currency fluctuation risk related to holding debt denominated in a currency other than Produquímica’s functional currency. As of September 30, 2017, the Company had swap agreements in place to hedge $35.6 million of loans denominated currencies other than Produquímica’s functional currency. Payments on these loans are due on various dates extending through September 2019. As of September 30, 2017, these foreign currency swap derivative instruments qualified and were designated as cash flow hedges. As of September 30, 2017, the Company expects to reclassify from accumulated other comprehensive loss to earnings during the next twelve months $0.1 million of net losses on derivative instruments related to its foreign currency swap agreements.

The following tables present the fair value of the Company’s hedged items as of September 30, 2017, and December 31, 2016 (in millions):

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Balance Sheet Location	September 30, 2017		Balance Sheet Location	September 30, 2017
Commodity contracts	Other current assets	$	0.1	Accrued expenses	$	0.7
Commodity contracts	Other assets	—		Other noncurrent liabilities	0.2
Swap contracts	Other current assets	—		Accrued expenses	0.1
Swap contracts	Other assets	—		Other noncurrent liabilities	0.1
Total derivatives designated as hedging instruments(a)		0.1			1.1
Derivatives not designated as hedging instruments:
Swap contracts	Other current assets	$	—	Accrued expenses	$	7.0
Swap contracts	Other assets	—		Other noncurrent liabilities	—
Total derivatives not designated as hedging instruments		—			7.0
Total derivatives(b)		$	0.1		$	8.1

(a) The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its consolidated balance sheets approximately $0.1 million of its commodity contracts that are in receivable positions against its contracts in payable positions.

(b) The Company has commodity hedge and foreign currency swap agreements with three counterparties each, respectively. Amounts recorded as assets for the Company’s commodity contracts are receivable from three counterparties, and the amounts recorded as liabilities for the Company’s commodity contracts are payable to two counterparties. The amounts recorded as liabilities for the Company’s swap contracts are payable to two counterparties. There is also an immaterial amount receivable from one counterparty.

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Balance Sheet Location	December 31, 2016		Balance Sheet Location	December 31, 2016
Commodity contracts	Other current assets	$	1.2	Accrued expenses	$	0.3
Commodity contracts	Other assets	0.1		Other noncurrent liabilities	0.1
Total derivatives designated as hedging instruments(a)		1.3			0.4
Derivatives not designated as hedging instruments:
Swap contracts	Other current assets	$	—	Accrued expenses	$	25.8
Swap contracts	Other assets	—		Other noncurrent liabilities	—
Total derivatives not designated as hedging instruments		—			25.8
Total derivatives(b)		$	1.3		$	26.2

(a) The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its consolidated balance sheets approximately $0.4 million of its commodity contracts that are in a payable position against its contracts in receivable positions.

(b) The Company has commodity hedge and foreign currency swap agreements with two and five counterparties, respectively. Amounts recorded as assets for the Company’s commodity contracts are receivable from both counterparties, and amounts recorded as liabilities for the Company’s swap contracts are payable to all five counterparties.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements:

The Company’s financial instruments are measured and reported at their estimated fair value. Fair value is the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction. When available, the Company uses quoted prices in active markets to determine the fair values for its financial instruments (Level 1 inputs) or, absent quoted market prices, observable market-corroborated inputs over the term of the financial instruments (Level 2 inputs). The Company does not have any unobservable inputs that are not corroborated by market inputs (Level 3 inputs) other than those described in Note 2.

The Company holds marketable securities associated with its defined contribution and pre-tax savings plans, which are valued based on readily available quoted market prices. The Company also held short-term investments which were classified as trading securities with any gains or losses recognized through earnings. The Company sold these investments during the first quarter of 2017. The Company utilizes derivative instruments to manage its risk of changes in natural gas prices and its risk of changes in foreign currency exchange rates (see Note 11). The fair value of the natural gas and foreign currency swap derivative instruments are determined using market data of forward prices for all of the Company’s contracts. 

The estimated fair values for each type of instrument are presented below (in millions):

	September 30, 2017			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified retirement plan(a)	$	2.1		$	2.1		$	—		$	—
Total Assets	$	2.1		$	2.1		$	—		$	—
Liability Class:
Liabilities related to non-qualified retirement plan	$	(2.1	)	$	(2.1	)	$	—		$	—
Derivatives – natural gas instruments, net	(0.8		)	—			(0.8		)	—
Derivatives – foreign currency swaps, net	(7.2		)	—			(7.2		)	—
Total Liabilities	$	(10.1	)	$	(2.1	)	$	(8.0	)	$	—

(a) Includes mutual fund investments of approximately 30% in common stock of large-cap U.S. companies, 15% in common stock of small to mid-cap U.S. companies, 5% in international companies, 10% in bond funds, 20% in short-term investments and 20% in blended funds.

	December 31, 2016			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan(a)	$	1.8		$	1.8		$	—		$	—
Derivatives – natural gas instruments, net	0.9			—			0.9			—
Trading securities	1.8			—			1.8			—
Total Assets	$	4.5		$	1.8		$	2.7		$	—
Liability Class:
Liabilities related to non-qualified savings plan	$	(1.8	)	$	(1.8	)	$	—		$	—
Derivatives – foreign currency swaps, net	(25.8		)	—			(25.8		)	—
Total Liabilities	$	(27.6	)	$	(1.8	)	$	(25.8	)	$	—

(a) Includes mutual fund investments of approximately 25% in the common stock of large-cap U.S. companies, 10% in the common stock of small to mid-cap U.S. companies, 5% in the common stock of international companies, 5% in bond funds, 40% in short-term investments and 15% in blended funds.

Cash and cash equivalents, accounts receivable (net of allowance for bad debts) and payables are carried at cost, which approximates fair value due to their liquid and short-term nature. The Company’s investments related to its nonqualified retirement plan of $2.1 million and $1.8 million at September 30, 2017, and December 31, 2016, respectively, are stated at fair value based on quoted market prices. As of September 30, 2017, the estimated amount a third-party would pay for the Company’s fixed-rate 4.875% senior notes due July 2024, based on available trading information, totaled $245.6 million (Level 2) compared with the aggregate principal amount at maturity of $250.0 million. The estimated amount a third-party would pay at September 30, 2017, for the amounts outstanding under the Company’s term loans and revolving credit facility, based upon available bid information received from the Company’s lender, totaled $974.7 million (Level 2) compared with the aggregate principal balance of $990.7 million. The loans assumed in the Produquímica acquisition have floating rates and their fair value approximates their carrying value.

XML

Earnings per Share

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Earnings per Share

Earnings per Share:

The Company calculates earnings per share using the two-class method. The two-class method requires allocating the Company’s net earnings to both common shares and participating securities. The following table sets forth the computation of basic and diluted earnings per common share (in millions, except for share and per-share data):

	Three months ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
Numerator:
Net earnings	$	32.0		$	9.1		$	47.1		$	65.1
Less: net earnings allocated to participating securities(a)	(0.2		)	(0.1		)	(0.3		)	(0.3		)
Net earnings available to common shareholders	$	31.8		$	9.0		$	46.8		$	64.8
Denominator (in thousands):
Weighted-average common shares outstanding, shares for basic earnings per share	33,825			33,786			33,817			33,772
Weighted-average awards outstanding(b)	—			3			—			3
Shares for diluted earnings per share	33,825			33,789			33,817			33,775
Net earnings per common share, basic	$	0.94		$	0.27		$	1.38		$	1.92
Net earnings per common share, diluted	$	0.94		$	0.27		$	1.38		$	1.92

(a) Weighted participating securities include RSUs and PSUs that receive non-forfeitable dividends and consist of 169,000 and 165,000 weighted participating securities for the three and nine months ended September 30, 2017, respectively, and 148,000 weighted participating securities for both the three and nine months ended September 30, 2016.

(b) For the calculation of diluted earnings per share, the Company uses the more dilutive of either the treasury stock method or the two-class method to determine the weighted-average number of outstanding common shares. In addition, the Company had 695,000 and 637,000 weighted-average equity awards outstanding for the three and nine months ended September 30, 2017, respectively, and 547,000 and 509,000 weighted-average equity awards outstanding for the three and nine months ended September 30, 2016, respectively, which were anti-dilutive and therefore not included in the diluted earnings per share calculation.

XML

Accounting Policies and Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Basis of Consolidation

CMI is a holding company with no significant operations other than those of its wholly-owned subsidiaries. The consolidated financial statements include the accounts of CMI and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Equity Method Investments

The Company uses the equity method of accounting for equity securities when it has significant influence or when it has more than a minor ownership interest or more than minor influence over an investee’s operations but does not have a controlling financial interest. Initial investments are recorded at cost (including certain transaction costs) and are adjusted by the Company’s share of the investees’ undistributed earnings and losses.

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2016, as filed with the Securities and Exchange Commission in its Annual Report on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments considered necessary for a fair presentation, have been included.

Recent Accounting Pronouncements

In January 2017, the Financial Accounting Standards Board (the “FASB”) issued guidance to simplify the accounting for goodwill impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance will remain largely unchanged. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for annual and interim goodwill impairment testing dates after January 1, 2017. The Company plans to early adopt the guidance for its 2017 impairment testing.

In August 2016, the FASB issued guidance to clarify how certain cash receipts and payments should be presented and classified in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements.

In June 2016, the FASB issued guidance for estimating credit losses on certain types of financial instruments, including trade receivables, by introducing an approach based on expected losses. The expected loss approach will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, requires a modified retrospective transition method and early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements.

In March 2016, the FASB issued guidance to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company adopted this guidance in the first quarter of 2017 on a prospective basis, and prior periods have not been adjusted. The Company elected the option available under the new guidance to continue to estimate the effect of forfeitures in the calculation of share-based payment expense. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In February 2016, the FASB issued guidance which requires lessees to recognize on their balance sheet a right-of-use asset which represents a lessee’s right to use the underlying asset. Under this guidance, an entity must also recognize a lease liability which represents a lessee’s obligation to make lease payments for the right to use the asset. In addition, the standard requires expanded qualitative and quantitative disclosures. The guidance is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and requires a modified retrospective transition method. The Company is currently evaluating the impact of the adoption of this guidance on its consolidated financial statements.

In July 2015, the FASB issued guidance that requires entities to measure inventory within the scope of the standard at the lower of cost or net realizable value. “Net realizable value” is defined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company adopted this guidance in the first quarter of 2017. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In May 2014, the FASB issued guidance to provide a single, comprehensive revenue recognition model for all contracts with customers. The new revenue recognition model supersedes existing revenue recognition guidance and requires revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration an entity expects to receive in exchange for those goods or services. The guidance is effective for fiscal years beginning after December 15, 2017, and interim periods within those years, and early adoption is permitted. The guidance permits the use of either a full or modified retrospective transition method. The Company plans to use the modified retrospective transition method. While the Company has not identified any material differences in the amount and timing of revenue recognition for the revenue streams management has reviewed to date, the Company is still evaluating the impact of this guidance and has not concluded on the overall impact of adopting this guidance. Adoption of this guidance will significantly impact the Company’s financial statement disclosures regarding revenue.

Derivative Financial Instruments

The Company is subject to various types of market risks, including interest rate risk, foreign currency exchange rate transaction and translation risk and commodity pricing risk. Management may take actions to mitigate the exposure to these types of risks, including entering into forward purchase contracts and other financial instruments. Currently, the Company manages a portion of its commodity pricing and foreign currency exchange rate risks by using derivative instruments. The Company does not seek to engage in trading activities or take speculative positions with any financial instrument arrangement. The Company has entered into natural gas derivative instruments and foreign currency derivative instruments with counterparties it views as creditworthy. However, the Company does attempt to mitigate its counterparty credit risk exposures by, among other things, entering into master netting agreements with some of these counterparties.The Company records derivative financial instruments as either assets or liabilities at fair value in the consolidated balance sheets.

Derivatives qualify for treatment as hedges when there is a high correlation between the change in fair value of the derivative instrument and the related change in value of the underlying hedged item. Depending on the exposure being hedged, the Company must designate the hedging instrument as a fair value hedge, a cash flow hedge or a net investment in foreign operations hedge. For the qualifying derivative instruments that have been designated as hedges, the effective portion of the change in fair value is recognized through earnings when the underlying transaction being hedged affects earnings, allowing a derivative’s gains and losses to offset related results from the hedged item in the statements of operations. Any ineffectiveness related to these hedges was not material for any of the periods presented. For derivative instruments that have not been designated as hedges, the entire change in fair value is recorded through earnings in the period of change.

Earnings per Share

The Company calculates earnings per share using the two-class method. The two-class method requires allocating the Company’s net earnings to both common shares and participating securities.

XML

Acquisition (Tables)

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Schedule of consideration transferred

A summary of the acquisition-date fair value of the consideration transferred is presented in the table below:

Fair Value of Consideration Transferred (in millions)	October 3, 2016
Cash paid at closing	$	317.1
Additional cash due at closing	20.6
Fair value of contingent consideration	31.4
Fair value of 35% equity investment	178.7
Total	$	547.8

Schedule of recognized amounts of identifiable assets acquired and liabilities assumed

Based upon the final purchase price and the updated valuation, the final purchase price allocation is presented in the table below:

Recognized amounts of identifiable assets acquired and liabilities assumed (in millions):	Purchase Price Allocation
Cash and cash equivalents	$	73.8
Accounts receivable	89.4
Inventory	77.1
Other current assets	13.7
Property, plant and equipment	189.4
Identified intangible assets	81.2
Investment in equity method investee	24.5
Other noncurrent assets	6.9
Accounts payable	(27.1		)
Accrued expenses	(40.3		)
Current portion of long-term debt	(129.6		)
Other current liabilities	(14.0		)
Long-term debt, net of current portion	(62.0		)
Deferred income taxes, net	(66.0		)
Other noncurrent liabilities	(21.9		)
Total identifiable net assets	195.1
Goodwill	352.7
Total fair value of business combination	$	547.8

Schedule of identifiable intangible assets acquired

The estimated fair values and weighted average amortization period of the identifiable intangible assets are presented in the table below:

	Estimated Fair Value (in millions)		Weighted-Average Amortization Period (in years)
Trade names	$	36.9	11.0
Developed technology	37.5		5.3
Customer relationships	6.8		13.5
Total identifiable intangible assets	$	81.2	8.6

Schedule of unaudited combined pro forma results of operations

The following table presents combined unaudited pro forma results for the three and nine months ended September 30, 2016. The pro forma financial information combines the historical results of operations for Produquímica and Compass Minerals as though the acquisition occurred on January 1, 2015. The pro forma information does not purport to represent the actual results of operations that Produquímica and Compass Minerals would have achieved had the companies been combined during the periods presented nor is the information intended to project the future results of operations. Certain adjustments to Produquímica’s historical results have been made to conform to U.S. GAAP and amounts have been translated to U.S. dollars.

Unaudited Combined Pro Forma Results of Operations (in millions)	Three Months Ended September 30, 2016		Nine Months Ended September 30, 2016
Revenues	$	289.7	$	938.1
Net earnings	18.5		68.7

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2017

Inventory Disclosure [Abstract]

Inventories

Inventories consist of the following (in millions):

	September 30, 2017		December 31, 2016
Finished goods	$	260.3	$	206.1
Raw materials and supplies	75.7		74.5
Total inventories	$	336.0	$	280.6

XML

Property, Plant and Equipment, Net (Tables)

9 Months Ended

Sep. 30, 2017

Property, Plant and Equipment [Abstract]

Property, plant and equipment

Property, plant and equipment, net, consists of the following (in millions):

	September 30, 2017			December 31, 2016
Land, buildings and structures, and leasehold improvements	$	507.6		$	480.1
Machinery and equipment	914.9			848.2
Office furniture and equipment	51.5			28.3
Mineral interests	173.1			168.5
Construction in progress	267.2			243.6
	1,914.3			1,768.7
Less accumulated depreciation and depletion	(774.3		)	(676.4		)
Property, plant and equipment, net	$	1,140.0		$	1,092.3

XML

Long-term Debt (Tables)

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Long-term debt

Long-term debt consists of the following (in millions):

	September 30, 2017			December 31, 2016
Term Loans due July 2021	$	839.5		$	845.9
Revolving Credit Facility due July 2021	151.2			105.4
4.875% Senior Notes due July 2024	250.0			250.0
Banco Bradesco Loan due February 2017	—			13.2
Banco Votorantim Loan due April 2017	—			12.4
Banco Bradesco Loan due July 2017	—			4.8
Scotiabank Loan due August 2017	—			20.2
Scotiabank Loan due September 2017	—			15.1
Banco Votorantim Loan due September 2017	—			0.8
Banco Bradesco Loan due October 2017	—			16.8
Rabobank Loan due November 2017	22.4			22.6
Banco Itaú Loans due May 2019 to April 2020	2.3			3.1
Financiadora de Estudos e Projetos Loan due November 2023	14.1			7.4
Banco do Brasil Loans due October 2017	0.4			—
Banco do Brasil Loan due November 2017	0.5			—
Banco do Brasil Loan due February 2018	0.2			—
Banco Santander Loan due September 2019	20.5			—
Banco Itaú Loans due March 2019(a)	15.0			15.1
Banco Scotiabank Loan due September 2019	20.6			—
	1,336.7			1,332.8
Less unamortized debt issuance costs	(7.1		)	(7.8		)
Total debt	1,329.6			1,325.0
Less current portion	(55.4		)	(130.2		)
Long-term debt	$	1,274.2		$	1,194.8

(a) In September 2017, the maturity date of this loan was extended from September 2017 to March 2019.

XML

Operating Segments (Tables)

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Segment information

Segment information is as follows (in millions):

Three Months Ended September 30, 2017	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	124.7	$	40.3	$	123.2	$	2.5		$	290.7
Intersegment sales	—		1.5		—		(1.5		)	—
Shipping and handling cost	34.9		4.8		5.8		—			45.5
Operating earnings (loss) (b)	22.5		2.3		21.4		(14.8		)	31.4
Depreciation, depletion and amortization	13.5		9.2		7.5		2.5			32.7
Total assets (as of end of period)	948.7		593.1		844.2		60.8			2,446.8

Three Months Ended September 30, 2016	Salt		Plant Nutrition North America(c)		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	135.7	$	41.5	$	—	$	2.4		$	179.6
Intersegment sales	—		0.6		—		(0.6		)	—
Shipping and handling cost	33.3		5.1		—		—			38.4
Operating earnings (loss)	30.0		2.5		—		(13.0		)	19.5
Depreciation, depletion and amortization	12.2		8.3		—		1.3			21.8
Total assets (as of end of period)	1,249.3		794.1		—		59.0			2,102.4

Nine Months Ended September 30, 2017	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	508.5	$	140.0	$	250.6	$	7.4		$	906.5
Intersegment sales	—		4.4		—		(4.4		)	—
Shipping and handling cost	147.6		18.4		13.8		—			179.8
Operating earnings (loss) (b)	78.6		17.5		24.0		(41.3		)	78.8
Depreciation, depletion and amortization	39.1		26.7		18.2		5.1			89.1

Nine Months Ended September 30, 2016	Salt		Plant Nutrition North America		Plant Nutrition South America		Corporate & Other(a)			Total
Sales to external customers	$	546.9	$	140.4	$	—	$	7.5		$	694.8
Intersegment sales	—		2.7		—		(2.7		)	—
Shipping and handling cost	147.7		17.2		—		—			164.9
Operating earnings (loss)	136.0		12.5		—		(39.2		)	109.3
Depreciation, depletion and amortization	34.2		24.6		—		3.9			62.7

(a) Corporate and other includes corporate entities, records management operations and other incidental operations and eliminations. Operating earnings (loss) for corporate and other includes indirect corporate overhead, including costs for general corporate governance and oversight, as well as costs for the human resources, information technology, legal and finance functions.

(b) Operating results for the three months ended September 30, 2017 include $4.3 million of restructuring charges.

(c) In 2016, total assets for Plant Nutrition North America include the equity investment in Produquímica.

XML

Stockholders' Equity and Equity Instruments (Tables)

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Stock options valuation assumptions

The inputs used to calculate fair value for options granted in 2017 are included in the table below:

Fair value of options granted	$9.54
Exercise price	$68.00
Expected term (years)	4.5
Expected volatility	23.2%
Dividend yield	3.5%
Risk-free rate of return	1.8%

Stock-based compensation activity

The following table summarizes stock-based compensation activity during the nine months ended September 30, 2017:

	Stock Options				RSUs				PSUs(a)
	Number		Weighted-average exercise price		Number		Weighted-average fair value		Number		Weighted-average fair value
Outstanding at December 31, 2016	442,755		$	80.07	63,780		$	80.25	89,011		$	89.43
Granted	227,351		68.00		34,635		68.00		58,878		73.08
Exercised(b)	(3,366	)	76.03		—		—		—		—
Released from restriction(b)	—		—		(15,806	)	84.77		(12,946	)	105.77
Cancelled/expired	(80,606	)	76.05		(9,906	)	71.54		(19,416	)	88.18
Outstanding at September 30, 2017	586,134		$	75.97	72,703		$	74.62	115,527		$	79.47

(a) Until they vest, PSUs are included in the table at the target level at their grant date and at that level represent one share of common stock per PSU. The final performance period for the 2014 PSU grant ended in 2016. The Company cancelled 6,900 PSUs in 2017 related to the 2014 PSU grant.

(b) Common stock issued for exercised options and for vested and earned RSUs and PSUs was issued from treasury stock.

Components of and changes in accumulated other comprehensive income

The components of and changes in accumulated other comprehensive income (loss) (“AOCI”) as of and for the three and nine months ended September 30, 2017, and 2016, are as follows (in millions):

Three Months Ended September 30, 2017(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.3	)	$	(3.5	)	$	(93.6	)	$	(97.4	)
Other comprehensive income (loss) before reclassifications(b)	(0.5		)	—			46.1			45.6
Amounts reclassified from accumulated other comprehensive loss	(0.2		)	—			—			(0.2		)
Net current period other comprehensive income (loss)	(0.7		)	—			46.1			45.4
Ending balance	$	(1.0	)	$	(3.5	)	$	(47.5	)	$	(52.0	)

Three Months Ended September 30, 2016(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(0.2	)	$	(3.6	)	$	(71.8	)	$	(75.6	)
Other comprehensive income (loss) before reclassifications(b)	(0.3		)	—			(3.9		)	(4.2		)
Amounts reclassified from accumulated other comprehensive loss	0.2			—			—			0.2
Net current period other comprehensive income (loss)	(0.1		)	—			(3.9		)	(4.0		)
Ending balance	$	(0.3	)	$	(3.6	)	$	(75.7	)	$	(79.6	)

Nine Months Ended September 30, 2017(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	0.6		$	(3.7	)	$	(101.8	)	$	(104.9	)
Other comprehensive income (loss) before reclassifications(b)	(1.4		)	—			54.3			52.9
Amounts reclassified from accumulated other comprehensive loss	(0.2		)	0.2			—			—
Net current period other comprehensive income (loss)	(1.6		)	0.2			54.3			52.9
Ending balance	$	(1.0	)	$	(3.5	)	$	(47.5	)	$	(52.0	)

Nine Months Ended September 30, 2016(a)	Gains and (Losses) on Cash Flow Hedges			Defined Benefit Pension			Foreign Currency			Total
Beginning balance	$	(1.6	)	$	(3.8	)	$	(102.9	)	$	(108.3	)
Other comprehensive income (loss) before reclassifications(b)	(0.1		)	—			27.2			27.1
Amounts reclassified from accumulated other comprehensive loss	1.4			0.2			—			1.6
Net current period other comprehensive income (loss)	1.3			0.2			27.2			28.7
Ending balance	$	(0.3	)	$	(3.6	)	$	(75.7	)	$	(79.6	)

(a) With the exception of the cumulative foreign currency translation adjustment, for which no tax effect is recorded, the changes in the components of accumulated other comprehensive income (loss) presented in the tables above are reflected net of applicable income taxes.

(b) The Company recorded foreign exchange (gains) losses of $(22.0) million and $(20.6) million in the three and nine months ended September 30, 2017, respectively, and $3.8 million and $(22.9) million in the three and nine months ended September 30, 2016, respectively, in accumulated other comprehensive loss related to intercompany notes which were deemed to be of long-term investment nature.

Reclassifications out of accumulated other comprehensive income

The amounts reclassified from AOCI to (income) expense for the three and nine months ended September 30, 2017, and 2016, are shown below (in millions):

	Amount Reclassified from AOCI
	Three Months Ended September 30, 2017			Nine Months Ended September 30, 2017			Line Item Impacted in the Consolidated Statement of Operations
Gains and (losses) on cash flow hedges:
Natural gas instruments	$	0.2		$	0.2		Product cost
Foreign currency swaps	(0.5		)	(0.5		)	Interest expense
Income tax expense (benefit)	0.1			0.1
Reclassifications, net of income taxes	(0.2		)	(0.2		)
Amortization of defined benefit pension:
Amortization of loss	$	—		$	0.2		Product cost
Income tax expense (benefit)	—			—
Reclassifications, net of income taxes	—			0.2
Total reclassifications, net of income taxes	$	(0.2	)	$	—

	Amount Reclassified from AOCI
	Three Months Ended September 30, 2016			Nine Months Ended September 30, 2016			Line Item Impacted in the Consolidated Statement of Operations
Gains and (losses) on cash flow hedges:
Natural gas instruments	$	0.3		$	2.2		Product cost
Income tax expense (benefit)	(0.1		)	(0.8		)
Reclassifications, net of income taxes	0.2			1.4
Amortization of defined benefit pension:
Amortization of loss	$	—		$	0.2		Product cost
Income tax expense (benefit)	—			—
Reclassifications, net of income taxes	—			0.2
Total reclassifications, net of income taxes	$	0.2		$	1.6

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair value of hedged items

The following tables present the fair value of the Company’s hedged items as of September 30, 2017, and December 31, 2016 (in millions):

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Balance Sheet Location	September 30, 2017		Balance Sheet Location	September 30, 2017
Commodity contracts	Other current assets	$	0.1	Accrued expenses	$	0.7
Commodity contracts	Other assets	—		Other noncurrent liabilities	0.2
Swap contracts	Other current assets	—		Accrued expenses	0.1
Swap contracts	Other assets	—		Other noncurrent liabilities	0.1
Total derivatives designated as hedging instruments(a)		0.1			1.1
Derivatives not designated as hedging instruments:
Swap contracts	Other current assets	$	—	Accrued expenses	$	7.0
Swap contracts	Other assets	—		Other noncurrent liabilities	—
Total derivatives not designated as hedging instruments		—			7.0
Total derivatives(b)		$	0.1		$	8.1

(a) The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its consolidated balance sheets approximately $0.1 million of its commodity contracts that are in receivable positions against its contracts in payable positions.

(b) The Company has commodity hedge and foreign currency swap agreements with three counterparties each, respectively. Amounts recorded as assets for the Company’s commodity contracts are receivable from three counterparties, and the amounts recorded as liabilities for the Company’s commodity contracts are payable to two counterparties. The amounts recorded as liabilities for the Company’s swap contracts are payable to two counterparties. There is also an immaterial amount receivable from one counterparty.

	Asset Derivatives			Liability Derivatives
Derivatives designated as hedging instruments:	Balance Sheet Location	December 31, 2016		Balance Sheet Location	December 31, 2016
Commodity contracts	Other current assets	$	1.2	Accrued expenses	$	0.3
Commodity contracts	Other assets	0.1		Other noncurrent liabilities	0.1
Total derivatives designated as hedging instruments(a)		1.3			0.4
Derivatives not designated as hedging instruments:
Swap contracts	Other current assets	$	—	Accrued expenses	$	25.8
Swap contracts	Other assets	—		Other noncurrent liabilities	—
Total derivatives not designated as hedging instruments		—			25.8
Total derivatives(b)		$	1.3		$	26.2

(a) The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its consolidated balance sheets approximately $0.4 million of its commodity contracts that are in a payable position against its contracts in receivable positions.

(b) The Company has commodity hedge and foreign currency swap agreements with two and five counterparties, respectively. Amounts recorded as assets for the Company’s commodity contracts are receivable from both counterparties, and amounts recorded as liabilities for the Company’s swap contracts are payable to all five counterparties. 

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Fair value measurements

The estimated fair values for each type of instrument are presented below (in millions):

	September 30, 2017			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified retirement plan(a)	$	2.1		$	2.1		$	—		$	—
Total Assets	$	2.1		$	2.1		$	—		$	—
Liability Class:
Liabilities related to non-qualified retirement plan	$	(2.1	)	$	(2.1	)	$	—		$	—
Derivatives – natural gas instruments, net	(0.8		)	—			(0.8		)	—
Derivatives – foreign currency swaps, net	(7.2		)	—			(7.2		)	—
Total Liabilities	$	(10.1	)	$	(2.1	)	$	(8.0	)	$	—

(a) Includes mutual fund investments of approximately 30% in common stock of large-cap U.S. companies, 15% in common stock of small to mid-cap U.S. companies, 5% in international companies, 10% in bond funds, 20% in short-term investments and 20% in blended funds.

	December 31, 2016			Level One			Level Two			Level Three
Asset Class:
Mutual fund investments in a non-qualified savings plan(a)	$	1.8		$	1.8		$	—		$	—
Derivatives – natural gas instruments, net	0.9			—			0.9			—
Trading securities	1.8			—			1.8			—
Total Assets	$	4.5		$	1.8		$	2.7		$	—
Liability Class:
Liabilities related to non-qualified savings plan	$	(1.8	)	$	(1.8	)	$	—		$	—
Derivatives – foreign currency swaps, net	(25.8		)	—			(25.8		)	—
Total Liabilities	$	(27.6	)	$	(1.8	)	$	(25.8	)	$	—

(a) Includes mutual fund investments of approximately 25% in the common stock of large-cap U.S. companies, 10% in the common stock of small to mid-cap U.S. companies, 5% in the common stock of international companies, 5% in bond funds, 40% in short-term investments and 15% in blended funds.

XML

Earnings per Share (Tables)

9 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Computation of basic and diluted earnings per common share

The following table sets forth the computation of basic and diluted earnings per common share (in millions, except for share and per-share data):

	Three months ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
Numerator:
Net earnings	$	32.0		$	9.1		$	47.1		$	65.1
Less: net earnings allocated to participating securities(a)	(0.2		)	(0.1		)	(0.3		)	(0.3		)
Net earnings available to common shareholders	$	31.8		$	9.0		$	46.8		$	64.8
Denominator (in thousands):
Weighted-average common shares outstanding, shares for basic earnings per share	33,825			33,786			33,817			33,772
Weighted-average awards outstanding(b)	—			3			—			3
Shares for diluted earnings per share	33,825			33,789			33,817			33,775
Net earnings per common share, basic	$	0.94		$	0.27		$	1.38		$	1.92
Net earnings per common share, diluted	$	0.94		$	0.27		$	1.38		$	1.92

(a) Weighted participating securities include RSUs and PSUs that receive non-forfeitable dividends and consist of 169,000 and 165,000 weighted participating securities for the three and nine months ended September 30, 2017, respectively, and 148,000 weighted participating securities for both the three and nine months ended September 30, 2016.

(b) For the calculation of diluted earnings per share, the Company uses the more dilutive of either the treasury stock method or the two-class method to determine the weighted-average number of outstanding common shares. In addition, the Company had 695,000 and 637,000 weighted-average equity awards outstanding for the three and nine months ended September 30, 2017, respectively, and 547,000 and 509,000 weighted-average equity awards outstanding for the three and nine months ended September 30, 2016, respectively, which were anti-dilutive and therefore not included in the diluted earnings per share calculation.

XML

Accounting Policies and Basis of Presentation - Additional Information (Details) - Business		1 Months Ended
	Oct. 03, 2016	Oct. 31, 2016
Produquímica [Member]
Business Acquisition [Line Items]
Number of primary businesses	2	2

XML

Acquisition - Additional Information (Details) BRL in Millions				1 Months Ended	3 Months Ended					9 Months Ended
	Oct. 03, 2016 USD ($) Business	Dec. 23, 2015 BRL	Dec. 23, 2015 USD ($)	Oct. 31, 2016 Business	Sep. 30, 2017 USD ($)	Mar. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Sep. 30, 2016 USD ($)	Jun. 30, 2016 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Dec. 31, 2015 USD ($)
Business Acquisition [Line Items]
Aggregate purchase price										$ 0	$ 4,700,000
Gain on settlement of acquisition-related contingent consideration										1,900,000	0
Decrease in net earnings					$ (32,000,000)			$ (9,100,000)		(47,100,000)	(65,100,000)
Goodwill					421,600,000		$ 412,200,000			421,600,000
Plant Nutrition South America [Member]
Business Acquisition [Line Items]
Goodwill					358,100,000		352,800,000			358,100,000
New Tranche Term Loans Due July 2021 [Member] | Secured Debt [Member]
Business Acquisition [Line Items]
Face amount								$ 450,000,000			$ 450,000,000
Produquímica [Member]
Business Acquisition [Line Items]
Interest acquired	65.00%
Fair value of contingent consideration	$ 31,400,000
Percentage of equity interest prior to acquisition	35.00%
Fair value of equity interest prior to acquisition	$ 178,700,000
Gain from remeasurement of equity method investment							$ 59,300,000
Decrease in goodwill										3,600,000
Decrease in other noncurrent liabilities										4,400,000
Increase to net deferred income taxes										800,000
Goodwill	352,700,000
Accounts receivable contractual amount in excess of fair value	8,000,000
Revenue					123,200,000					250,600,000
Net earnings					29,500,000					$ 20,700,000
Produquímica [Member] | Increase in Depreciation Expense [Member]
Business Acquisition [Line Items]
Decrease in net earnings					$ 1,900,000
Produquímica [Member] | Plant Nutrition South America [Member]
Business Acquisition [Line Items]
Gain on settlement of acquisition-related contingent consideration						$ 1,900,000
Goodwill	$ 352,700,000
Produquímica [Member]
Business Acquisition [Line Items]
Ownership interest in investment		35.00%	35.00%
Aggregate purchase price		BRL 452.4	$ 114,100,000						$ 4,700,000
Number of primary businesses | Business	2			2
Produquímica [Member] | Term Loan due May 2017 [Member] | Term Loan [Member]
Business Acquisition [Line Items]
Face amount												$ 100,000,000.0

XML

Acquisition - Fair Value of Consideration Transferred (Details) - Produquímica [Member] $ in Millions	Oct. 03, 2016 USD ($)
Business Acquisition [Line Items]
Cash paid at closing	$ 317.1
Additional cash due at closing	20.6
Fair value of contingent consideration	31.4
Fair value of 35% equity investment	178.7
Total	$ 547.8
Equity method investment ownership interest	35.00%

XML

Acquisition - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016	Oct. 03, 2016
Business Acquisition [Line Items]
Goodwill	$ 421.6	$ 412.2
Produquímica [Member]
Business Acquisition [Line Items]
Cash and cash equivalents			$ 73.8
Accounts receivable			89.4
Inventory			77.1
Other current assets			13.7
Property, plant and equipment			189.4
Identified intangible assets			81.2
Investment in equity method investee			24.5
Other noncurrent assets			6.9
Accounts payable			(27.1)
Accrued expenses			(40.3)
Current portion of long-term debt			(129.6)
Other current liabilities			(14.0)
Long-term debt, net of current portion			(62.0)
Deferred income taxes, net			(66.0)
Other noncurrent liabilities			(21.9)
Total identifiable net assets			195.1
Goodwill			352.7
Total fair value of business combination			$ 547.8

XML

Acquisition - Identifiable Intangible Assets Acquired (Details) - Produquímica [Member] $ in Millions	Oct. 03, 2016 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Fair Value (in millions)	$ 81.2
Weighted-Average Amortization Period (in years)	8 years 7 months 6 days
Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Fair Value (in millions)	$ 36.9
Weighted-Average Amortization Period (in years)	11 years
Developed Technology [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Fair Value (in millions)	$ 37.5
Weighted-Average Amortization Period (in years)	5 years 3 months 18 days
Customer Relationships [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Fair Value (in millions)	$ 6.8
Weighted-Average Amortization Period (in years)	13 years 6 months

XML

Acquisition - Unaudited Combined Pro Forma Results of Operations (Details) - Produquímica [Member] - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2016
Business Acquisition [Line Items]
Revenues	$ 289.7	$ 938.1
Net earnings	$ 18.5	$ 68.7

XML

Inventories (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Inventory Disclosure [Abstract]
Finished goods	$ 260.3	$ 206.1
Raw materials and supplies	75.7	74.5
Total inventories	$ 336.0	$ 280.6

XML

Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 1,914.3	$ 1,768.7
Less accumulated depreciation and depletion	(774.3)	(676.4)
Property, plant and equipment, net	1,140.0	1,092.3
Land, Buildings and Structures, and Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	507.6	480.1
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	914.9	848.2
Office Furniture and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	51.5	28.3
Mineral Interests [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	173.1	168.5
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 267.2	$ 243.6

XML

Goodwill and Intangible Assets, Net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 4.1	$ 1.1	$ 12.2	$ 3.2
Goodwill [Line Items]
Goodwill	421.6		421.6		$ 412.2
Plant Nutrition, North America [Member]
Goodwill [Line Items]
Goodwill	57.5		57.5		53.6
Plant Nutrition South America [Member]
Goodwill [Line Items]
Goodwill	$ 358.1		$ 358.1		$ 352.8

XML

Income Taxes (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2016
Operating Loss Carryforwards [Line Items]
Reduction of valuation allowance	$ 12.0
Discrete income tax benefit	13.0
Foreign Federal [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	52.0		$ 53.6
Foreign Federal 2033 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 10.8		7.5
Expiration date (beginning in 2033)	Dec. 31, 2033
State [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 1.3		$ 0.9
Expiration date (beginning in 2033)	Dec. 31, 2033
Canadian Provincial [Member]
Income Tax Examination [Line Items]
Total reassessments including interest	$ 104.4
Amount of security posted in the form of a performance bond	63.6
Amount of security posted in the form of cash	35.2
Amount of security payable	$ 5.6
Canadian Provincial [Member] | Minimum [Member]
Income Tax Examination [Line Items]
Years under examination	2002
Canadian Provincial [Member] | Maximum [Member]
Income Tax Examination [Line Items]
Years under examination	2012
Canadian Federal and Provincial [Member] | Tax Year 2004 Through 2006 [Member]
Income Tax Examination [Line Items]
Total reassessment amount including penalty and interest	$ 94.7
Canadian Federal and Provincial [Member] | Tax Year 2007 Through 2008 [Member]
Income Tax Examination [Line Items]
Amount of security posted in the form of a performance bond	10.2
Total reassessment amount including penalty and interest	37.2
Amount of security in the form of a bank letter guarantee	$ 8.0
Canadian Federal and Provincial [Member] | Minimum [Member] | Tax Year 2004 Through 2006 [Member]
Income Tax Examination [Line Items]
Years under examination	2004
Canadian Federal and Provincial [Member] | Minimum [Member] | Tax Year 2007 Through 2008 [Member]
Income Tax Examination [Line Items]
Years under examination	2007
Canadian Federal and Provincial [Member] | Maximum [Member] | Tax Year 2004 Through 2006 [Member]
Income Tax Examination [Line Items]
Years under examination	2006
Canadian Federal and Provincial [Member] | Maximum [Member] | Tax Year 2007 Through 2008 [Member]
Income Tax Examination [Line Items]
Years under examination	2008
Scenario, Forecast [Member]
Operating Loss Carryforwards [Line Items]
Reduction of valuation allowance		$ 25.0

XML

Long-term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Long-term debt, gross	$ 1,336.7	$ 1,332.8
Less unamortized debt issuance costs	(7.1)	(7.8)
Total debt	1,329.6	1,325.0
Less current portion	(55.4)	(130.2)
Long-term debt	1,274.2	1,194.8
Banco Bradesco Due February 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.0	13.2
Banco Votorantim Due April 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.0	12.4
Banco Bradesco Due July 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.0	4.8
Scotiabank Due August 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.0	20.2
Scotiabank Due September 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.0	15.1
Banco Votorantim Due September 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.0	0.8
Banco Bradesco Due October 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.0	16.8
Rabobank Due November 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	22.4	22.6
Banco Itau Due May 2019 To April 2020 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	2.3	3.1
Financiadora de Estudos e Projetos Due November 2023 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	14.1	7.4
Banco Do Brasil Due October 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.4	0.0
Banco Do Brasil Due November 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.5	0.0
Banco Do Brazil due February 2018 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	0.2	0.0
Banco Santander Due September 2019 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	20.5	0.0
Banco Itau Loan due March 2019 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	15.0	15.1
Banco Scoitabank Due September 2019 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	20.6	0.0
Revolving Credit Facility [Member] | Revolving Credit Facility Due July 2021 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	151.2	105.4
Secured Debt [Member] | Term Loans Due July 2021 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	839.5	845.9
Senior Notes [Member] | 4.875% Senior Notes due July 2024 [Member]
Debt Instrument [Line Items]
Long-term debt, gross	$ 250.0	$ 250.0
Interest rate stated percentage	4.875%

XML

Long-term Debt - Additional Information (Details) - USD ($)	1 Months Ended			9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Apr. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Oct. 03, 2016
Debt Instrument [Line Items]
Refinancing expense				$ 100,000	$ 1,500,000
Issuance costs recorded as expense				1,700,000	1,000,000
Proceeds from issuance of long-term debt				52,900,000	850,000,000
Write-off of existing deferred financing costs			$ 100,000
Produquímica [Member]
Debt Instrument [Line Items]
Interest acquired						65.00%
Credit Agreement Amendment [Member]
Debt Instrument [Line Items]
Refinancing expense	$ 600,000
Issuance costs recorded as expense	100,000
Capitalized deferred financing costs	500,000			$ 500,000
Brazilian Loans [Member] | Secured Debt [Member]
Debt Instrument [Line Items]
Debt refinanced	$ 32,100,000
Brazilian Loans Due March 2019 And September 2019 [Member] | Minimum [Member] | Certificado De Deposito Interbancario (CDI) [Member]
Debt Instrument [Line Items]
Variable rate, percentage of reference rate	116.25%			116.25%
Brazilian Loans Due March 2019 And September 2019 [Member] | Maximum [Member] | Certificado De Deposito Interbancario (CDI) [Member]
Debt Instrument [Line Items]
Variable rate, percentage of reference rate	118.00%			118.00%
Brazilian Loans Due March 2019 And September 2019 [Member] | Secured Debt [Member]
Debt Instrument [Line Items]
Proceeds from issuance of long-term debt	$ 41,100,000
New Tranche Term Loans Due July 2021 [Member]
Debt Instrument [Line Items]
Refinancing expense		$ 2,200,000
Issuance costs recorded as expense		700,000
Capitalized deferred financing costs		$ 1,500,000			1,500,000
New Tranche Term Loans Due July 2021 [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Variable interest rate		2.00%
New Tranche Term Loans Due July 2021 [Member] | Secured Debt [Member]
Debt Instrument [Line Items]
Face amount		$ 450,000,000			$ 450,000,000
Term Loans due May 2017 [Member] | Secured Debt [Member]
Debt Instrument [Line Items]
Debt refinanced			471,000,000
Revolving Credit Facility due August 2017 [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Debt refinanced			125,000,000
Secured Credit Agreement Due July 2021 [Member]
Debt Instrument [Line Items]
Refinancing expense			5,800,000
Issuance costs recorded as expense			1,400,000
Capitalized deferred financing costs			4,400,000
Secured Credit Agreement Due July 2021 [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Face amount			$ 300,000,000
Secured Credit Agreement Due July 2021 [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Variable interest rate			1.75%
Secured Credit Agreement Due July 2021 [Member] | Secured Debt [Member]
Debt Instrument [Line Items]
Face amount			$ 400,000,000

XML

Commitments and Contingencies (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2017	Sep. 30, 2017	Dec. 31, 2016
Loss Contingencies [Line Items]
Maximum exposure for other labor matters		$ 46.0
Produquímica [Member]
Loss Contingencies [Line Items]
Contingent liabilities assumed		11.5
Cote Blanche [Member]
Loss Contingencies [Line Items]
Reserve for expected payments required to resolve the dispute			$ 7.4
Settlement amount	$ 7.7
Loss on settlement		0.0
Brazilian Tax Litigation And Assessments [Member]
Loss Contingencies [Line Items]
Reserve for expected payments required to resolve the dispute		$ 18.7

XML

Operating Segments (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) Business segment	Sep. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment			3
Segment Reporting Information [Abstract]
Sales	$ 290.7	$ 179.6	$ 906.5	$ 694.8
Shipping and handling cost	45.5	38.4	179.8	164.9
Operating earnings (loss)	31.4	19.5	78.8	109.3
Depreciation, depletion and amortization	32.7	21.8	89.1	62.7
Total assets (as of end of period)	2,446.8	2,102.4	2,446.8	2,102.4	$ 2,466.5
Restructuring charges	4.3
Operating Segments [Member] | Salt [Member]
Segment Reporting Information [Abstract]
Sales	124.7	135.7	508.5	546.9
Shipping and handling cost	34.9	33.3	147.6	147.7
Operating earnings (loss)	22.5	30.0	78.6	136.0
Depreciation, depletion and amortization	13.5	12.2	39.1	34.2
Total assets (as of end of period)	948.7	1,249.3	948.7	1,249.3
Operating Segments [Member] | Plant Nutrition, North America [Member]
Segment Reporting Information [Abstract]
Sales	40.3	41.5	140.0	140.4
Shipping and handling cost	4.8	5.1	18.4	17.2
Operating earnings (loss)	2.3	2.5	17.5	12.5
Depreciation, depletion and amortization	9.2	8.3	26.7	24.6
Total assets (as of end of period)	593.1	794.1	$ 593.1	794.1
Operating Segments [Member] | Plant Nutrition South America [Member]
Segment Reporting Information [Line Items]
Number of primary businesses | Business			2
Segment Reporting Information [Abstract]
Sales	123.2	0.0	$ 250.6	0.0
Shipping and handling cost	5.8	0.0	13.8	0.0
Operating earnings (loss)	21.4	0.0	24.0	0.0
Depreciation, depletion and amortization	7.5	0.0	18.2	0.0
Total assets (as of end of period)	844.2	0.0	844.2	0.0
Corporate and Other [Member]
Segment Reporting Information [Abstract]
Sales	2.5	2.4	7.4	7.5
Shipping and handling cost	0.0	0.0	0.0	0.0
Operating earnings (loss)	(14.8)	(13.0)	(41.3)	(39.2)
Depreciation, depletion and amortization	2.5	1.3	5.1	3.9
Total assets (as of end of period)	60.8	59.0	60.8	59.0
Intersegment Sales [Member]
Segment Reporting Information [Abstract]
Sales	(1.5)	(0.6)	(4.4)	(2.7)
Intersegment Sales [Member] | Salt [Member]
Segment Reporting Information [Abstract]
Sales	0.0	0.0	0.0	0.0
Intersegment Sales [Member] | Plant Nutrition, North America [Member]
Segment Reporting Information [Abstract]
Sales	1.5	0.6	4.4	2.7
Intersegment Sales [Member] | Plant Nutrition South America [Member]
Segment Reporting Information [Abstract]
Sales	$ 0.0	$ 0.0	$ 0.0	$ 0.0

XML

Stockholders' Equity and Equity Instruments - Plan Information (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	May 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reissued shares of treasury stock (in shares)	5,424
Tax deficiency from equity compensation awards recorded as an increase to income tax expense	$ 0.6
Compensation expense recorded during period pursuant to stock-based compensation plans	$ 3.8	$ 3.8
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years
Options expiration period	7 years
Number of shares available from conversion (in shares)	1
Fair value measurement method	Black-Scholes option valuation model
Reissued shares of treasury stock (in shares)	3,366
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Number of shares available from conversion (in shares)	1
Service period	3 years
Reissued shares of treasury stock (in shares)	15,806
TSR PSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value measurement method	Monte-Carlo simulation model
Performance period of PSUs	3 years
TSR PSUs [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares earned (in hundredths)	0.00%
TSR PSUs [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares earned (in hundredths)	150.00%
ROIC PSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period of PSUs	3 years
ROIC PSUs [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares earned (in hundredths)	0.00%
ROIC PSUs [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares earned (in hundredths)	200.00%
PSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reissued shares of treasury stock (in shares)	12,946
2015 Incentive Award Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for issuance (in shares)			3,000,000

XML

Stockholders' Equity and Equity Instruments - Summary of Fair Value Assumptions and Methodology (Details) - Stock Options [Member]	9 Months Ended
	Sep. 30, 2017 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of options granted (in dollars per share)	$ 9.54
Exercise price (in dollars per share)	$ 68.00
Expected term (years)	4 years 6 months
Expected volatility	23.20%
Dividend yield	3.50%
Risk-free rate of return	1.80%

XML

Stockholders' Equity and Equity Instruments - Activity (Details)	9 Months Ended
	Sep. 30, 2017 $ / shares shares
Stock Options [Member]
Number
Outstanding at beginning of period (in shares)	442,755
Granted (in shares)	227,351
Exercised (in shares)	(3,366)
Cancelled/Expired (in shares)	(80,606)
Outstanding at end of period (in shares)	586,134
Weighted-average exercise price
Weighted-average exercise price at beginning of period (in dollars per share) | $ / shares	$ 80.07
Weighted-average exercise price, Granted (in dollars per share) | $ / shares	68.00
Weighted-average exercise price, Exercised (in dollars per share) | $ / shares	76.03
Weighted-average exercise price, Cancelled/Expired (in dollars per share) | $ / shares	76.05
Weighted-average exercise price at end of period (in dollars per share) | $ / shares	$ 75.97
RSUs [Member]
Number
Outstanding at beginning of period (in shares)	63,780
Granted (in shares)	34,635
Released from restriction (in shares)	(15,806)
Cancelled/Expired (in shares)	(9,906)
Outstanding at end of period (in shares)	72,703
Weighted-average fair value
Weighted-average fair value at beginning of period (in dollars per share) | $ / shares	$ 80.25
Weighted-average fair value, Granted (in dollars per share) | $ / shares	68.00
Weighted-average fair value, Released from restriction (in dollars per share) | $ / shares	84.77
Weighted-average fair value, Cancelled/Expired (in dollars per share) | $ / shares	71.54
Weighted-average fair value at end of period (in dollars per share) | $ / shares	$ 74.62
PSUs [Member]
Number
Outstanding at beginning of period (in shares)	89,011
Granted (in shares)	58,878
Released from restriction (in shares)	(12,946)
Cancelled/Expired (in shares)	(19,416)
Outstanding at end of period (in shares)	115,527
Weighted-average fair value
Weighted-average fair value at beginning of period (in dollars per share) | $ / shares	$ 89.43
Weighted-average fair value, Granted (in dollars per share) | $ / shares	73.08
Weighted-average fair value, Released from restriction (in dollars per share) | $ / shares	105.77
Weighted-average fair value, Cancelled/Expired (in dollars per share) | $ / shares	88.18
Weighted-average fair value at end of period (in dollars per share) | $ / shares	$ 79.47
PSU at grant date (in shares per unit)	1
PSUs [Member] | 2014 Grant [Member]
Number
Cancelled/Expired (in shares)	(6,900)

XML

Stockholders' Equity and Equity Instruments - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance			$ 717.1
Ending balance	$ 748.0		748.0
Losses (gains) on foreign exchange of intercompany notes of long-term nature	(22.0)	$ 3.8	(20.6)	$ (22.9)
Gains and (Losses) on Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(0.3)	(0.2)	0.6	(1.6)
Other comprehensive income (loss) before reclassifications	(0.5)	(0.3)	(1.4)	(0.1)
Amounts reclassified from accumulated other comprehensive loss	(0.2)	0.2	(0.2)	1.4
Net current period other comprehensive income (loss)	(0.7)	(0.1)	(1.6)	1.3
Ending balance	(1.0)	(0.3)	(1.0)	(0.3)
Defined Benefit Pension [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(3.5)	(3.6)	(3.7)	(3.8)
Other comprehensive income (loss) before reclassifications	0.0	0.0	0.0	0.0
Amounts reclassified from accumulated other comprehensive loss	0.0	0.0	0.2	0.2
Net current period other comprehensive income (loss)	0.0	0.0	0.2	0.2
Ending balance	(3.5)	(3.6)	(3.5)	(3.6)
Foreign Currency [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(93.6)	(71.8)	(101.8)	(102.9)
Other comprehensive income (loss) before reclassifications	46.1	(3.9)	54.3	27.2
Amounts reclassified from accumulated other comprehensive loss	0.0	0.0	0.0	0.0
Net current period other comprehensive income (loss)	46.1	(3.9)	54.3	27.2
Ending balance	(47.5)	(75.7)	(47.5)	(75.7)
Total [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(97.4)	(75.6)	(104.9)	(108.3)
Other comprehensive income (loss) before reclassifications	45.6	(4.2)	52.9	27.1
Amounts reclassified from accumulated other comprehensive loss	(0.2)	0.2	0.0	1.6
Net current period other comprehensive income (loss)	45.4	(4.0)	52.9	28.7
Ending balance	$ (52.0)	$ (79.6)	$ (52.0)	$ (79.6)

XML

Stockholders' Equity and Equity Instruments - Amount Reclassified from AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product cost	$ 169.1	$ 96.0	$ 524.1	$ 340.8
Interest expense	(13.5)	(5.4)	(39.5)	(16.8)
Income tax expense (benefit)	(12.5)	3.1	(7.7)	24.1
Gains and (losses) from cash flow hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications, net of income taxes	0.2	(0.2)	0.2	(1.4)
Amortization of defined benefit pension [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications, net of income taxes	0.0	0.0	(0.2)	(0.2)
Reclassifications, net of income taxes [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications, net of income taxes	(0.2)	0.2	0.0	1.6
Reclassifications, net of income taxes [Member] | Gains and (losses) from cash flow hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product cost	0.2	0.3	0.2	2.2
Interest expense	(0.5)		(0.5)
Income tax expense (benefit)	0.1	(0.1)	0.1	(0.8)
Total reclassifications, net of income taxes	(0.2)	0.2	(0.2)	1.4
Reclassifications, net of income taxes [Member] | Amortization of defined benefit pension [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Product cost	0.0	0.0	0.2	0.2
Income tax expense (benefit)	0.0	0.0	0.0	0.0
Total reclassifications, net of income taxes	$ 0.0	$ 0.0	$ 0.2	$ 0.2

XML

Derivative Financial Instruments - Additional Information (Details) MMBTU in Millions, $ in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2017 USD ($)	Sep. 30, 2017 USD ($) MMBTU	Dec. 31, 2016 USD ($) MMBTU
Commodity Contracts [Member]
Derivatives, Fair Value [Line Items]
Notional amount (in MMBtus) | MMBTU		3.3	2.3
Net losses to be reclassified from accumulated other comprehensive loss to earnings during the next 12 months		$ 0.6
Commodity Contracts [Member] | Derivatives Designated as Hedging Instruments [Member]
Derivatives, Fair Value [Line Items]
Underlying risk		change in natural gas prices
Percent of forecasted usage to be hedged (up to 90%)	90.00%	90.00%
Maximum period which the Company hedges in advance of forecasted purchase		36 months
Swap Contracts [Member]
Derivatives, Fair Value [Line Items]
Gain (loss) on changes in fair value of derivative instruments	$ (4.9)	$ (10.2)
Swap Contracts [Member] | Derivatives Designated as Hedging Instruments [Member]
Derivatives, Fair Value [Line Items]
Underlying risk		foreign currency fluctuation risk
Notional amount	35.6	$ 35.6
Gain (loss) expected to be reclassified during the next twelve months	(0.1)	$ (0.1)
Swap Contracts [Member] | Derivatives Not Designated as Hedging Instruments [Member]
Derivatives, Fair Value [Line Items]
Underlying risk		foreign currency fluctuation risk
Notional amount	$ 22.4	$ 22.4	$ 119.6

XML

Derivative Financial Instruments - Fair Value of Hedged Items (Details) $ in Millions	Sep. 30, 2017 USD ($) counterparty	Dec. 31, 2016 USD ($) counterparty
Derivatives, Fair Value [Line Items]
Asset Derivatives	$ 0.1	$ 1.3
Liability Derivatives	8.1	26.2
Commodity Contracts [Member]
Derivatives, Fair Value [Line Items]
Netting of contracts in a receivable position against contracts in payable positions	$ 0.1
Netting of contracts in a payable position against contracts in receivable positions		$ 0.4
Number of counterparties | counterparty	3	2
Number of counterparties for amounts recorded as assets | counterparty	3
Number of counterparties for amounts recorded as liabilities | counterparty	2
Swap Contracts [Member]
Derivatives, Fair Value [Line Items]
Number of counterparties | counterparty	3	5
Number of counterparties for amounts recorded as assets | counterparty	1
Number of counterparties for amounts recorded as liabilities | counterparty	2	5
Derivatives Designated as Hedging Instruments [Member]
Derivatives, Fair Value [Line Items]
Asset Derivatives	$ 0.1	$ 1.3
Liability Derivatives	1.1	0.4
Derivatives Designated as Hedging Instruments [Member] | Commodity Contracts [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Asset Derivatives	0.1	1.2
Derivatives Designated as Hedging Instruments [Member] | Commodity Contracts [Member] | Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Liability Derivatives	0.7	0.3
Derivatives Designated as Hedging Instruments [Member] | Commodity Contracts [Member] | Other Assets [Member]
Derivatives, Fair Value [Line Items]
Asset Derivatives	0.0	0.1
Derivatives Designated as Hedging Instruments [Member] | Commodity Contracts [Member] | Other Noncurrent Liabilities [Member]
Derivatives, Fair Value [Line Items]
Liability Derivatives	0.2	0.1
Derivatives Designated as Hedging Instruments [Member] | Swap Contracts [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Asset Derivatives	0.0
Derivatives Designated as Hedging Instruments [Member] | Swap Contracts [Member] | Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Liability Derivatives	0.1
Derivatives Designated as Hedging Instruments [Member] | Swap Contracts [Member] | Other Assets [Member]
Derivatives, Fair Value [Line Items]
Asset Derivatives	0.0
Derivatives Designated as Hedging Instruments [Member] | Swap Contracts [Member] | Other Noncurrent Liabilities [Member]
Derivatives, Fair Value [Line Items]
Liability Derivatives	0.1
Derivatives Not Designated as Hedging Instruments [Member]
Derivatives, Fair Value [Line Items]
Asset Derivatives	0.0	0.0
Liability Derivatives	7.0	25.8
Derivatives Not Designated as Hedging Instruments [Member] | Swap Contracts [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Asset Derivatives	0.0	0.0
Derivatives Not Designated as Hedging Instruments [Member] | Swap Contracts [Member] | Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Liability Derivatives	7.0	25.8
Derivatives Not Designated as Hedging Instruments [Member] | Swap Contracts [Member] | Other Assets [Member]
Derivatives, Fair Value [Line Items]
Asset Derivatives	0.0	0.0
Derivatives Not Designated as Hedging Instruments [Member] | Swap Contracts [Member] | Other Noncurrent Liabilities [Member]
Derivatives, Fair Value [Line Items]
Liability Derivatives	$ 0.0	$ 0.0

XML

Fair Value Measurements (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Liability Class:
Mutual fund investments percentage of fund invested in common stock of large-cap U.S. (in hundredths)	30.00%	25.00%
Mutual fund investments percentage of fund invested in common stock of small cap to mid-cap (in hundredths)	15.00%	10.00%
Mutual fund investments percentage of fund invested in common stock of international companies (in hundredths)	5.00%	5.00%
Mutual fund investments percentage of fund invested in bond funds (in hundredths)	10.00%	5.00%
Mutual fund investments percentage of fund invested in short-term investments (in hundredths)	20.00%	40.00%
Mutual fund investments percentage of fund invested in blended funds (in hundredths)	20.00%	15.00%
Term loan [Member]
Debt Instrument [Line Items]
Aggregate principal amount due at maturity	$ 990,700,000
Fair value of credit agreement debt	974,700,000
Fair Value, Measurements, Recurring [Member]
Asset Class:
Mutual fund investments in a non-qualified retirement plan	2,100,000	$ 1,800,000
Derivatives – natural gas instruments, net		900,000
Trading securities		1,800,000
Total Assets	2,100,000	4,500,000
Liability Class:
Liabilities related to non-qualified retirement plan	(2,100,000)	(1,800,000)
Derivatives – natural gas instruments, net	(800,000)
Derivatives – foreign currency swaps, net	(7,200,000)	(25,800,000)
Total Liabilities	(10,100,000)	(27,600,000)
Fair Value, Measurements, Recurring [Member] | Level One [Member]
Asset Class:
Mutual fund investments in a non-qualified retirement plan	2,100,000	1,800,000
Derivatives – natural gas instruments, net		0
Trading securities		0
Total Assets	2,100,000	1,800,000
Liability Class:
Liabilities related to non-qualified retirement plan	(2,100,000)	(1,800,000)
Derivatives – natural gas instruments, net	0
Derivatives – foreign currency swaps, net	0	0
Total Liabilities	(2,100,000)	(1,800,000)
Fair Value, Measurements, Recurring [Member] | Level Two [Member]
Asset Class:
Mutual fund investments in a non-qualified retirement plan	0	0
Derivatives – natural gas instruments, net		900,000
Trading securities		1,800,000
Total Assets	0	2,700,000
Liability Class:
Liabilities related to non-qualified retirement plan	0	0
Derivatives – natural gas instruments, net	(800,000)
Derivatives – foreign currency swaps, net	(7,200,000)	(25,800,000)
Total Liabilities	(8,000,000)	(25,800,000)
Fair Value, Measurements, Recurring [Member] | Level Three [Member]
Asset Class:
Mutual fund investments in a non-qualified retirement plan	0	0
Derivatives – natural gas instruments, net		0
Trading securities		0
Total Assets	0	0
Liability Class:
Liabilities related to non-qualified retirement plan	0	0
Derivatives – natural gas instruments, net	0
Derivatives – foreign currency swaps, net	0	0
Total Liabilities	$ 0	$ 0
4.875% Senior Notes [Member] | Senior Notes [Member]
Debt Instrument [Line Items]
Interest rate stated percentage	4.875%
Fair value of senior notes	$ 245,600,000
Aggregate principal amount due at maturity	$ 250,000,000.0

XML

Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Numerator:
Net earnings	$ 32.0	$ 9.1	$ 47.1	$ 65.1
Less: net earnings allocated to participating securities	(0.2)	(0.1)	(0.3)	(0.3)
Net earnings available to common shareholders	$ 31.8	$ 9.0	$ 46.8	$ 64.8
Denominator (in thousands):
Weighted-average common shares outstanding, shares for basic earnings per share (in shares)	33,825	33,786	33,817	33,772
Weighted-average awards outstanding (in shares)	0	3	0	3
Shares for diluted earnings per share (in shares)	33,825	33,789	33,817	33,775
Net earnings per common share, basic (in dollars per share)	$ 0.94	$ 0.27	$ 1.38	$ 1.92
Net earnings per common share, diluted (in dollars per share)	$ 0.94	$ 0.27	$ 1.38	$ 1.92
Participating securities (in shares)	169	148	165	148
Weighted anti-dilutive awards outstanding (in shares)	695	547	637	509